Long-term costs and effects of psychotherapy in personality disorders by Horn, E.K. (Eva)
Long-term
 Costs and Eff
ects of Psychotherapy in Personality D
isorders           Eva K
. H
orn
Long-term Costs and Effects  
of Psychotherapy in  
Personality Disorders
Eva K. Horn
U bent van harte uitgenodigd 
voor het bijwonen van de 
openbare verdediging van  
het proefschrift 
“Long-term Costs and 
Effects  
of Psychotherapy in  
Personality Disorders” 
van Eva Horn 
op dinsdag 19 april 2016  
om 13.30 uur in de Andries 
Querido Zaal van het Erasmus 
Medisch Centrum,  
Dr. Molewaterplein 50  
in Rotterdam. 
Na de verdediging bent u 
welkom op de receptie  
ter plaatse.
Paranimfen
Dineke Feenstra 
(dinekefeenstra@hotmail.com)
Moniek Vlasveld 
(moniekvlasveld@hotmail.com)
13104 - Eva Horn_OM.indd   1 19-02-16   10:40

Long-term Costs and Effects of  
Psychotherapy in Personality Disorders
Eva K.Horn
Cover: Ridderprint BV, Ridderkerk, the Netherlands
Layout: Ridderprint BV - www.ridderprint.nl
Printed by: Ridderprint BV - www.ridderprint.nl
ISBN: 978-94-6299-324-2
Long-Term Costs and Effects of  
Psychotherapy in Personality Disorders
Kosten en Effecten van  
Psychotherapie bij Persoonlijkheidsstoornissen
Proefschrift
ter verkrijging van de graad van doctor aan de
Erasmus Universiteit Rotterdam
op gezag van de
rector magnificus
prof.dr. H.A.P. Pols
en volgens besluit van het College voor Promoties.
De openbare verdediging zal plaatsvinden op
dinsdag 19 april 2016 om 13:30 uur
door
Eva Karin Horn
geboren te Saarbrücken, Duitsland
Promotiecommissie
Promotor: Prof.dr. J.J. van Busschbach
Overige leden: Prof.dr. C.L. Mulder
 Prof.dr. W.B.F. Brouwer
 Prof.dr. P. Luyten
Copromotor: Dr. R. Verheul
COnTEnTs
Chapter 1 Introduction 7
Chapter 2 Long-term Effectiveness of Psychotherapy in Personality 
Disorders
19
Chapter 3 Effectiveness of Psychotherapy in Personality Disorders Not 
Otherwise Specified (PDNOS): A Comparison of Different 
Treatment Modalities
49
Chapter 4 Effectiveness of Short-Term Inpatient Psychotherapy based on 
Transactional Analysis in Patients with Personality Disorders: A 
Matched Control Study using Propensity Score
79
Chapter 5 Cost-Effectiveness of Short-term Inpatient Psychotherapy 
based on Transactional Analysis in Patients with Personality 
Disorders
105
Chapter 6 Tailoring Psychotherapy in patients with Personality Disorders: 
Matching the level of psychological strengths to the level of 
stabilizing versus destabilizing psychotherapy.
129
Chapter 7 Discussion 153
Summary 171
Summary (in Dutch) 175
Acknowledgments 179
PhD Portfolio 183
Curriculum Vitae 187

ChaPtEr 1
Introduction

9Introduction
1
The Study of Cost Effectiveness of Personality Disorder Treatment (SCEPTRE) showed 
that patients with personality disorder (PD) benefit from psychotherapy (Bartak, 2011; 
Soeteman, 2010). It should be noted, however, that especially in patients with a Cluster 
C PD, treatment effects depend on treatment modality (outpatient, day hospital or 
inpatient treatment) and length of treatment. Furthermore, some particular combina-
tions of treatment modality and length of treatment were found to have a favorable 
cost-effectiveness. So far, analyses in the SCEPTRE study are limited to the use of three 
year follow-up data and patients with PD Not Otherwise Specified (PDNOS) were ex-
cluded. The (cost-)effectiveness studies in this thesis use the SCEPTRE data up to five 
years follow-up and do include patients with PDNOS. What is more, the (cost-)effective-
ness of one specific promising treatment was investigated in-depth, namely Short-Term 
Inpatient Treatment based on Transactional Analysis (STIP-TA).
This introduction starts with an outline of the context of and the rationale for the 
SCEPTRE investigation. What follows next is a description of the concept of evidence 
based medicine, i.e. the scientific paradigm on which this research effort is based, and an 
overview of the scientific evidence of the effectiveness of psychotherapy in PD. Next, the 
design of SCEPTRE and the observed outcomes are reported. This introductory chapter 
concludes with the objectives and the content of the current thesis.
nEED fOr (COsT-)EffECTivEnEss rEsEarCh
Over the years, mental health care has become more accessible and, at the same time, 
seeking help for mental health problems is becoming more accepted (Schomerus et al., 
2012). The liberalization of the mental health care market in the Netherland has led to 
the availability of more health care providers and more and different treatments (Bijen-
hof, Folkertsma, Kommer, Slobbe, & Polder, 2012). This trend is inevitably accompanied 
with an increase in costs. In the Netherlands, from 2005 to 2010, mental health care 
costs for patients with PD went up by approximately 70% for men and by even 187% for 
women (Bijenhof et al., 2012). The recent budget constrains made it even more neces-
sary to justify interventions in terms of their effectiveness and cost-effectiveness and 
in addition shifted attention to evidence based treatments. This is especially true for 
expensive interventions with limited published evidence for its effectiveness, such as 
inpatient treatment of PD.
The publication of the DSM-III in 1980 (American Psychiatric Association, 1987), in which 
the criteria of personality disorders were explicitly established for the first time and 
which was followed by the DSM-IV in 1994 (American Psychiatric Association, 1994), led 
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to more attention for personality disorders and their treatment. The general diagnostic 
criteria of the DSM-IV-TR (American Psychiatric Association, 2000) and which are incor-
porated in the DSM-5 (American Psychiatric Association, 2013) are listed below.
According to DSM-IV-TR, the diagnosis of a personality disorder must satisfy the following 
general criteria, in addition to the specific criteria listed under the specific personality disor-
der under consideration.
A. An enduring pattern of inner experience and behavior deviating markedly from the 
expectations of the individual’s culture. This pattern is manifested in two (or more) of the 
following areas:
 (1) cognition (perception and interpretation of self, others and events)
 (2)  affect (the range, intensity, lability and appropriateness of emotional response)
 (3) interpersonal functioning
 (4) impulse control
B. The enduring pattern is inflexible and pervasive across a broad range of personal and 
social situations.
C. The enduring pattern leads to clinically significant distress or impairment in social, oc-
cupational or other important areas of functioning.
D. The pattern is stable and of long duration and its onset can be traced back at least to 
adolescence or early adulthood.
E. The enduring pattern is not better accounted for as a manifestation or consequence of 
another mental disorder.
F. The enduring pattern is not due to the direct physiological effects of a substance (e.g., a 
drug of abuse, a medication) or a general medical condition (e.g., head trauma).
Textbox. General diagnostic criteria for a DSM-IV-TR Axis II personality disorder (APA, 2000)
De Viersprong; iniTiaTOr Of ThE sCepTre sTuDy
The recent history of De Viersprong nicely illustrates these developments. A special-
ized psychotherapeutic center for the treatment of PD patients in the Netherlands, De 
Viersprong started as a “therapeutic community” in the 1950s with long-term inpatient 
treatments, which could last up to two years. The past decade has seen a reduction in its 
inpatient treatments, both in the number of beds and in the length of treatments. At the 
same time the institute has been investing in research on the effectiveness of treatments 
and the relationship between costs and effects, with the aim to offer evidence based 
treatments to patients with PD. Such investigations should ultimately provide evidence 
whether the high costs of inpatient treatments can be justified with possible savings 
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elsewhere, and/or better health outcomes. This train of thought led to the initiation of 
the SCEPTRE study in 2003, i.e. a large quasi-experimental investigation of the effective-
ness and cost-effectiveness of different dosages of psychotherapies for PD (Bartak, 2011; 
Soeteman, 2010).
EviDEnCE basED TrEaTmEnTs: ThE basis fOr sCEPTrE
The SCEPTRE investigation was based on the concept of evidence based medicine, de-
fined in 1996 by Sackett, Rosenberg, Gray, Haynes, and Richardson as “the conscientious, 
explicit and judicious use of current best evidence in making decisions about the care of the 
individual patient. It means integrating individual clinical expertise with the best available 
external clinical evidence from systematic research.” An increasing interest in evidence 
based medicine stimulated studies on psychotherapeutic treatments in PD patients; 
such studies had so far been relatively rare, with most research concentrating on various 
manualized psychotherapies for patients with borderline PD. The SCEPTRE initiative tried 
to fill that gap with a large controlled study in all clusters of PD, including the PDNOS.
sCiEnTifiC EviDEnCE On EffECTivEnEss Of PsyChOThEraPy fOr PD 
PaTiEnTs
The evidence of psychotherapeutic treatments in PD patients is mixed and largely 
depends on the PD diagnosis. In a systematic overview of studies involving cluster 
A, B and C PDs, Perry, Banon and Ianni (1999) estimated effect sizes of 1.1 to 1.3 pre-
treatment to post-treatment. More specifically, for cognitive behavior therapies a mean 
effect size of 0.87 was found and for psychodynamic therapies a mean effect size of 1.79 
(Leichsenring & Leibing, 2003). The very few studies on cluster A patients consist of case 
reports or have otherwise included small study populations. Some studies show that 
cluster A patients hardly respond to psychotherapy whereas other studies show that 
they do (Dixon-Gordon, Turner, & Chapman, 2011; Gude & Vaglum, 2001; Thunnissen, 
2007). A possible explanation for this discrepancy is that studies often employ only a 
limited follow-up period and that these patients seem to improve slowly (Thunnissen, 
2007). Alternatively, selection bias might have played a role. Cluster B, and more specifi-
cally BPD, has been studied more extensively. Several systematic reviews addressed the 
psychological and pharmacological treatment of borderline (Lieb, Vollm, Rucker, Tim-
mer, & Stoffers, 2010; Stoffers et al., 2012) and antisocial PD (Gibbon et al., 2010; Glenn, 
Johnson, & Raine, 2013; Khalifa et al., 2010). The authors of a recent Cochrane review 
on psychological treatments in BPD concluded that these are effective and deserve an 
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important place in the management of patients with BPD (Stoffers et al., 2012). A recent 
review on antisocial PD showed some effectiveness of CBT and MBT (Glenn et al., 2013). 
Other cluster B PDs, i.e. narcissistic and histrionic PD, have been less researched. People 
with a narcissistic PD seem to profit from psychotherapeutic treatments but drop-out 
is high (Levy, Reynoso, Wasserman, & Clarkin, 2007). Studies on cluster C PD patients 
showed that psychodynamic, cognitive (behavioural) therapy and brief relational thera-
py all seemed to be effective. Medium to large effects were found up to three years after 
baseline (Dixon-Gordon et al., 2011). At present no explicit treatment studies on patients 
with PDNOS have been published. In the day hospital treatment study of Karterud et al. 
(2003) in a mixed population, the best treatment results were found in PDNOS patients 
(Karterud et al., 2003).
sTuDy Of COsT-EffECTivEnEss Of PErsOnaLiTy DisOrDEr TrEaTmEnT 
(sCEPTrE)
The studies referred to above provide evidence that psychotherapeutic treatments in PD 
patients are effective. Remarkably, typically there are hardly any or no differences in ef-
fectiveness between specific treatments and theoretical orientations (Bartak, Soeteman, 
Verheul, & Busschbach, 2007; Budge et al., 2013). This is a common finding in studies of 
psychological treatments and is often referred to as the “Dodo Bird verdict”. The Dodo 
Bird verdict implies that all psychotherapies lead to approximately equivalent effects 
seeing that common factors such as ‘the belief in the treatment’ and ‘the therapeutic 
alliance’ underlie the effectiveness of psychotherapy (Wampold et al., 1997).
Importantly, many if not all comparative studies have focussed on equal dosages of 
psychotherapy. As various studies have observed dose-effect associations in PD, it is 
plausible to hypothesize that treatment effectiveness is driven in whole or in part by the 
setting (outpatient, day hospital or inpatient treatment) and the length of treatment. 
Furthermore, as setting and length of treatment largely determine the costs of treat-
ment, the SCEPTRE study could link variance in costs to variance in effectiveness.
In the SCEPTRE trial, 1,379 patients completed the intake procedure (2003-2006) and 
were selected for various treatment dosages in six mental health care centres in the 
Netherlands: De Viersprong, Netherlands Institute for Personality Disorders, Halsteren; 
GGZ WNB, Bergen op Zoom and Roosendaal; Centre of Psychotherapy Pro Persona, Lun-
teren; Altrecht, Utrecht; Zaans Medical Centre, Zaandam; and the Centre of Psychotherapy 
Arkin, Amsterdam (van Manen et al., 2011). The treatments under study varied greatly 
in setting, length of treatment, and theoretical orientation. The dosages, which were 
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the focus of the study, were defined as followed: outpatient, day hospital and inpatient 
treatments. More specific, in the cluster C study, the length of treatment (short- or 
long-term) could be added to the setting to make a further distinction. That was not 
possible in clusters A and B, because of the small numbers of patients in the resulting 6 
subgroups. Assignment to treatment was based on the results of standardized assess-
ments and the expert opinions of clinicians from the participating health care centres, 
as it had appeared to be impossible to randomize patients to treatments with this great 
variation. The SCEPTRE study thus follows a quasi-experimental study design. To cor-
rect for the initial differences between patients in different treatments, we made use of 
the propensity score and the multiple propensity score (Spreeuwenberg et al., 2010). 
The studies presented in this thesis included 921 of those 1,379 patients, in different 
compositions. Previous studies so far had used patient data up to three year follow-up 
in the analyses. Anna Bartak presented short- (12 months follow-up) and mid-term (18 
months follow-up) effectiveness results in her thesis (2010). She showed that dosage 
had some influence on effectiveness (Bartak et al., 2010, 2011a, 2011b). In cluster A, day 
hospital and inpatient treatments were found associated with the best results. How-
ever, as the treatment groups were not readily comparable, the general conclusion as 
that cluster A patient can profit from psychotherapy (Bartak et al., 2011a). In cluster B, 
inpatient treatments were found most effective (Bartak et al., 2011b), and in cluster C 
large effects in favor of short-term inpatient treatments were found (Bartak et al., 2010). 
The thesis of Djøra Soeteman (2010) showed that dosage had some influence on the 
cost-effectiveness of psychotherapy. More precisely, when the costs were added to the 
analyses and the costs and effects were modeled over five years, outpatient and day 
hospital treatments were the most cost-effective treatments for cluster B (Soeteman et 
al., 2010), while short-term day hospital and short-term inpatient treatments were the 
most cost-effective treatments in cluster C (Soeteman et al., 2011). Cost-effectiveness 
was not modeled for cluster A patients due to the low number of patients.
The studies in the present thesis draw on the studies presented by Anna Bartak and 
Djøra Soeteman. We used the now available data up to five years, presented the three 
and five years’ long-term effects for clusters A, B, C PD, and PDNOS, and combined ef-
fectiveness with cost-effectiveness in a short-term inpatient treatment study. Further-
more, one could argue that patients low on psychological strength cannot benefit from 
treatment with the high level of destabilization that is typical for short-term inpatient 
psychotherapy. We therefore took into account the interaction between the patient’s 
psychological strength and the treatment’s level of destabilization with respect to out-
come in all patients and over all treatments.
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ObjECTivE anD rEsEarCh quEsTiOns Of This ThEsis
The objective was to address aspects of the SCEPTRE study that had been left unexplored 
so far and which have not yet been addressed in earlier publications. We formulated the 
following three research questions:
1. Are the improvements previously observed in patients with a cluster A, B, or C PD or 
PDNOS stable over five years of follow-up? Are there differences in the effectiveness 
of outpatient, day hospital, and inpatient treatments on the long-term outcome in 
patients with a cluster A, B, or C PD or PDNOS?
2. What are the effectiveness and cost-effectiveness of Short-Term Inpatient Psycho-
therapy based on Transactional Analysis (STIP-TA) in PD patients?
3. Is there an interaction between the patient’s psychological strength and the treat-
ment’s level of destabilization with respect to outcome?
COnTEnT Of This ThEsis
This thesis presents data collected from a quasi-experimental study. Chapter 2 reports 
on the long-term effectiveness in patients with a cluster A, B and/or C PD. Chapter 3 
explores the long-term effectiveness in patients with a PDNOS. Chapter 4 compares 
the effectiveness of a specific treatment in PD, namely “STIP-TA” to that of other psy-
chotherapies in patients with mainly a cluster C PD or PDNOS. Chapter 5 compares the 
cost-effectiveness of STIP-TA to that of other psychotherapies over three years’ follow-
up. Chapter 6 reports on the matching hypothesis that patients high on psychological 
strengths profit more from predominantly destabilizing treatments while patients low 
on psychological strengths profit more from predominantly stabilizing treatments. 
Chapter 7 is the general discussion where the findings of this thesis are summarized 
and the implications for clinical practice and future research are discussed.
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Chapter 2
summary
background
The effectiveness of specialized psychotherapy in personality disorders (PDs) is well 
documented. Previous research on short- and mid-term follow-up showed some 
dosage-effect relationships, with superiority of short-term inpatient psychotherapy in 
patients with cluster C PD being the most significant finding. This manuscript reports 
about the 5-year follow-up of patients with PD in various treatment modalities.
methods
Five hundred nineteen patients with a DSM-IV-TR cluster A, B, and/or C PD, assigned to 
outpatient, day hospital or inpatient treatments were followed up to five years. In pa-
tients with cluster C PD, short-term treatments (< 6 months) were further distinguished 
from long-term treatments. Primary outcome was symptom severity (GSI). Secondary 
outcomes were psychosocial functioning (OQ-45) and health related quality of life (EQ-
5D). Multiple propensity scores were used to correct for initial baseline differences.
results
Uncorrected results showed that all patient groups except cluster A outpatients report-
ed significantly less symptom severity (effect sizes .65 to 1.82), and that initial positive 
outcomes were maintained over the 5-year follow-up. Corrected differences between 
the modalities were small and mostly non-significant. In cluster C patients, short-term 
inpatient treatments were superior over most of the other modalities.
Conclusions
After five year follow-up, patients still maintained a better level of symptoms and func-
tioning than before treatment. Differences between treatment modalities were small. 
The previously observed superiority of short-term inpatient psychotherapy in patients 
with cluster C PDs at 12 month follow-up was still present at 5- year follow-up.
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inTrODuCTiOn
The effectiveness and cost-effectiveness of specialized psychotherapy in personality 
disorders (PDs) is well documented both on the short- and on the long-term (Binks et 
al., 2006; Dixon-Gordon, Turner, & Chapman, 2011; Hadjipavlou & Ogrodniczuk, 2010; 
Leichsenring & Leibing, 2003; Perry, Banon, & Ianni, 1999). This evidence is also reflected 
in current guidelines of e.g. the UK (National Institute for Health and Clinical Excellence, 
2009a, 2009b), Australia (National Health and Medical Research Council, 2012), and the 
Netherlands (Trimbos-institute, 2008). Differences in effects among psychotherapeutic 
orientations turned out to be small (Bartak, Soeteman, Verheul, & Busschbach, 2007; 
Budge et al., 2013). Earlier research on the short- and mid-term effectiveness showed small 
differences between treatment modalities in terms of length and the setting of the treat-
ment: outpatient, day hospital an inpatient treatment (Bartak et al, 2010, 2011a, 2011b). 
This article reports about the long-term outcome of these studies at 5 years after baseline.
Almost half of all patients (46%) in mental health care have a DSM-IV personality dis-
order (PD) (Zimmerman, Rothschild, & Chelminski, 2005). This makes PDs one of the 
most frequent disorders treated by psychiatrists, psychologists and other mental health 
care workers in outpatient care with diagnoses of cluster C PD and PDNOS being most 
prevalent (Zimmerman et al., 2005). The burden of disease is high: PDs are characterized 
by enduring maladaptive patterns of behaviour, which often lead to impairments in 
different areas, such as occupational or social functioning, additional psychopathology, 
a diminished global functioning, and a low quality of life (Kvarstein & Karterud, 2012; 
Samuels, 2011; Soeteman, Verheul, & Busschbach, 2008). Since one aspect of PDs is 
their long-lasting, persisting pathology, long-term follow-up of patients is significant to 
determine whether treatment is capable to produce long-lasting change.
Until now, treatments studied have mostly focused on patients with a specific personality 
pathology (e.g. borderline personality disorders [BPD]), or on comparisons of different psy-
chotherapies (Bateman & Fonagy, 2009; Giesen-Bloo et al., 2006). A recent review showed 
that so-called evidence-based treatments were more effective than treatment as usual (TAU) 
but comparative trials on active treatments have not yet provided conclusive evidence for 
the superiority of one theoretical orientation over another (“equivalence effect” or “dodo 
bird effect”) (Budge et al., 2013). Studies further suggest that treatment characteristics other 
than theoretical orientation might be more important determinants of (cost-) effectiveness, 
such as a well-structured and coherent theoretic framework (Bateman & Fonagy, 2000), the 
strength of the therapeutic alliance (Falkenstrom, Granstrom, & Holmqvist, 2013), or modality 
(setting and/or duration) of treatment (Bartak et al., 2007). The long-term effectiveness of dif-
ferent modalities (setting and/or duration) of psychotherapy is the focus of the present study.
22
Chapter 2
In cluster A, studies on psychotherapeutic treatments are rare and existing studies 
have rather small study populations and often focus on schizotypal PD. Results of these 
studies are mixed with a few studies showing that cluster A patients have poor results 
but other studies showing that patients with a cluster A PD can profit from treatment 
as much as patients with a cluster B and/or C PD (Dixon-Gordon et al., 2011; Gude & 
Vaglum, 2001; Thunnissen, 2007). A possible explanation for these mixed results is the 
finding that cluster A patients seem to improve more slowly and thus need more time to 
show positive results (Thunnissen, 2007).
Cluster B, and more specifically BPD, have been studied more extensively. Systematic 
reviews have been conducted concerning the psychological and pharmacological treat-
ment of borderline (Lieb, Vollm, Rucker, Timmer, & Stoffers, 2010; Stoffers et al., 2012) 
and antisocial PD (Gibbon et al., 2010; Khalifa et al., 2010). The authors of a recent Co-
chrane review on psychological treatments in BPD concluded that psychotherapeutic 
treatments are effective, although more studies are necessary (Stoffers et al., 2012). Less 
research is done on the narcissistic, antisocial, and histrionic PD. A review on antisocial 
PD showed some effectiveness of cognitive behavioural treatment (CBT) and mentaliza-
tion based treatment (MBT) (Glenn, Johnson, & Raine, 2013).
Studies on cluster C patients showed that psychodynamic, cognitive (behavioural) 
therapy and brief relational therapy all seemed to be effective. Medium to large effects 
were evident up to three years after baseline (Dixon-Gordon et al., 2011).
Between 2010 and 2011 several articles were published on the effectiveness of psycho-
therapy in personality disorders (PDs) on the basis of the SCEPTRE study (trial register 
ISRCTN: 73817429), a longitudinal multicentre study, which includes more than 900 
patient treated for different personality disorders in The Netherlands. As earlier studies 
showed that the choice of theoretical framework had little effect on treatment effec-
tiveness, SCEPTRE focused on the dosage or modality of treatment as the moderator 
of effect. The published articles of Bartak et al. presented the results up to 18 month of 
follow-up (Bartak et al., 2010, 2011a, 2011b). Significant improvements of symptoms, 
interpersonal functioning, and quality of life, and some significant differences between 
treatment modalities were found. In cluster A, day hospital and inpatient treatments, in 
cluster B inpatient treatments, and in cluster C short-term inpatient treatments seemed 
to produce best results. Five year follow-up using data of patients with PD not otherwise 
specified (PDNOS) was published recently and showed mostly comparable effectiveness 
of these treatment dosages at long-term follow-up (Horn et al., 2014).
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In the present study we present the long-term results up to five years after baseline 
using data of patients with cluster A, B, and C PD obtained from SCEPTRE. The study pro-
tocol was approved by the Medical Ethics Committee of the Erasmus University Medical 
Centre in Rotterdam, the Netherlands. This study aims to extend the evidence on the 
effectiveness of psychotherapy for patients with cluster A, B, and C PDs. It is the first 
study to investigate the long-term effectiveness of various modalities of psychotherapy 
in these patient groups. The effectiveness of outpatient, day hospital, and inpatient 
psychotherapy is investigated over five years after baseline.
 
The following research questions will be addressed:
1) Is the improvement in symptom severity, interpersonal functioning, and quality of life 
found in earlier short-term studies stable over time?
2) Are there differences in the effectiveness of outpatient, day hospital and/or inpatient 
treatments on the long-term?
mEThODs
study population and design
During a 3-year period, 1,379 patients completed the intake procedure in six mental 
health care centres in the Netherlands and were selected for treatment (De Viersprong, 
Netherlands Institute for Personality Disorders, Halsteren; GGZ WNB, Bergen op Zoom 
and Roosendaal; Centre of Psychotherapy Pro Persona, Lunteren; Altrecht, Utrecht; Zaans 
Medical Centre, Zaandam; Centre of Psychotherapy Arkin, Amsterdam). Assignment to 
treatment was based on the results of standardized assessments and the expert opinion 
of clinicians from the participating health care centres. Of the 1,379 patients who were 
selected for treatment, 959 were enrolled in the SCEPTRE study. One hundred and forty 
six patients did not meet the inclusion criteria: age between 18 and 70 years (n = 13), 
significant personality pathology (n = 34), referred for treatment aimed at personality 
pathology (n = 99). Nine patients met the exclusion criteria: insufficient command of the 
Dutch language (n = 6), organic cerebral impairment (n = 1), mental retardation (n = 1), 
and schizophrenia (n = 1). One hundred and thirty-three patients were excluded due to 
unreliable or missing baseline data, 100 patients refused to participate and 32 patients 
were excluded due to logistic reasons (e.g. it was not possible to make an appointment 
to inform patients about the study). Five hundred and eighty eight patients had a Cluster 
A, B, and/or C PD and had received at least two sessions of outpatient psychotherapy or 
at least two days of day hospital or inpatient psychotherapy (see figure 2.1). Of these, 
519 (88%) had completed at least one follow-up assessment and were included in the 
present study.
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  





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figure 2.1. Patient Flow.
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Treatments
The six mental health care centres offered a variety of psychotherapeutic treatments 
tailored to a PD patient population. Their treatments differed according to several fea-
tures. As this study focused on different treatment modalities, three modalities were 
compared. Outpatient (i.e., individual or group psychotherapy sessions, up to two 
sessions per week), day hospital (i.e., at least one morning/afternoon per week, various 
forms of psychotherapeutic and psychosocial treatment, but patients sleep at home), 
and inpatient (i.e., patients stay at the institutions up to five days a week, various forms 
of psychotherapeutic and psychosocial treatments) psychotherapy with the following 
characteristics (mean ±SD):
1. outpatient psychotherapy, .85 ±. 44 sessions per week, 13.58 ± 7.26 months, treat-
ments with integrative (31%), cognitive-behavioural (28%), psychodynamic (25%) or 
an other (16%) orientation;
2. day hospital psychotherapy, 3.21 ± 1.44 days per week, 9.38 ± 4.04 months, treat-
ments with integrative (82%), psychodynamic (13%) or cognitive-behavioural (6%) 
orientation;
3. inpatient psychotherapy 4.97 ±. 16 days per week, 7.75 ± 3.68 months, treatments 
with integrative (40%), psychodynamic (31%) or cognitive-behavioural (29%) orienta-
tion.
Day hospital and inpatient programs typically consisted of group psychotherapy as a 
core element, mostly in combination with one or more non-verbal or expressive group 
therapies, individual psychotherapy, milieu therapy, coaching for social problems, 
community meetings, and/or pharmacological treatment (Bartak et al., 2010). One 
hundred-and-one psychotherapists who were all licensed psychiatrists or psychologists 
participated in this study. On average, they had 14.9 ± 10.1 years of postgraduate clini-
cal experience. The treatments under study can be considered highly representative of 
regular clinical practice in the Netherlands, as therapists did not receive specific training 
for this study and treatment integrity was not monitored. Analyses were carried out on 
the basis of intended treatments.
assessments
An extensive standard assessment battery of instruments was administered to the 
patients before treatment assignment. PDs were measured using the Dutch version 
of the Structured Interview for DSM-IV Personality (SIDP-IV) (De Jong, Derks, van Oel, 
& Rinne, 1996; Pfohl, Blum, & Zimmerman, 1997). The primary outcome measure was 
symptom severity. Symptom severity was measured using the Dutch version of the 
Brief Symptom Inventory (De Beurs & Zitman, 2006; Derogatis & Melisaratos, 1983), a 
validated self-report scale derived from the revised Symptom Checklist 90 (Arrindell & 
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Ettema, 2003; Derogatis, 1983). In this study, we used the mean score of the 53 items of 
the Brief Symptom Inventory, i.e. the Global Severity Index (GSI), ranging from zero to 
four. Secondary outcome measures were psychosocial functioning and health-related 
quality of life. Psychosocial functioning was measured using two subscales of the Out-
come Questionnaire-45 (OQ-45), i.e. Interpersonal Relations and Social Role (Lambert et 
al., 2004). Health-related quality of life was measured using the EQ-5D (EuroQolGroup, 
1995). A recent study in the Netherlands measured and valuated the EQ-5D, resulting in 
the Dutch EQ-5D value set, which was used to calculate utilities for EQ-5D health states 
(Lamers, Stalmeier, McDonnell, Krabbe, & van Busschbach, 2005).
The assessment battery included three additional instruments, which were used as 
potential confounders for the estimation of the propensity score (see below). First, the 
Dutch version of the Dimensional Assessment of Personality Pathology-Basic Question-
naire (DAPP-BQ) was used to measure type and degree of personality pathology (Lives-
ley, 2002; van Kampen, 2002). Second, to measure patients’ motivation for treatment, 
the two scales of the Motivation for Treatment Questionnaire (MTQ-8) were used: Need 
for Help, and Readiness to Change (van Beek & Verheul, 2008). Third, the core compo-
nents of personality pathology were measured using the Severity Indices of Personality 
Problems (SIPP-118), a 118-item questionnaire aimed to measure five core domains of 
personality pathology, i.e. Self-Control, Identity Integration, Responsibility, Relational 
Functioning, and Social Concordance (Verheul et al., 2008).
All outcome measures were assessed at baseline and several follow-up points. Three 
treatment centres had assessments at baseline, end of treatment, at six and 12 months 
after the end of treatment, and at 36 and 60 months after baseline. Three other centres 
had assessments at baseline and at 12, 24, 36, and 60 months after baseline. Different 
time points were used due to logistic reasons (Bartak et al., 2010). Follow-up response 
was high, thereby enhancing the robustness of the multi-level analyses. We included all 
patients with at least one follow-up measure, as multi-level models make optimal use of 
incomplete repeated measures data and are robust for drop-out when the drop-out is 
missing at random (Little & Rubin, 1987). Twenty-eight percent had one to three follow-
ups, 37% had four follow-ups, 29% had five follow-ups, and 7% had six follow-ups. No 
significant differences (p<.05) were found between patients with and without follow-up 
concerning the outcome measures at baseline.
statistical analyses
We first examined the uncorrected results on all outcome measures over five years after 
baseline. We used multilevel modelling to deal with: (1) the dependency of the repeated 
measures within the same subject in time, and (2) the longitudinal data with observations 
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unequally spaced in time (see ‘Assessments’). To estimate the uncorrected treatment effects 
over five years after baseline, we used a random intercept and random slope model with 
time as level I and patient number as level II. In addition to a linear time effect, we modelled 
the time effect through linear splines with knots every six months, which allowed the esti-
mated course of the dependant variable to bend at these time points. Non-significant knots 
(p≥0.05) were deleted from the models until a parsimonious model was reached that did 
not differ significantly from the original saturated model. This resulted in a final best fitting 
model with the following independent variables: dummy variables indicating group mem-
bership, time, a knot-point at three years allowing a change in the slope of the time effect at 
3 years, interaction between group membership and time, and interaction between group 
membership and the change in slope at three years. Subsequently, we calculated within-
group effect sizes (ES, Cohen’s d) using the estimated pooled standard deviations from the 
models to describe change from baseline up to five years in each group (Cohen, 1988).
To evaluate clinically significant change at five years after baseline in terms of the GSI, we 
followed the criteria by Jacobson and Truax (Jacobson & Truax, 1991). We only used patients 
with a five year follow-up measure and we did not correct the results for initial baseline dif-
ferences. The cut-off and reliable change index of the manual of the BSI were used (Deroga-
tis, 2011). Fisher’s exact test was used to test for differences between the treatment groups.
Since this is a non-randomised study, the comparison of the groups had to be corrected 
for the influence of potential confounders, i.e. initial patient differences between modali-
ties and related to outcome. To adjust for these differences and avoid bias in effect estima-
tion, we included a multiple propensity score in our analyses. The classic propensity score 
is defined as the conditional probability of assignment to one of two modalities given a 
set of observed pre-treatment variables (Bartak et al., 2009; Rosenbaum & Rubin, 1983). 
The multiple propensity score is an extension of the classic propensity score to more than 
two modalities and has proven to be feasible in mental health research (Spreeuwenberg 
et al., 2010). To identify relevant confounders, a comprehensive list of social, economic, 
and diagnostic variables based on the literature and clinical knowledge was carefully 
considered by both clinicians and researchers (Bartak et al., 2009). All variables signifi-
cantly related to a specific outcome were used to estimate the multiple propensity scores 
in a multinomial logistic regression analysis, with group membership as the dependent 
variable (Brookhart et al., 2006). For illustration, the propensity score for cluster C for the 
GSI was estimated using the following variables: age, level of education, baseline scores 
of the GSI, EQ-5D, DAPP-BQ (Emotional Dysregulation, Dissocial Behaviour, Inhibition), 
OQ-45 (Symptom Distress, Interpersonal Relations, Social Role), MTQ-8 (Need for Help, 
Readiness to change), SIPP-118 (Self-Control, Identity Integration, Relational Function-
ing, Social Concordance, Responsibility), SIDP-IV Dimensional score (cluster A PD, cluster 
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C PD and total score), amount of cluster C traits, and diagnoses of avoidant and depen-
dant PD (see appendix table for a complete list of potential and included confounders 
for all patient groups and all outcome measures). By using the propensity score method, 
the overlap in propensity score distributions (and thus the overlap in relevant variables) 
between modalities can be visualised and judged. In earlier investigations about the ef-
fectiveness of psychotherapy on short- and mid-term follow-up with patients with cluster 
A, B and C PDs, this visual judgement led to the exclusion of a group (in cluster C), a less 
refined differentiation between modalities (in cluster A), and to a less firm interpretation 
of results (cluster A), as the propensity score distributions were too far apart (Bartak et al., 
2010, 2011a, 2011b). Abovementioned remarks about the cluster A and C studies also ap-
plied to the current study, despite the longer follow-up period. The analyses on the total 
group were carried out on the uncorrected results only, as the groups were not readily 
comparable, the propensity scores were too far apart. Subsequently a multilevel model, 
including multiple propensity scores to correct for initial patient differences, was used to 
compare change in outcome variables across modalities. Dependent variables were the 
change scores (from baseline) observed during follow-up for each of the outcome mea-
sures. Independent variables were dummy variables indicating group membership, time, 
a knot point at three years, interaction between group membership and time, interaction 
between group membership and a knot point at three years, and the multiple propensity 
scores with their mutual interactions. This model was used to estimate differences in 
change scores at 60 months after baseline in pair wise comparisons of the six modalities.
The analyses were performed using IBM SPSS Statistics 20.0 for data preparation and 
SAS 9.2 for multi-level modelling.
additional analyses
The five modalities of cluster C PD.
In order to be able to compare results of this study with the earlier publication on cluster 
C (Bartak et al., 2010), additional analyses were done to inspect long-term treatment 
effects in more detail. The three main modalities were split up into five subgroups, i.e. 
long-term (more than six months) outpatient treatment, short- (up to six months) and 
long-term day-hospital treatment, and short- and long-term inpatient treatment. The 
eighteen patients following short-term outpatient treatment were not included in the 
analyses. See Bartak et al. (Bartak et al., 2010) for a description of the modalities.
Treatment Compliance. 
Patients were allocated to their treatment modality in terms of setting and duration pre-
ceding their treatment. A secondary analysis was carried out on patients who followed 
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their initial, intended treatment modality and patients who changed their treatment 
modality.
Comorbidity. 
The patient groups in the current study showed considerable comorbidity on axis 2 of 
the DSM-IV (see table 2.1). Therefore, additional analyses were carried out to compare 
Table 2.1. Patient characteristics, treatment variables and PD diagnoses of cluster A, B, and C PD and the 
total PD group.1
Patient characteristics
Cluster a Cluster b Cluster C Total
N=59 N=210 N=416 N=519
Mean ±SD
Age 29.3 ± 8.1 31.5 ± 8.5 33.8 ± 9.6 33.2 ± 9.4
N (%)
Gender
Male 18 (31) 61 (29) 126 (30) 160 (31)
Education*
High (EQF≥6) 14 (24) 65 (31) 147 (35) 177 (34)
Medium (EQF 3 to 5) 18 (31) 73 (35) 167 (40) 202 (39)
Low (EQF≤2) 27 (46) 72 (34) 102 (25) 140 (27)
General way of living  
(with or without children)
Alone 19 (32) 92 (44) 169 (41) 222 (43)
With partner 22 (37) 75 (36) 162 (39) 190 (37)
With parent(s) 12 (20) 23 (11) 52 (13) 67 (13)
With other people 6 (10) 20 (10) 33 (8) 40 (8)
Children
Care for child(ren) 10 (17) 35 (17) 94 (23) 108 (21)
Civil status
Married/steady relationship 8 (14) 26 (12) 93 (22) 102 (20)
Divorced/widowed 4 (7) 18 (9) 39 (9) 47 (9)
Never married 47 (80) 166 (79) 284 (68) 370 (71)
Mode of employment
Paid work/study 40 (68) 130 (62) 270 (65) 333 (64)
Previous treatment
Outpatient 44 (75) 173 (82) 344 (83) 428 (83)
Inpatient 13 (22) 44 (21) 73 (18) 98 (19)
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Table 2.1. Patient characteristics, treatment variables and PD diagnoses of cluster A, B, and C PD and the 
total PD group.1 (continued)
Treatment variables
Cluster a Cluster b Cluster C Total
N=59 N=210 N=416 N=519
Mean ±SD
Frequency
Outpatient (sessions/week) .96 ±.64 .72 ±.41 .89 ±.47 .84 ±.46
Day Hospital (days/week) 3.32 ±1.60 3.47 ±1.41 3.14 ±1.48 3.30 ±1.50
Inpatient (days/week) 5.00 ±.00 4.97 ±.14 4.97 ±.14 5.00 ±.20
Duration (months)
Outpatient 13.21 ±6.03 14.54 ±6.56 13.36 ±6.71 13.74±6.84
Day Hospital 10.32 ±4.49 10.30 ±4.76 8.89 ±3.99 9.34±4.12
Inpatient 8.53 ±2.34 9.07 ±2.97 7.83 ±3.42 8.15±3.40
N (%)
Theoretical orientation
Outpatient
Cognitive-behavioural 5 (24) 16 (34) 27 (27) 34 (28)
Psychodynamic 4 (19) 5 (11) 27 (27) 31 (25)
Integrative 10 (48) 14 (30) 29 (29) 36 (30)
Other 2 (10) 12 (26) 16 (16) 21 (17)
Day Hospital
Cognitive-behavioural 3 (16) 6 (7) 10 (6) 12 (6)
Psychodynamic 3 (16) 16 (20) 18 (11) 25 (13)
Integrative 13 (36) 60 (73) 137 (83) 158 (81)
Inpatient
Cognitive-behavioural 4 (21) 30 (37) 38 (25) 58 (29)
Psychodynamic 1 (5) 12 (15) 54 (35) 63 (31)
Integrative 14 (74) 39 (48) 63 (41) 81 (40)
PD diagnoses
Outpatient
N=122
Day hospital
N=195
inpatient
N=202
Overall
n=519
N (%)
Cluster A only 4 (3) 2 (1) 5 (3) 11 (2)
Cluster B only 15 (12) 31 (16) 39 (19) 85 (16)
Cluster C only 63 (52) 105 (54) 112 (55) 280 (54)
Cluster A and B 4 (3) 0 (0) 3 (2) 7 (1)
Cluster A and C 8 (7) 6 (3) 4 (2) 18 (4)
Cluster B and C 23 (19) 40 (21) 32 (16) 95 (18)
Cluster A, B, and C 5 (4) 11 (6) 7 (4) 23 (4)
*EQF= European Qualifications Framework.
1 As the patient groups were overlapping, the total N is lower than the sum of cluster A, B, and C.
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patients with one or more PDs of one cluster (pure) with patients with PDs from more 
than one cluster (mixed) on the primary outcome.
rEsuLTs
Total sample
Description total group
Mean age of the sample was 33.2 years and the majority (69%) of all patients was female 
(see table 2.1). More than 80% of patients had a history of outpatient treatment; almost 
20% had a history of inpatient treatment. The largest part of patients (80%) had a cluster 
C PD, 41% had a cluster B PD and 11% had a diagnosis of cluster A (patients could have 
more than one PD diagnosis). Fifty-three percent of all treatments were described as 
integrative, 23% of treatments were psychodynamic, 20% cognitive behavioural, and 4% 
were described as an other theoretical orientation.
Outcomes total group
Sixty months after baseline, uncorrected results showed within-group effect sizes from 
.89 (large effect, outpatient treatment) to 1.30 and 1.38 (very large effect, day hospital 
and inpatient treatment, see table 2.2). The improvement was significant for all dosages 
Table 2.2. Effect sizes at 60 months for three treatment modalities split up in Cluster A, B, and C (uncor-
rected).
Cluster a (n=59)
variable Treatment group n
mean ±sD Within-group effect 
size (Cohen’s d)Baseline 60 months
GSI1 Outpatient 21 1.39 ±.68 1.09 ±.83 .41
Day hospital 19 1.99 ±.62 .90 ±.62 1.81*
Inpatient 19 1.92 ±.83 .72 ±.48 1.82*
OQ-45
Social Role
Outpatient 21 15.91 ±4.71 10.58 ±4.81 1.15
Day hospital 19 18.84 ±5.36 10.70 ±5.72 1.51*
Inpatient 19 17.33 ±5.67 10.83 ±4.26 1.33*
OQ-45
Interpersonal 
Relations
Outpatient 21 21.22 ±5.41 17.66 ±7.97 .54
Day hospital 19 23.67 ±6.50 15.65 ±6.81 1.24*
Inpatient 19 25.49 ±4.61 14.90 ±6.39 1.95*
EQ-5D1 Outpatient 21 .67 ±.18 .71 ±.36 .14
Day hospital 19 .45 ±.28 .66 ±.37 .66*
Inpatient 19 .54 ±.30 .81 ±.25 1.00*
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Table 2.2. Effect sizes at 60 months for three treatment modalities split up in Cluster A, B, and C (uncor-
rected). (continued)
Cluster B (n=210)
variable Treatment group n
mean ±sD Within-group effect 
size (Cohen’s d)Baseline 60 months
GSI Outpatient 47 1.53 ±.77 1.05 ±.73 .65*
Day hospital 82 1.75 ±.61 .87 ±.68 1.37*
Inpatient 81 1.93 ±.66 .88 ±.77 1.47*
OQ-45
Social Role
Outpatient 47 15.51 ±4.51 11.86 ±4.95 .78*
Day hospital 82 16.42 ±4.48 10.46 ±5.72 1.17*
Inpatient 81 17.32 ±5.42 11.53 ±5.34 1.08*
OQ-45
Interpersonal 
Relations
Outpatient 47 21.36 ±7.14 16.65 ±8.69 .60*
Day hospital 82 21.26 ±6.00 14.02 ±8.27 1.01*
Inpatient 81 23.49 ±5.97 16.35 ±7.79 1.04*
EQ-5D Outpatient 47 .58 ±.27 .67 ±.32 .31
Day hospital 82 .48 ±.27 .71 ±.29 .83*
Inpatient 81 .50 ±.27 .77 ±.20 1.14*
Cluster C (n=416)
variable Treatment group n
mean ±sD Within-group effect 
size (Cohen’s d)Baseline 60 months
GSI Outpatient 99 1.39 ±.69 .85 ±.64 .82*
Day hospital 162 1.57 ±.64 .80 ±.68 1.17*
Inpatient 155 1.77 ±.65 .77 ±.70 1.49*
OQ-45
Social Role
Outpatient 99 15.32 ±4.73 11.79 ±5.27 .71*
Day hospital 162 15.85 ±4.93 10.74 ±4.90 1.04*
Inpatient 155 17.28 ±4.39 11.71 ±5.06 1.18*
OQ-45
Interpersonal 
Relations
Outpatient 99 21.00 ±6.30 15.81 ±7.85 .73*
Day hospital 162 21.61 ±5.97 15.33 ±7.79 .91*
Inpatient 155 24.02 ±5.38 15.72 ±7.22 1.31*
EQ-5D Outpatient 99 .60 ±.24 .74 ±.26 .56*
Day hospital 162 .55 ±.27 .74 ±.26 .72*
Inpatient 155 .50 ±.27 .78 ±.24 1.10*
GSI=Global Severity Index. OQ-45=Outcome Questionnaire-45. EQ-5D=EuroQol-5D.
*significant differences (p<.05) between baseline and follow-up.
1significant differences on baseline (p<0.05)
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(p<.0001). Thirty-four percent of patients following outpatient psychotherapy, 49% of 
patients following day hospital psychotherapy, and 59% of patients following inpatient 
psychotherapy showed clinical significant change (see table 2.3).
Cluster a
Description cluster A
Of the 59 patients with a cluster A PD, 85% had a diagnosis of paranoid PD, 10% of 
schizoid PD, and 10% of schizotypal PD. The largest part (98%) had one cluster A PD, 
2% had two cluster A PDs. We found significant differences (p<.05) between the three 
modalities at baseline concerning age, civil status, living situation, education, care for 
children, and baseline scores of the MTQ-8 (Need for Help), GSI, OQ-45 (Total Score), EQ-
5D, and the SIPP-118 (Identity Integration). Overall, the outpatient group deviated from 
the day hospital and inpatient group in having less severe problems, whilst differences 
between the latter two groups were negligible.
Outcomes cluster A
Sixty months after baseline, uncorrected results showed within-group effect sizes from 
.41 (medium effect, outpatient treatment) to 1.81 and 1.82 (very large effect, day hospital 
and inpatient treatment; see table 2.2). The improvement was significant for day hospital 
and inpatient treatments, but marginally significant for the outpatient treatments (d=.41, 
p=.053). See figure 2.2 for a visual display of the modelled GSI scores. Fourty to 46% of 
Table 2.3. Clinical significant change rates at 60 months for Cluster A, B, and C split up in the three treat-
ment modalities.
Gsi n CsC1
Cluster A Outpatient 14 43%
Day hospital 13 46%
Inpatient 10 40%
Cluster B* Outpatient 33 24%
Day hospital 42 45%
Inpatient 50 54%
Cluster C* Outpatient 68 31%
Day hospital 104 49%
Inpatient 102 60%
Total group* Outpatient 86 43%
Day hospital 115 49%
Inpatient 129 59%
* significant difference between treatment groups (p<.05)
1 CSC=clinical significant change; patients moved from a dysfunctional range to a normative range and also 
demonstrated reliable change
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all cluster A patients showed clinical significant change (see table 2.3). In the secondary 
outcome variables, comparable results were found. Notably, concerning quality of life as 
outcome variable, patients in the outpatient group already started with a good quality 
of life and showed almost no improvement after five years (EQ-5D, d=.14, p=.60).
When the analyses were corrected for the influence of baseline differences by the pro-
pensity score, day hospital and inpatient treatments were significantly more effective in 
decreasing symptom severity than outpatient treatments (see table 2.4). On the second-
ary outcomes, no significant differences were present. However, since the propensity 
scores were too far apart which means that patients in the three modalities were too 
different to be readily comparable, these results should be interpreted cautiously.
Cluster b
Description cluster B
In cluster B, 77% had a diagnosis of borderline PD, 23% of narcissistic PD, 12% of histri-
onic PD, and 9% of antisocial PD. The largest part had one cluster B disorder (81%), 16% 
had two cluster B PDs, and 2% had three cluster B PDs.
Outcomes cluster B
In cluster B, the improvement after five years was significant for all three groups on all 
outcome measures, except for outpatients showing only marginal significance on qual-
ity of life (EQ-5D, d=.31, p=.07). Effect sizes for the primary outcome (GSI) ranged from 
.65 (medium effect, outpatient treatment) to 1.47 (large effect, inpatient treatment; see 
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figure 2.2. Course of the GSI up to five years.
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table 2.2). See figure 2.2 for the modelled GSI scores. Twenty-four percent of outpatients 
to 54% of inpatients showed clinical significant change (table  2.3). Corrected results 
showed that patients in inpatient treatments outperformed patients in outpatient 
treatments concerning quality of life (see table 2.4). No significant differences between 
modalities were found concerning symptom severity and interpersonal functioning.
Table 2.4. Difference scores at 60 months for three treatment groups split up in Cluster A, B, and C (cor-
rected).
Cluster a (n=59)
variable Treatment group n Outpatient Day hospital
GSI Outpatient 21
Day hospital 19 .57*
Inpatient 19 .86** .27
OQ-45
Social Role
Outpatient 21
Day hospital 19 1.47
Inpatient 19 1.89 .42
OQ-45
Interpersonal Relations
Outpatient 21
Day hospital 19 1.56
Inpatient 19 3.44 1.88
EQ-5D Outpatient 21
Day hospital 19 .08
Inpatient 19 .17 .09
Cluster B (n=210)
variable Treatment group n Outpatient Day hospital
GSI Outpatient 47
Day hospital 82 .23
Inpatient 81 .29 .06
OQ-45
Social Role
Outpatient 47
Day hospital 82 .93
Inpatient 81 -.42 -1.36
OQ-45
Interpersonal Relations
Outpatient 47
Day hospital 82 2.08
Inpatient 81 .94 -1.14
EQ-5D Outpatient 47
Day hospital 82 .06
Inpatient 81 .15* .08
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Cluster C
Description cluster C
In cluster C, 63% had a diagnosis of avoidant PD, 49% had a diagnosis of obsessive-
compulsive PD, and 22% of dependent PD. More than two third (71%) had one cluster C 
disorder, 24% had two cluster C PDs, and 5% had three cluster C PDs.
Outcomes cluster C
In the cluster C population, effect sizes on the GSI can be considered large (.82 for out-
patient and 1.17 for day hospital treatment) or very large (1.49 for inpatient treatment; 
see table 2.2). Effect sizes of the secondary outcome measures ranged from .56 (EQ-5D, 
outpatient treatment) to 1.31 (OQ-45 Interpersonal Relations, inpatient treatment). 
The improvements found were significant in all three groups for all outcome measures. 
Thirty-one percent of outpatients to 60% of inpatients showed clinical significant 
change (table 2.3). No significant differences between the three modalities on the pri-
mary outcome measure were visible when corrected for initial differences (see table 2.4).
Table 2.4. Difference scores at 60 months for three treatment groups split up in Cluster A, B, and C (cor-
rected). (Continued)
Cluster C (n=416)
variable Treatment group n Outpatient Day hospital
GSI Outpatient 99
Day hospital 162 .07
Inpatient 155 .16 .08
OQ-45
Social Role
Outpatient 99
Day hospital 162 .65
Inpatient 155 .13 -.53
OQ-45
Interpersonal Relations
Outpatient 99
Day hospital 162 .31
Inpatient 155 1.14 .83
EQ-5D Outpatient 99
Day hospital 162 .01
Inpatient 155 .07 .06
GSI=Global Severity Index. OQ-45=Outcome Questionnaire-45. EQ-5D=EuroQol-5D.
Positive coefficients indicate that the treatment group shown in the left column is superior, negative coef-
ficients indicate that the treatment group in the above row is superior.
* p < 0.05, ** p < 0.01, *** p < 0.001.
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additional analyses
The five modalities of cluster C PD
When the three modalities were split up into five modalities by introducing length of 
treatment as a differentiating factor, uncorrected results showed that most improve-
ment was observed in the short-term inpatient group with an effect size of 2.28 for the 
GSI. Long-term day hospital and long-term inpatient treatments reached effect sizes 
of 1.41 (long day hospital) and 1.24 (long inpatient) on the GSI, whereas long-term 
outpatient and short-term day hospital treatments reached effect sizes of .82 and .95, 
respectively. The clinical significant change rates ranged from 32% for patients in long-
term outpatient psychotherapy to 70% for patients in short-term inpatient therapies. We 
found strong and significant effects in improvement of symptom severity for patients 
in short-term inpatient treatments compared to long-term outpatient (b=.39, p=.01), 
short-term day hospital (b=.33, p=.02), and long-term inpatient treatment (b=-.35, 
p=.01), and marginally significant differences compared to long-term day hospital treat-
ment (b=.31, p=.07).
Treatment Compliance
Nineteen percent of patients changed their intended treatment modalities during treat-
ment (cluster A: 25%, cluster B: 17%, cluster C: 19%). Analyses on differences between 
patients who stayed in their planned modality and patients who did not were carried 
out every twelve months after baseline. No significant differences were found on the 
GSI up to five year follow-up between patients who stayed in their planned modality and 
patients who did not (at 60 month follow-up; cluster A: b=.14, p=.85, cluster B: b=-.64, 
p=.25, cluster C: b=-.27, p=.41).
Comorbidity
Results between patients with DSM-IV axis 2 comorbidity and patients without showed 
that only within patients with a cluster C PD who followed day hospital treatment, a 
significant difference emerged on the primary outcome: patients with comorbidity 
showed more progress than the group without comorbidity (b=-.28, p=.03). In cluster 
C patients, additional analyses were done on five treatment modalities. These analyses 
showed a significant difference in the long-term day hospital cluster C group in favour 
of the group with comorbidity (b=-.47, p=.01).
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DisCussiOn
The current study showed that the improvement in symptoms, interpersonal function-
ing, and quality of life after psychotherapy in PD patients was stable or further increased 
compared to 12 or 18 months after the start of treatment (Bartak et al., 2010, 2011a, 
2011b). Psychotherapy seemed to produce good and long-lasting results up to five 
years in a severely disordered PD group. Little differences in effectiveness were found 
between three treatment modalities (outpatient, day hospital, and inpatient) at five 
years after baseline. Exceptions were found in cluster A, where we found a superiority 
of day hospital and inpatient treatments compared to outpatient treatments in terms of 
psychiatric symptomatology. These results, however, have to be interpreted cautiously 
due to the differences between the patient groups. In cluster B at five year follow-up, 
inpatients reported a better quality of life compared to outpatients. In cluster C we only 
found significant differences when treatment modalities were split up in five modalities. 
This resulted in a superiority of short-term inpatient treatments compared to long-term 
outpatient, short-term day hospital and long-term inpatient treatments in terms of 
symptom severity.
In all three clusters, we found most progress during the first year after baseline. During 
the follow-up, gained progress was maintained or further improved. This is in line which 
research that showed that most improvement occurs during treatment (Simon, 2009), 
and that gained progress is maintained or further improved (e.g. Zanarini, Frankenburg, 
Reich, & Fitzmaurice, 2010; Gunderson et al., 2011).
strengths & limitations
The most obvious strengths of this study are the high number of patients, the long-term 
follow-up over five years, a high follow-up response, the wide range of treatments under 
study, and the naturalistic design with the use of a sophisticated statistical technique 
to mimic a randomized allocation to treatments (multiple propensity score). Obviously, 
the need for such a sophisticated statistical technique also marks the most important 
limitation, i.e. patients were not randomized to treatment. This leaves the possibility 
that the propensity score has not been able to fully compensate the skewness of the 
background variables. In cluster A, baseline differences were substantial and the overlap 
of the propensity score distributions was limited. Consequently, it was not possible to 
directly compare patients in the three treatment modalities and we do not know wheth-
er treatment effects can solely be attributed to the treatment or whether these should 
be rather attributed to patient characteristics (Bartak et al., 2011a). Another limitation 
of the propensity score is that it can only correct for background variables included in 
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the propensity score. Given the high number of variables analyzed and included in the 
propensity score, we did the best we can to cover a wide range of variables.
A second limitation of this study is that the theoretical orientation of the therapy is pos-
sibly associated with setting and duration. However, as plead in the introduction, we 
think that the theoretical orientation of the therapy had little effect on outcome, and 
therefore could have only limited effect on the results found. Other aspects of treat-
ment, such as a coherent theoretical structure or the strength of the therapeutic alliance 
seem more effective ingredients of treatment than the theoretical orientation (Bateman 
& Fonagy, 2000).
A further limitation of this study is the absence of a control group without treatment. We 
do not know which part of the improvement is due to therapy and which part is due to 
e.g. natural recovery. For ethical reasons, it would not be possible to compare an active 
treatment with a placebo or waiting list. The current study can be understood as an 
example of “comparative effectiveness” (Institute of Medicine, 2009). The changeability 
of PDs is still an ongoing discussion (Morey & Hopwood, 2013). Research showed that 
PD patients in treatment have a seven-fold faster recovery than patients without treat-
ment (Perry et al., 1999) and that psychotherapeutic treatment can lead to remission of 
symptoms (Zanarini, Frankenburg, Reich, & Fitzmaurice, 2012). In a recent meta-analysis 
it was concluded that psychotherapy should aim on behaviour change, instead of global 
personality change, as the change of fundamental personality structures may be unreal-
istic (Ferguson, 2010). We do not know whether the underlying personality pathology in 
our study changed as our outcome variables relied on certain assessment instruments 
and on self-report. However, it seems unlikely that the large effect sizes on outcome 
found in the current study can occur when the underlying pathology still exists in its 
original form.
The high level of comorbidity in our patient group made it difficult to differentiate be-
tween the clusters A, B, and C PDs. However, as this study was not a RCT with stringent 
exclusion criteria, the high level of comorbidity demonstrates a representative patient 
group. Indeed the overlap found in clinical practice between clusters of PD has initiated 
a discussion to the change of the classification model to a more dimensional model, 
as was suggested during the design of the DSM-5 (Skodol et al., 2011). The results of 
the current study only showed small differences between patients with and without 
comorbidity on the DSM-IV axis 2. Only in patients with a cluster C PD in (long-term) day 
hospital treatments, comorbidity on axis 2 was related to more progress compared to 
patients without comorbidity. The presence of comorbidity on axis 2 did therefore not 
seem to have a large influence on treatment effectiveness in the current study.
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research and clinical implications
As we found little differences in effectiveness when corrected for initial differences, 
we cannot state that one treatment modality is better than the other for cluster A and 
B PD. Within cluster A and B, the results of this study suggest counterintuitive clinical 
implications: more intensive, inpatient treatments are not superior to less intensive, 
outpatient treatments. When choosing a treatment, other characteristics than effective-
ness, like costs of the treatment and the burden of treatment on everyday life, might 
therefore become more important. Policy makers might be inclined to further reduce 
more expensive day hospital and inpatient treatments and to further invest in cheaper 
outpatient treatments. Such line of reasoning ignores that other studies show that high 
costs of intensive treatments in PD can be compensated by savings in other health care 
areas and work-related costs (e.g. Soeteman et al., 2010; Soeteman et al., 2011; van Asselt 
et al., 2008). The current study showed superiority of short-term inpatient treatments to 
most other treatments in cluster C PDs. As it was not possible to split up the treatments 
of cluster A and B patients in terms of setting and duration, we do not know whether 
a short-term inpatient treatment would be most successful in these treatment groups, 
too. However, not all patients might be able to handle the high pressure which is associ-
ated with this treatment. Gullestad, Johansen, Hoglend, Karterud, and Wilberg (2013) 
reported that day hospital treatments resulted in worse treatment effects in patients 
with low reflective functioning (i.e. a low level of mentalizing) compared to individual 
outpatient therapy. Van Manen, Horn, Stijnen, van Busschbach, and Verheul (2015) on 
the other hand, studied the effect of stabilizing and destabilizing treatments in PD 
patients with high or low psychological strengths and found slightly better outcomes 
in patients who followed destabilizing therapies, independent of their psychological 
strengths. More studies on the influence of intensity of treatment are already planned 
or executed. Two notable examples are the dosage trial on MBT (MBT-DOS), in which 
intensive outpatient MBT is compared to day hospital MBT in BPD patients (Laurenssen 
et al., 2014) and a study on short-term (12 weeks) inpatient DBT followed by six months 
of outpatient DBT compared to outpatient DBT only for BPD patients (van den Bosch, 
Sinnaeve, Hakkaart-van Roijen, & van Furth, 2014).
As mentioned in the introduction, most studies in PD aim to compare different theoreti-
cal treatment models, with its own theoretical factors underlying the disorder and which 
are the focus of treatment, such as mentalization in MBT (Bateman & Fonagy, 2004) or 
schemas in SFT (Young, Klosko, & Weishaar, 2003). However, differences in treatment 
effectiveness are rather small (Budge et al., 2013). Our results suggest that treatment 
modality in terms of setting does not make much difference in treatment effectiveness. 
Which mechanisms of change are then present in PD patients and have to be addressed 
in an effective treatment? A recent review on potential mechanisms of change in psy-
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chotherapeutic treatments for personality disorders found that most evidence points 
to the importance of the therapeutic alliance and the resolution of ruptures in the alli-
ance in the process of change (Forster, Berthollier, & Rawlinson, 2014). Further research 
should rather focus on the effective ingredients of psychotherapy instead of comparing 
different theoretical orientations of treatments and to take into account patient charac-
teristics as predictors for treatment effectiveness (Livesley, 2012).
COnCLusiOn
After five year follow-up of psychotherapy, PD patients still maintained a better level 
of symptoms, psychosocial functioning, and health-related quality of life than before 
treatment. Little differences were found between the treatment modalities. The mainly 
small differences which were found in the short-term were still present at the long-term, 
notably in cluster C, where the greater superiority of short-term inpatient treatments 
consisted.
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Effect sizes and clinical significant change rates at 60 months for Cluster C split up in five treatment modali-
ties
variable
Treatment 
group
n
(modelling)
mean ±sD
Effect size 
(Cohen’s d)
n
(CsC)
% CsC1
Baseline
60 
months
GSI Outpatient long 81 1.47 ±.69 .93 ±.63 .82 56 32%*
Day hospital short 79 1.44 ±.64 .81 ±.69 .95 50 46%*
long 83 1.69 ±.62 .78 ±.68 1.41 54 52%*
Inpatient short 61 1.74 ±.51 .60 ±.50 2.28 40 70%*
long 94 1.79 ±.72 .88 ±.76 1.24 62 53%*
GSI=Global Severity Index, CSC=Clinical Significant Change.
*significant differences between treatment groups (p≤.05)
1 patients both moved from a dysfunctional range to a normative range and also demonstrated reliable 
change
supplementary material 2.2.
Difference scores at 60 months for five treatment groups split up in Cluster C (corrected).
variable Treatment group n
Outpatient Day hospital inpatient
long short long short
GSI Outpatient long 81
Day hospital short 79 .05
long 83 .17 .12
Inpatient short 61 .39** .33* .31
long 94 .06 .01 -.10 -.35*
GSI=Global Severity Index.
Positive coefficients indicate that the treatment group shown in the left column is superior, negative coef-
ficients indicate that the treatment group in the above row is superior. * p < 0.05, ** p < 0.01, *** p < 0.001.
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Objective
Although personality disorder not otherwise specified (PDNOS) is highly prevalent and 
associated with a high burden of disease, only a few treatment studies in this patient 
group exist. This study is the first to investigate the effectiveness of different modalities 
of psychotherapy in patients with PDNOS, i.e. short-term (up to six months) and long-
term (more than six months) outpatient, day hospital, and inpatient psychotherapy.
method
A total of 205 patients with PDNOS were assigned to one of six treatment modalities. Ef-
fectiveness was assessed over 60 months after baseline. The primary outcome measure 
was symptom severity, and the secondary outcome measures included psychosocial 
functioning and quality of life. The study design was quasi-experimental and the multiple 
propensity score was used to control for initial differences between treatment groups.
results
All treatment modalities showed positive outcomes, especially in terms of improve-
ments of symptom severity and social role functioning. At 12-month follow-up, after 
adjustment for initial differences between the treatment groups, short-term outpatient 
psychotherapy and short-term inpatient psychotherapy showed most improvement 
and generally outperformed the other modalities concerning symptom severity. At 
60 months after baseline, effectiveness remained but observed differences between 
modalities mostly diminished.
Conclusion
Patients with PDNOS benefit from psychotherapy both at short-term and long-term 
follow-up. Short-term outpatient psychotherapy and short-term inpatient psycho-
therapy seem to be superior to the other treatment modalities at 12-month follow-up. 
At 60-month follow-up, treatments showed mostly comparable effectiveness.
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inTrODuCTiOn
According to the DSM-IV-TR, the category of personality disorder not otherwise specified 
(PDNOS) can be used for “disorders of personality functioning (…) that do not meet criteria 
for any one personality disorder (…), but that together cause clinically significant distress 
or impairment in one or more important areas of functioning” (American Psychiatric As-
sociation, 2000). Numerous studies showed that PDNOS is one of the most prevalent 
mental disorders in clinical practice (Coid, Yang, Tyrer, Roberts, & Ullrich, 2006; Verheul, 
Bartak, & Widiger, 2007; Wilberg, Hummelen, Pedersen, & Karterud, 2008; Zimmerman 
& Coryell, 1989; Zimmerman, Rothschild, & Chelminski, 2005). A meta-analysis on the 
prevalence and use of PDNOS diagnoses showed that 3-6% of the general population 
and 8-13% of clinical samples met the diagnostic criteria for a PDNOS diagnosis (Verheul 
& Widiger, 2004). The relative prevalence, defined as the prevalence of PDNOS divided 
by the overall axis II percentage without PDNOS, was estimated at 21-49% (Verheul 
& Widiger, 2004). As is the case for patients with specific PD, the burden of disease of 
patients with PDNOS is high (Soeteman, Hakkaart-van Roijen, Verheul, & Busschbach, 
2008a; Soeteman, Verheul, & Busschbach, 2008b; Verheul & Widiger, 2004). In terms of 
quality of life, PDNOS patients report a quality of life score on the EuroQol (EQ-5D) of 
between .42 (negativistic PD) and .62 (mixed PD). Such EQ-5D scores represent a range 
comparable to patients with haemodialysis, rheumatic disease, lung cancer, Parkinson’s 
disease, or diabetes type II (Soeteman et al., 2008b). In terms of the economic burden, a 
PDNOS diagnosis is associated with high costs for society (Soeteman et al., 2008a). As is 
the case for PD patients in general, patients with PDNOS show a wide range of problems, 
such as substance use or self-mutilation (Johnson et al., 2005; Verheul et al., 2007; Wil-
berg et al., 2008). In terms of severity of symptoms, personality problems, and relational 
problems, patients with PDNOS seem to fall within an intermediate position between 
patients without personality disorder (PD) and patients meeting the full criteria for one 
of the ten formal PDs in DSM-IV-TR (Verheul et al., 2007; Wilberg et al., 2008). However, 
patients with a diagnosis of PDNOS in addition to a formal PD diagnosis have typically 
higher symptom severity, more personality problems, and more relational problems 
than those with a formal PD diagnosis alone (Verheul et al., 2007).
Since 2000, researchers and clinicians have become increasingly interested in psycho-
therapy for PD patients. This has resulted in numerous studies and the development of 
new evidence-based therapies. There is now sufficient evidence that psychotherapy is 
the treatment of choice in PDs (Karterud et al., 2003; Leichsenring & Leibing, 2003). This 
is reflected in treatment guidelines (e.g., National Institute for Health and Clinical Excel-
lence, 2009a, 2009b; Trimbos-institute, 2008). Specialized psychotherapeutic treatments 
have proven to be effective for PD in general (Gabbard, 2000; Leichsenring & Leibing, 
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2003), more effective than being on a waiting list or general psychiatric outpatient care, 
and to be associated with faster recovery rates compared to natural recovery (Bateman 
& Fonagy, 2008; Perry, Banon, & Ianni, 1999; Petersen et al., 2008). Approximately 75 
years ago, Rosenzweig suggested that common factors were responsible for the effec-
tiveness of psychotherapies making them equally effective in outcome. This effect was 
later called the ‘dodo bird effect’ by Luborsky et al. (e.g. Wampold et al., 1997). However, 
comparative trials have not yet provided conclusive evidence for the superiority of one 
theoretical orientation over another. Furthermore, the available studies suggest that 
other treatment characteristics, such as dosage (Bartak, Soeteman, Verheul, & Bussch-
bach, 2007) or level of destabilization (van Manen, Horn, Stijnen, Busschbach, & Verheul, 
2015), might be more important determinants of (cost-) effectiveness than theoretical 
orientation per se (e.g.Leichsenring & Leibing, 2003).
However according to our knowledge, there are no explicit treatment studies on PDNOS 
patient groups, despite their high prevalence and high burden of disease. Treatment 
studies on PD populations typically focus on formal PDs and do not report results for 
the PDNOS group separately (e.g., Gabbard, 2000; Winston et al., 1994; Zanarini, 2009; 
Zanarini, Frankenburg, Reich, & Fitzmaurice, 2010). We found one general PD treatment 
study reporting results separately for PDNOS patients following short-term and long-
term day hospital treatment (Karterud et al., 2003) and three case studies of patients 
with a PDNOS diagnosis (Newman, 2002; Savoja et al., 2011; Warren, 2012). In the study 
of Karterud et al. (2003) the best treatment results in a day hospital were found in PD 
patients with a diagnosis of PDNOS, a cluster C PD, or borderline PD. Furthermore, few 
studies have focused on the differences in effectiveness of different treatment modali-
ties, despite the fact that they account for large differences in costs. These differences in 
costs are likely to have a high impact on cost-effectiveness ratios and become still more 
important given current restricted health care budgets (Bartak et al., 2007). Recently, a 
study on the effectiveness of five treatment modalities for cluster C PDs was conducted 
and showed that the effectiveness of psychotherapy differed substantially across the 
various modalities at 12 months after baseline (Bartak et al., 2010). A similar pattern, al-
though not statistically significant, was found in cluster B patients (Bartak et al., 2011b). 
This implies that treatment modality does matter, at least in the treatment of cluster B 
and C PD patients at relatively short-term follow-up. These findings suggest that a similar 
short-term effect might be present in patients with PDNOS. Since PDs are characterized 
by pervasive and persistent patterns of experiences and behaviors, long-term follow-up 
studies should also generate more information on the changeability of symptoms. For 
this reason, we looked for evidence that treatment modalities matter in the large study 
used by Bartak et al., (2010, 2011a, 2011b), selecting PDNOS patients and extending 
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the follow up period to 60 months. We expected a similar pattern of results compared 
to cluster C PDs, as the problem severity in both groups is similar (Verheul et al., 2007).
aim of the study
The present study aimed to extend the evidence of the effectiveness of psychotherapy to 
patients with PDNOS. Effectiveness of six treatment modalities in patients with PDNOS, 
i.e. short-term (up to six months) and long-term (more than six months) outpatient, day 
hospital, and inpatient psychotherapy, was investigated over 60 months after baseline.
The two questions we wanted to address in this study were:
• Did PDNOS patients profit from psychotherapy in terms of severity of symptoms, rela-
tional functioning, and quality of life, and did the results remain stable over time?
• Were there differences in effectiveness between different treatment modalities in 
PDNOS patients, and did these differences remain stable over time?
The paper reported on the results obtained from the Study on Cost-Effectiveness of 
Personality Disorder Treatment (SCEPTRE), which is a large multi-centre study in the 
Netherlands (trial register ISRCTN: 73817429).
mEThODs
study population and design
During a 3-year period (2003-2006), 1,379 patients completed the intake procedure 
in six mental health centers in the Netherlands and were selected for treatment (De 
Viersprong Netherlands Institute for Personality Disorders, Halsteren; GGZ WNB, Bergen 
op Zoom and Roosendaal; Centre of Psychotherapy Pro Persona, Lunteren; Altrecht, 
Utrecht; Zaans Medical Centre, Zaandam; Centre of Psychotherapy Arkin, Amsterdam). 
The six centers offer outpatient, day hospital, and/or inpatient psychotherapeutic treat-
ments, tailored to PD patients. Patients had to go through an extensive intake procedure 
prior to treatment allocation. The intake procedure consisted of one or two assessment 
sessions with an intake clinician, a semi-structured interview for PD diagnosis and 
questionnaires (see ‘Assessments’), after which, allocation to treatment was discussed 
by an intake team and afterwards with the patient (van Manen et al., 2011). Of the 1,379 
patients who participated in the intake procedure, 959 (70%) were enrolled in the SCEP-
TRE study (see figure 3.1). To avoid overlap with earlier studies on the effectiveness of 
different treatment modalities in PD patients (Bartak et al., 2010, 2011a, 2011b), patients 
with a diagnosis of one of the cluster PDs were excluded, which left 219 patients (23%) 
with a PDNOS diagnosis only who were allocated to treatment. Of these, 205 (94%) had 
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completed at least one follow-up assessment, had received a “minimally effective dosage” 
of psychotherapy (defined as at least two sessions of outpatient psychotherapy or at 
least two treatment days of day hospital or inpatient psychotherapy) and were included 
in the present study. All patients provided written informed consent prior to inclusion.
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figure 3.1. Patient Flow.
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Treatments
The six mental health care centers offer a variety of psychotherapeutic treatments tai-
lored to a PD patient population. The treatments under study can be considered highly 
representative of regular clinical practice for PD in the Netherlands, as therapists did 
not receive specific training for this study and treatment integrity was not monitored 
(Bartak et al., 2010). One hundred-and-one psychotherapists who were all licensed 
psychiatrists or psychologists participated in the study. On average, they had 14.9 ±10.1 
years of postgraduate clinical experience. All treatment centers offered treatments 
with varying theoretical orientations, such as a psychodynamic orientation (27% of all 
given treatments), a cognitive-behavioral orientation (21% of all given treatments), or 
an integrative orientation (combining different theoretical frameworks, 52% of all given 
treatments).
The study focused on different treatment modalities in terms of setting and duration. 
The duration of treatments was defined as ‘short-term’ for treatments which lasted up to 
six months, and ‘long-term’ for treatments which lasted more than six months. The set-
tings were defined as outpatient psychotherapy (i.e. individual or group psychotherapy 
sessions, up to two sessions per week), day hospital psychotherapy (i.e. at least one 
morning/afternoon per week, various forms of psychotherapeutic and psychosocial 
treatments, where patients sleep at home), and inpatient psychotherapy (i.e. stay at the 
institutions five days a week, various forms of psychotherapeutic and psychosocial treat-
ments, where patients sleep in the institutions). Day hospital and inpatient programs 
typically consisted of group psychotherapy as a core element, mostly in combination 
with one or more non-verbal or expressive group therapies, individual psychotherapy, 
milieu therapy, coaching for social problems, discussions about household tasks and liv-
ing together, community meetings, and/or pharmacological treatment. Before the start 
of the treatment, psychotherapists were asked to register the intended treatment in 
terms of setting and duration. When the treatment was finished, therapists were asked 
once more to register the setting and duration of the actual treatment received. Since 
this study conformed to the intention-to-treat principle, the treatments described are 
the intended treatments and are not necessarily the actual treatments received.
The six treatment modality groups in this study had the following characteristics (in-
tended treatments, mean (SD)):
1. short-term outpatient psychotherapy (N=17): sessions per week: .84 (.26), duration: 
4.82 (1.27) months, 57% group therapy, 43% individual therapy;
2. long-term outpatient psychotherapy (N=47): sessions per week: .88 (.46), duration: 
16.34 (7.22) months, 32% group therapy, 68% individual therapy;
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3. short-term day hospital psychotherapy (N=24): days per week: 3.06 (1.31), duration: 
5.75 (.74) months;
4. long-term day hospital psychotherapy (N=33): days per week: 3.02 (1.39), duration: 
12.30 (2.56) months;
5. short-term inpatient psychotherapy (N=52): days per week: 5.00 (0.00), duration: 4.06 
(1.43) months; and
6. long-term inpatient psychotherapy (N=32): days per week: 4.94 (0.21), duration: 11.22 
(3.12) months.
assessments
An extensive standard assessment battery of instruments was administered to the 
patients before treatment assignment.
Diagnosis of PD
PDs were assessed using the Dutch version of the Structured Interview for DSM-IV 
Personality (SIDP-IV; De Jong, Derks, van Oel, & Rinne, 1996; Pfohl, Blum, & Zimmerman, 
1997). This interview covers the 10 formal DSM-IV axis II diagnoses, as well as the two 
appendix diagnoses, i.e. depressive and negativistic PD. Furthermore, the self-defeating 
PD was assessed (American Psychiatric Association, 1987). Interviewers were thoroughly 
trained masters-level psychologists who received monthly booster sessions to avoid 
drift from the interviewer guidelines. Inter-rater reliability was evaluated in 25 video-
taped interviews which were rated by three observer-raters. Percentage of agreement 
between observer-raters ranged from 84% (avoidant PD) to 100% (schizoid) (median 
95%). To estimate the intraclass correlation coefficients (ICC(2,1)) for the sum of DSM-IV 
PD traits present (i.e. scores ‘2’ or ‘3’), 25 videotaped interviews were rated by three (out 
of 25) random observers, which resulted in 75 observations. With analysis of variance 
the between patients, the between observers and the residual variance components 
were calculated. The ICCs were calculated as the between patients variance divided by 
the total variance. The ICC ranged from 0.31 (schizotypal PD) through 0.88 (depressive 
PD) (median 0.66). A diagnosis of PDNOS can be obtained in two ways: (1) meeting the 
diagnostic criteria for an appendix PD (DSM-IV-TR depressive or negativistic PD, DSM-
III-R self-defeating PD) but not for any specific cluster PD, or (2) meeting the criteria for a 
mixed PD: meeting ten or more diagnostic criteria of various PDs but not for any specific 
PD. The definition of mixed PD in the current study is in agreement with some earlier 
studies (Pagan, Oltmanns, Whitmore, & Turkheimer, 2005; Wilberg et al., 2008) but not 
with other studies in which a cut-off of only five criteria was suggested (Coccaro, Nayyer, 
& McCloskey, 2012; Verheul et al., 2007). Since in clinical practice mostly ten or more 
criteria have to be met, we chose to use this definition.
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Outcome measures
The primary outcome measure was symptom severity. This was measured using the 
Dutch version of the Brief Symptom Inventory (De Beurs & Zitman, 2006; Derogatis 
& Melisaratos, 1983), a validated self-report scale derived from the revised Symptom 
Checklist-90 (Arrindell & Ettema, 2003; Derogatis, 1983). In this study, we used the mean 
score of the 53 items of the Brief Symptom Inventory, i.e. the Global Severity Index 
(GSI), ranging from zero to four. Cronbach’s Alpha was α=.96. The secondary outcome 
measures included psychosocial functioning and quality of life. Psychosocial function-
ing was measured using two subscales of the Outcome Questionnaire-45 (OQ-45), i.e. 
Interpersonal Relations and Social Role (Lambert et al., 2004). Cronbach’s Alpha was 
α=.74 for Interpersonal Relations and α=.58 for Social Role. Furthermore, health-related 
quality of life was measured using the EQ-5D (EuroQolGroup, 1995). A recent study in 
the Netherlands elicited valuations for the EQ-5D, resulting in the Dutch EQ-5D value set, 
which is used to calculate utilities for EQ-5D health states (Lamers, Stalmeier, McDonnell, 
Krabbe, & van Busschbach, 2005). Cronbach’s was α=.50. All outcome measures were 
assessed at baseline and several follow-up points. Three treatment centers conducted 
their assessments at baseline, end of treatment, at six and 12 months after the end of 
treatment, and at 36 and 60 months after baseline. Three other centers conducted their 
assessments at baseline and at 12, 24, 36, and 60 months after baseline. Different assess-
ment points were used due to logistic reasons.
Additional baseline measures
The assessment battery at baseline included three supplementary instruments to assess 
variables that were used as potential confounders for the propensity score (PS) estima-
tion. First, the Dutch version of the Dimensional Assessment of Personality Pathology-
Basic Questionnaire (DAPP-BQ) was used to measure type and degree of personality 
pathology in four domains, i.e. emotional dysregulation, dissocial behavior, inhibition, 
and compulsivity (Livesley, 2002; van Kampen, 2002). Second, to measure patients’ moti-
vation for treatment, the two scales of the Motivation for Treatment Questionnaire (MTQ-
8) were used: Need for Help and Readiness to Change (van Beek & Verheul, 2008). Third, 
the core components of personality pathology were measured using the Severity Indices 
of Personality Problems-Short Form-118 (SIPP-118), a 118-item questionnaire aimed to 
measure five core domains of personality pathology, i.e. Self Control, Identity Integration, 
Responsibility, Relational Functioning, and Social Concordance (Verheul et al., 2008).
Data completeness
Follow-up response was high, thereby enhancing the robustness of the multi-level 
analyses. We included all patients with at least one follow-up measure as multi-level 
models make optimal use of incomplete repeated measures data and are robust for 
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selective drop-out when the drop-out is missing at random (Little & Rubin, 1987). 
Figure  3.2 illustrates the proportion of patients who provided different numbers of 
follow-up assessments.
Drop-outs (6%) and completers (94%) differed significantly on only one baseline mea-
sure of the four assessed outcome variables (OQ-45 Social Role: t(213)=2.54, p=.012). 
Drop-outs had a higher mean score (M=18.00, SD=3.36) compared to completers 
(M=14.59 SD=4.75), which implies that they experienced more difficulties adjusting to 
their social role.
statistical analyses
We used multilevel modeling to deal with: (1) the dependency of the repeated mea-
sures within the same subject in time, and (2) the longitudinal data with observations 
unequally spaced in time (see ‘Outcome measures’).
First, we examined the uncorrected results on all outcome measures over 60 months 
after baseline in 12 month intervals. To estimate the uncorrected treatment effects over 
60 months after baseline, we used a random intercept and random slope model with 
time as level I and patient number as level II. In addition to a linear time effect, we pos-
tulated knots (or splines) every six months which allowed the estimated course of the 
dependant variable to bend at these time points. Non-significant knots (p<0.05) were 
deleted from the models until a parsimonious model was reached that did not differ 
significantly from the original saturated model. This resulted in a final best fitting model 
drop-out, 
N=14, 6%
1-3 follow-ups, 
N=61, 28%
5 follow-ups, 
6 follow-ups, 
N=28, 13%
Proportion of follow-up assessments
4 follow-ups, 
N=66, 30%
N=50, 23%
figure 3.2. Follow-up ratios.
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with the change scores (from baseline) observed during follow-up for each of the out-
come measures as dependent variables and the following independent variables: time, 
a spline (knot point at three years), dummy variables indicating group membership, 
interaction between time and group membership, and interaction between spline and 
group membership. Subsequently, we calculated within-group effect sizes (ES, Cohen’s 
d) using the estimated pooled standard deviations from the models to describe change 
from baseline over 60 months in each group (Cohen, 1988).
Second, since this is a non-randomized study, the comparisons of the groups had to be 
corrected for the influence of potential confounders, i.e. initial patient differences be-
tween treatment groups that are related to outcome. We included a multiple propensity 
score in our analyses to adjust for these differences and avoid bias in effect estimation. 
The classic propensity score is defined as the conditional probability of assignment to 
one of two treatment groups given a set of observed pre-treatment variables (Bartak 
et al., 2009; Rosenbaum & Rubin, 1983). The PS is designed to reduce selection bias by 
equating groups based on their pre-treatment variables and to reduce the number of 
covariates by combining these pre-treatment variables into one PS. By using the PS, the 
random assignment to one of two treatments is imitated as the PS adjusts for (observed) 
baseline differences between patients in different treatment groups. After adjustment, 
the distribution of these pre-treatment variables is similar in the two treatment groups 
(for an illustration see Bartak et al., 2009). The multiple PS is an extension of the clas-
sic propensity score to more than two treatment groups and its feasibility in mental 
health research has been illustrated earlier (Spreeuwenberg et al., 2010). To identify 
relevant confounders, we considered a broad list of social, economic, and diagnostic 
variables carefully selected by both clinicians and researchers, which were based on the 
literature and clinical knowledge (Bartak et al., 2009). Only pre-treatment characteris-
tics significantly related to the studied outcome variables were used to estimate the 
multiple propensity scores. A simulation study of Brookhart et al. (2006) showed that 
the addition of variables which were related to treatment but which were not related 
to the outcome led to an increase of the variance of the estimated treatment effect and 
removed only a small amount of bias. The multiple propensity scores were achieved by a 
multinomial regression analysis, with group membership as the dependent variable and 
pre-treatment variables significantly related to the outcome as independent variables 
(see appendix table). The propensity score method allows the possibility of visualization 
and judgment of the overlap in propensity score distributions (and thus the overlap 
in relevant variables) between treatment groups. The overlap on the PS distributions 
showed that these were sufficient for the comparison of the six treatment groups. 
Furthermore, significance testing on variables related to the outcome showed that by 
correcting for the multiple PS initial significant differences between treatment groups 
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disappeared. In earlier investigations in patients with cluster A, B, and C PDs, this visual 
judgment led to a less firm interpretation of the results (cluster A) or to the exclusion 
of treatment groups (cluster C), as the propensity score distributions were too far apart 
(Bartak et al., 2010, 2011a, 2011b).
After the analyses of the uncorrected results with the first multi-level model, a second 
multilevel model was used to compare change in outcome variables across treatment 
groups. This model included the multiple propensity scores to correct for initial patient 
differences. Dependent variables were the change scores (from baseline) observed dur-
ing follow-up for each of the outcome measures. Independent variables were time, a 
spline (knot point at three years), dummy variables indicating group membership, the 
multiple propensity scores, interaction between time and group membership, interac-
tion between spline and group membership, and the mutual interactions of the multiple 
propensity scores. This model was used to estimate differences in change scores over 60 
months after baseline in pair wise comparisons of the six treatment groups. Unstandard-
ized coefficients (b) were used to describe the size of the effect.
The analyses of outcomes were based on the intention-to-treat (ITT) principle. The 
analyses were performed using IBM SPSS Statistics 20.0 for data preparation and the 
estimation of the multiple propensity scores, and SAS 9.2 for multilevel modeling. The 
study protocol was approved by the Medical Ethics Committee of the Erasmus University 
Medical Centre in Rotterdam, the Netherlands.
rEsuLTs
sample
The sample consisted of 205 patients with a diagnosis of PDNOS and at least one follow-
up measurement (see figure 3.1). The mean age of the sample was 35.1 (SD=10.3) years, 
and 72% of the sample was female. Educational level was high (European Qualifications 
Framework [EQF]≥6) for 33%, medium (EQF 3 to 5) for 43%, and low (EQF≤2) for 23% 
(van der Sanden, Smit, & Dashorst, 2012). About one quarter (24%) of the patients were 
married or were in steady relationships, and about one quarter (27%) of the sample lived 
together with children. Two-thirds (66%) of the sample was employed or was study-
ing (see table  3.1). One hundred and thirty-four patients (65%) met the criteria for a 
mixed PD only, 34 patients (17%) met the criteria for an appendix diagnosis only, and 
37 patients (18%) met the criteria for both a mixed and an appendix PD. On average, 
14.6 (6-29) diagnostic criteria were fulfilled. For patients with a mixed PD, traits from one 
or more of the appendix diagnoses were most common (M=5.4 SD=2.4), followed by 
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traits from cluster C (M=4.8 SD=1.9) and traits from cluster B (M=3.2 SD=2.5). The least 
number of traits came from cluster A (M=1.5 SD=1.8). Of the patients with an appendix 
diagnosis, the majority (64 patients, 90%) had a depressive PD, five patients (7%) had a 
self-defeating PD, and five patients (7%) had a negativistic PD.1 A significant difference 
was found on one of the assessed outcome scales at baseline (OQ Interpersonal Rela-
tions) between patients with a mixed PD only (M=18.38 SD=5.79), patients with an ap-
pendix PD only (M=17.70 SD=6.16), and patients with both a mixed PD and an appendix 
PD (M=21.44 SD=5.87; F(2,202)=4.68, p=.01). Patients with both diagnoses reported a 
more dysfunctional interpersonal functioning compared to patients with a mixed PD 
(p=.006) or appendix PD only (p=.008).
Treatment adherence
Forty-five patients (22%) changed their intended treatment group: Of these, 38 patients 
stayed in the same setting, but for a longer (N=16) or shorter (N=22) period than planned. 
Three patients changed their treatment setting and their treatment lengths and four 
patients changed their treatment setting only. Of these, five patients followed a less 
intensive treatment and two patients a more intensive treatment (in terms of setting). 
When the intended treatment was stopped earlier than planned, this was mostly done 
in agreement with the treatment staff [N=13 (48%)], or because of the patient dropping 
out [N=13 (48%)]. One patient was forced to leave earlier by the treatment staff (4%).
Effectiveness results
Uncorrected outcomes
Sixty months after baseline, within-group effect sizes of the uncorrected scores of 
symptom severity (GSI) ranged from .91 (large effect, short-term outpatient) to 1.42 
(very large effect, short-term day hospital; see table 3.2). A positive significant change 
was found for all treatment modalities. See figure 3.3 for the course of the GSI scores.
Improvements also appeared in terms of psychosocial functioning and quality of life. 
Effect sizes for these outcome measures were somewhat smaller compared to symptom 
severity, but a positive significant change was evident in most measures at 60 months 
(except for OQ-45 Interpersonal Relations in short-term day hospital, and EQ-5D in 
short-term outpatient and short-term day hospital). Effect sizes ranged from .30 (small 
effect, OQ-45 Interpersonal Relations, short-term day hospital) to 1.46 (very large effect, 
OQ-45 Interpersonal Relations, long-term inpatient) (see table 3.3).
1 Because patients could have more than one appendix diagnosis, the sum of the prevalence is higher 
than 100%.
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Table 3.2. Within-group effect sizes over 60 months, primary outcome GSI (uncorrected).
Treatment group n
mean (sD)
Within-group effect size
(Cohen’s d)
Baseline* 12m 24m 36m 48m 60m 12m 24m 36m 48m 60m
Outpatient short 17 1.05 
(.44)
0.49 
(0.43)
0.48 
(0.47)
0.47 
(0.52)
0.52 
(0.57)
0.57 
(0.63)
1.33 1.29 1.24 1.07 0.91
long 47 1.21 
(.59)
0.72 
(0.67)
0.70 
(0.64)
0.67 
(0.60)
0.63 
(0.56)
0.59 
(0.51)
0.78 0.84 0.92 1.02 1.14
Day hospital short 24 1.37 
(.57)
0.75 
(0.59)
0.68 
(0.58)
0.61 
(0.57)
0.59 
(0.56)
0.58 
(0.57)
1.09 1.23 1.36 1.41 1.42
long 33 1.53 
(.62)
0.83 
(0.60)
0.82 
(0.64)
0.80 
(0.68)
0.76 
(0.73)
0.71 
(0.79)
1.17 1.14 1.14 1.15 1.17
Inpatient short 52 1.40 
(.53)
0.54 
(0.48)
0.63 
(0.52)
0.72 
(0.57)
0.68 
(0.61)
0.63 
(0.65)
1.72 1.48 1.25 1.27 1.31
long 32 1.59 
(.54)
0.95 
(0.63)
0.92 
(0.65)
0.89 
(0.67)
0.82 
(0.69)
0.75 
(0.71)
1.11 1.14 1.17 1.26 1.35
*means differ significantly at baseline (p<.05)
Table 3.3. Within-group effect sizes at 60 months, secondary outcomes (uncorrected).
variable Treatment group n
mean (sD) Within-group
effect size
(Cohen’s d)Baseline 60months
OQ-45
Social Role
Outpatient short 17 13.27 (5.01) 8.14 (5.56) 1.00
long 47 13.90 (4.37) 10.08 (3.11) 1.02
Day hospital short 24 13.56 (4.80) 9.58 (5.39) 0.80
long 33 14.35 (4.66) 10.15 (5.09) 0.87
Inpatient short 52 15.90 (4.80) 10.53 (5.26) 1.08
long 32 15.16 (4.55) 9.69 (4.51) 1.23
OQ-45
Interpersonal 
Relations*
Outpatient short 17 15.61 (3.85) 10.78 (4.15) 1.24
long 47 18.55 (6.52) 12.83 (5.65) 0.95
Day hospital short 24 15.64 (6.01) 13.80 (6.59) 0.30
long 33 19.50 (6.35) 14.31 (5.33) 0.90
Inpatient short 52 19.39 (5.71) 13.51 (6.40) 0.98
long 32 21.69 (4.31) 13.45 (6.86) 1.46
EQ-5D Outpatient short 17 0.68 (0.20) 0.79 (0.18) 0.60
long 47 0.67 (0.21) 0.82 (0.16) 0.81
Day hospital short 24 0.57 (0.28) 0.68 (0.21) 0.45
long 33 0.58 (0.28) 0.75 (0.30) 0.59
Inpatient short 52 0.57 (0.28) 0.73 (0.27) 0.59
long 32 0.53 (0.25) 0.75 (0.23) 0.93
*means differ significantly at baseline (p<.05)
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Corrected outcomes
We concluded that the overlap in the propensity scores was sufficient for all between-
group comparisons, indicating that the propensity score was capable to correct for 
initial baseline differences (see ‘Methods’). After correction for all relevant pre-treatment 
differences with the multiple propensity score, no significant differences were found 
between treatment modalities concerning either of the outcome measures at 60-month 
follow-up (see table  3.4). However, analyses on the intervening time points on the 
primary outcome measure did show significant differences up to 36-month follow-up. 
Strongest differences were found at 12-month follow-up (less at 24 months), mainly 
due to the low gains of long-term inpatient psychotherapy. Significant differences were 
found in favor of short-term outpatient psychotherapy compared to long-term inpa-
tient psychotherapy (b=-.57, p=.01), long-term outpatient psychotherapy compared to 
long-term inpatient psychotherapy (b=-.34, p=.05), short-term inpatient psychotherapy 
compared to short-term day hospital (b=.33, p=.02), and finally short-term inpatient 
psychotherapy compared to long-term inpatient psychotherapy (b=-.60, p=.00). Over 
time, these differences diminished and from 48 month follow-up onwards, all significant 
differences had disappeared. Concerning the secondary outcome measures, no signifi-
cant differences at 60 months after baseline were found.
1
1.5
2
G
SI
short outpatient
long outpatient
short day hospital
long day hospital
short inpatient
0
0.5
baseline 12m 24m 36m 48m 60m
Months
long inpatient
figure 3.3. Within-group results on the GSI.
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The results of this study were based on the classification of treatments on the basis of in-
tention to treat (see methods section). When completion of the intended treatment was 
introduced as a covariate, no significant differences were found between patients who 
followed their intended treatment and the ones who did not on the primary outcome 
measure (GSI). There was a trend that the initial (statistical insignificant) differences 
between these two groups became even smaller over time (b=.17, p=.07 at 12-month 
follow-up, b=-.01, p=.95 at 60-month follow-up). In the secondary outcome measures, 
the same pattern and insignificant differences were found.
Table 3.4. Difference scores (b) at 60 months (corrected).
variable Treatment group n
Outpatient Day hospital inpatient
short long short long short
GSI Outpatient short 17
long 47 -0.04
Day hospital short 24 -0.08 -0.04
long 33 -0.08 -0.04 0.00
Inpatient short 52 -0.01 0.03 0.06 0.06
long 32 -0.30 -0.27 -0.23 -0.23 -0.29
OQ-45
Social Role
Outpatient short 17
long 47 -2.67
Day hospital short 24 -2.42 0.25
long 33 -2.05 0.62 0.37
Inpatient short 52 -2.30 0.37 0.13 0.51
long 32 -1.74 0.93 0.68 -1.34 0.56
OQ-45
Interpersonal 
Relations
Outpatient short 17
long 47 -1.72
Day hospital short 24 -4.74 -3.01
long 33 -3.68 -1.96 1.06
Inpatient short 52 -2.04 -0.32 2.69 3.40
long 32 -3.63 -1.91 1.10 -5.14 -1.59
EQ-5D Outpatient short 17
long 47 0.04
Day hospital short 24 -0.07 -0.12
long 33 -0.02 -0.06 0.05
Inpatient short 52 -0.01 -0.05 0.06 0.11
long 32 -0.05 -0.09 0.03 -0.19 -0.04
GSI=Global Severity Index. OQ-45=Outcome Questionnaire-45. EQ-5D=EuroQol-5D.
b= unstandardized beta coefficients. Positive coefficients indicate that the treatment group shown in the 
left column is superior, negative coefficients indicate that the treatment group in the above row is superior.
* p < 0.05, ** p < 0.01, *** p < 0.001.
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DisCussiOn
This is the first study to compare the effectiveness of various treatment modalities in 
patients with PDNOS. Patients in all treatment modalities showed positive outcomes 
at short- and long-term follow-up, especially in terms of improvements of symptom 
severity and social role functioning. This study provides evidence that PDNOS patients 
profit from psychotherapy and that accomplished changes are maintained over time. 
Strongest differences were found at 12-month follow-up. In terms of symptom severity, 
short-term outpatient psychotherapy, long-term outpatient and short-term inpatient 
psychotherapy was found to be superior to long-term inpatient psychotherapy. Short-
term inpatient psychotherapy was found to be superior to short-term day hospital 
treatment. At 60-month follow-up, the observed differences between modalities were 
diminished. The higher effect sizes of the short-term outpatient and short-term inpatient 
psychotherapies decreased, while the lower effect sizes of the long-term outpatient and 
long-term inpatient psychotherapies increased. Concerning day hospital treatment, we 
found a deviant course over time, i.e. an increase in effect size of the short-term modal-
ity, and a stable effectiveness over time for the long-term modality.
Embedding of previous studies
To the best of our knowledge, the study of Karterud et al. (2003) on day hospital treat-
ment in PD patients is the only study reporting treatment results separately for PDNOS 
patients (Karterud et al., 2003). The admission GSI score of PDNOS patients in their study 
(M=1.4, sd=.6) was comparable to the baseline GSI score in our day hospital patients 
(short-term day hospital M=1.37, sd=.57, long-term day hospital M=1.53, sd=.62). 
However mean GSI scores at one year follow-up were lower in the current sample (short-
term day hospital M=.75, sd=.59/long-term day hospital M=.83, sd=.60) and effect sizes 
were therefore higher than in the sample of Karterud et al (M=1.1, sd=.7). It is difficult 
to explain where these differences came from, given the same GSI score at baseline and 
while other variables were unknown.
Within the same SCEPTRE project, three studies were published on the effectiveness of 
different modalities of psychotherapy in patients of the DSM-IV-TR cluster A, B, and C 
PDs, respectively. These studies revealed invariably positive effects at 12 or 18 months 
after baseline (long-term follow-up is not available, yet, (Bartak et al., 2010, 2011a, 
2011b). A comparison with these populations showed that PDNOS patients reported 
the healthiest scores on all outcome measures at baseline, thus reporting the least psy-
chological distress, a better psychosocial functioning, and a higher quality of life, which 
is in accordance with earlier studies (Verheul et al., 2007; Wilberg et al., 2008). Given the 
different follow-up time points (12 and 18 months) and treatment groups (three, five and 
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six groups), it was possible to compare the effectiveness between PDNOS and cluster A, 
B, and C patient groups in a general way only. This comparison demonstrated that con-
cerning symptom severity, PDNOS patients in outpatient and inpatient psychotherapies 
showed higher effect sizes compared to cluster A, B, and C PD patients. PDNOS patients 
in day hospital psychotherapies, however, seemed to benefit more compared to cluster 
A and C patients, but benefitted less compared to cluster B patients. Furthermore, three 
long-term studies on the effectiveness of psychotherapeutic treatments lasting one to 
three years in PDs showed results comparable to the current study. First, in the study of 
Chiesa & Fonagy (2003), and Chiesa, Fonagy, & Holmes (2003), a steady drop in the GSI 
score and therefore a steady increase in effectiveness was found in a group of PD patients 
of which more than half met the criteria for a PDNOS diagnosis (Chiesa & Fonagy, 2003; 
Chiesa, Fonagy, & Holmes, 2003). Treatments consisted of an inpatient and a step-down 
program (consisting of inpatient treatment which was followed by outpatient treat-
ment) and results were presented at three and six years follow-up. Second, in studies on 
mainly BPD patients, Giesen-Bloo et al. (2006) showed stable differences for outpatient 
schema-focused therapy vs. transference-focused therapy at three years follow-up, and 
finally Bateman & Fonagy (2008) showed stable effectiveness for day hospital MBT vs. 
treatment as usual (general psychiatric services) at eight years follow-up. These studies 
support the notion that PDNOS patients have a similar development in psychotherapy 
compared to other PDs.
Possible explanations of findings
Generally, we found higher but decreasing effects in short-term outpatient and short-
term inpatient psychotherapies, and lower but increasing effects in long-term outpatient 
and long-term inpatient psychotherapies. This led to insignificant differences between 
treatment groups at long-term follow-up which is in line with earlier effectiveness stud-
ies on psychotherapeutical treatments and supports the conclusion that differences in 
effectiveness of active treatments in PD are negligible, also called “equivalence effect” or 
“dodo-bird effect” (Budge et al., 2013; Wampold et al., 1997). Five possible explanations 
for the results found are set out hereafter.
First, the axis-I study of Knekt et al. (2008) on the effectiveness of short-term (i.e., five 
to six months) and long-term (i.e., up to three years) psychodynamic psychotherapy for 
patients with mood and anxiety disorders showed similar results. Within the first year 
after the start of the treatment, the short-term psychotherapy group showed better 
results than the long-term group in terms of psychiatric symptoms, while at three year 
follow-up the long-term group even exceeded the short-term group in terms of treat-
ment success. Knekt et al. explained this difference as being due to the difference in 
duration of treatment which influences the orientation and aim of therapy. In short-term 
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therapies, an active and problem-based orientation is applied, which patients can make 
use of, and profit from, in a short period of time. On the other hand, long-term therapies 
aim for “more global changes by affecting the patient’s long-term vulnerability to stressors”, 
requiring more time to achieve good results.
Second, explanations for the superiority of the short-term psychotherapies in the short-
term are that these typically have a highly structured format, a consistently applied 
theoretic orientation, and are focused with respect to treatment targets right from the 
start of treatment. Such aspects are typically less pronounced in long-term treatments. 
Both the level of structure and the consistent application of a comprehensible, coherent 
theoretical orientation can be considered key components of effective psychotherapies 
(Bateman & Fonagy, 2000).
Third, high pressure in the therapy might accelerate the therapy effect. However, high 
pressure is difficult to imagine bearable in long-term treatment. Short-term treatments 
are therefore in a better position to use high pressure, facilitating changes to come more 
quickly.
Fourth, since this PDNOS population is characterized by slightly milder symptoms com-
pared to patients with formal PD diagnoses, potential iatrogenic effects could occur in 
long-term hospitalization which could account for the poorer short-term effects for the 
long-term inpatient psychotherapy (Fonagy & Bateman, 2006).
Fifth, evidence suggested that the best outcome is usually apparent a few weeks or 
months after the termination of treatment, followed by some relapse and a consolidation 
of results (Perry et al., 1999). This would give the short-term treatments an advantage on 
short-term follow-up, as these treatments had already finished and could explain part 
of the results found.
strengths and limitations
The most important strength is the inclusion of a large number of patients as well as the 
rather equal division of patients over various treatment modalities. Another strength is 
its representativeness and therefore high external validity due to the naturalistic design 
of the study, a minimal set of exclusion criteria, and a long-term follow-up period of five 
years.
This study has also several limitations. First, the study is limited by the fact that patients 
were not randomized. However, comparisons between markedly different treatment 
modalities or dosages, as were made in this study, are not feasible in a randomized 
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study. Most patients would probably refuse to be randomly assigned to a condition 
which consists of either three months outpatient psychotherapy or 12 months inpatient 
psychotherapy (an example of the greatest contrast). However, this limitation is mitigat-
ed by the fact that we controlled as rigorously as possible for initial patient differences 
as potential confounders by means of the multiple propensity score. It is important to 
acknowledge that this score corrects for observed differences only, and it cannot correct 
for unobserved differences. Therefore it is possible that the treatment groups differed 
on aspects that we did not measure and therefore could not control for. However, we 
controlled for a substantial number of social and diagnostic variables, which minimizes 
the possibility that important variables were overlooked. Second, another limitation is 
the difference of loss to follow-up which was higher in the long-term psychotherapies 
compared to the short-term psychotherapies. This concern is somewhat mitigated 
since we found no significant differences in the outcome measures at baseline between 
patients with and without follow-up, with one exception, and the general low loss to 
follow-up. Third, this study focused on treatment dosage and did not take into account 
other treatment attributes such as the potential impact of theoretical orientation and 
medication use or patient attributes, such as Axis I comorbidity. However, we came 
across two complications to investigate the impact of theoretical orientation. First, 
more than 50% of the given treatments were considered integrative treatments (e.g., 
Schema-Focused Therapy (SFT), Dialective Behavior Therapy (DBT) and Mentalization 
Based Treatment (MBT)). Second, as theoretical orientation was associated with setting 
and duration, a different research design would have been necessary to explore the ef-
fect of theoretical orientations in addition to treatment modalities. Furthermore, studies 
for PD typically show that theoretical orientations only account for small differences in 
effectiveness (Bartak et al., 2007). Nevertheless, we consider this study to be a starting 
point for further research. Future studies are recommended to take these other treat-
ment and patient attributes into account. Fourth, the absence of a control condition 
without psychotherapy or a placebo condition makes it less straightforward to conclude 
that psychotherapy works in patients with PDNOS. Part of the effectiveness could also 
be due to natural recovery or regression towards the mean. Nevertheless, in the review 
of Perry et al. (1999) it was concluded that psychotherapeutic treatments may lead to 
a sevenfold increase in speed of recovery in comparison with natural recovery. Fifth, a 
limitation is that effectiveness is determined by self-report. From the present study we 
know that patients report less complaints and a better functioning, but we do not have 
information whether patients still meet criteria for a PD diagnosis after five years. Sixth 
and finally, sites overlapped only partially in terms of the (equal) availability of the six 
modalities. Disentangling the site effect would reduce statistical power. The reason why 
we did not do so is that we could not think of any valid reason why, given the specialist 
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expertise of the six sites involved in this study, sites would have a clinically important 
and interpretable impact on treatment effectiveness.
Clinical and scientific implications
As this is the first large-scale treatment study in patients with PDNOS, it is difficult to 
translate the results into definitive conclusions and strong recommendations for clinical 
practice. It might be that short-term psychotherapeutic treatments are preferred for this 
patient population since patients in these treatment modalities improved quickly. Fur-
thermore, since all treatment modalities seemed to be equally effective in the long run, 
it might be preferable to make treatment choices based on pragmatic reasons. Therefore 
a treatment with the least impact on every-day life and - for economic reasons - the least 
costly treatment could be the way forward.
Our results have several implications for future research. First, a cost-effectiveness study 
is essential to inform policy makers in a budget-constrained health care system. The 
cheapest treatment is not necessarily the most cost-effective treatment. Patients who 
have followed an intensive – and therefore expensive – but effective treatment might 
function better and consume less additional care after treatment compared to patients 
who followed less intensive and less effective treatments. In other words, intensive 
and expensive treatments might provide more long term benefits thereby ultimately 
proving superior to cheaper and less intensive therapies. Therefore, a state-of-the art 
cost-effectiveness analysis should be performed, as has already been carried out for 
cluster B and cluster C PDs (Soeteman et al., 2010; Soeteman et al., 2011). Since the 
costs of short-term treatments are generally lower compared to their longer counter-
parts (especially compared to long-term inpatient psychotherapy) and they show a 
rather high effectiveness, it might be expected that short-term outpatient and inpatient 
psychotherapies in PDNOS are more cost-effective than longer-term alternatives. Sec-
ond, subgroup analyses directed at ‘what works for whom’ could give more valuable 
information for clinical practice about which treatments work best for which category 
of patients instead for which category of diagnoses. This is even more important in this 
patient group since various definitions of PDNOS are used in clinical practice and across 
studies, limiting the comparability and generalizability of study findings (Coccaro et al., 
2012; Verheul & Widiger, 2004; Wilberg et al., 2008). Third, more research about the effect 
of dosage would be valuable. In the current study, dosage was defined as a product of 
setting in three and duration in two stratifications. The study of a further division in 
smaller units of time could give more useful information for clinical practice.
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Conclusions
In conclusion, based on long-term follow-up, all treatment modalities were shown to be 
approximately equally effective treatments in a PDNOS population. However, short-term 
outpatient and short-term inpatient psychotherapy, limited to a duration of six months, 
displayed higher effect sizes on short-term follow-up. This study provides the first 
evidence for the benefit of different treatment modalities for one of the most prevalent 
mental disorders in clinical practice: PDNOS. Further state-of-the-art cost-effectiveness 
studies will inform us about the most cost-effective treatments.
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absTraCT
background
Controlled studies on the effectiveness of inpatient psychotherapy in personality 
disorders (PD) are rare. This study aims to compare 3-month short-term inpatient psy-
chotherapy based on Transactional Analysis (STIP-TA) with other psychotherapies (OP) 
up to 36 months follow-up.
methods
PD patients following STIP-TA were matched with OP patients using the propensity 
score. Primary outcome measure was general psychiatric symptomatology; secondary 
outcomes were psychosocial functioning and quality of life.
results
In 67 pairs of patients, both STIP-TA and OP showed large symptomatic and functional 
improvements. However, STIP-TA showed more symptomatic improvement at all time 
points as compared to OP. At 36 months, 68% of STIP-TA patients were symptomatically 
recovered compared to 48% in OP.
Conclusions
STIP-TA outperformed OP in terms of improvements in general psychiatric symptom-
atology and quality of life. Superiority of STIP-TA was most pronounced at 12–month 
follow-up, but remained intact over the course of the three-year follow-up.
Declaration of interest
None.
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inTrODuCTiOn
There is now compelling evidence to support the hypothesis that personality disorders 
(PDs) are treatable and changeable (e.g. Arnevik, Wilberg, Urnes, Johansen, Monsen, & 
Karterud, 2010; Binks, Fenton, McCarthy, Lee, Adams, & Duggan, 2006; Dixon-Gordon, 
Turner, & Chapman, 2011; Gabbard, 2000; Leichsenring & Leibing, 2003; Perry, Banon, 
& Ianni, 1999; Stoffers, Vollm, Rucker, Timmer, Huband, & Lieb, 2012).Based on the 
evidence, various systematic literature reviews and clinical guidelines conclude that 
psychotherapy is the treatment of first choice (e.g. Bartak, Soeteman, Verheul, & Buss-
chbach, 2007; Landelijke Stuurgroep Multidisciplinaire Richtlijnontwikkeling in de GGZ, 
2008; National Institute for Health and Clinical Excellence, 2009a, 2009b). Although most 
studies concern well-known treatments for borderline personality disorder (BPD), such 
as Schema-Focused Therapy (SFT), Transference-Focused Psychotherapy (TFP), Dialec-
tical Behaviour Therapy (DBT), and Mentalization-Based Treatment (MBT) (e.g. Dixon-
Gordon, Turner, & Chapman 2011; Gabbard, 2000), a growing number of studies docu-
ment psychotherapy’s effectiveness in other PDs as well. In the past ten years, several 
reviews were done on the effectiveness of psychotherapeutic treatments in general PD 
patients. Positive results were reported for time-limited psychodynamic psychotherapy 
and cognitive behavioural therapy (Leichsenring & Leibing, 2003; Matusiewicz, Hop-
wood, Banducci, & Lejuez, 2010; Town, Abbass, & Hardy, 2011; Verheul & Herbrink, 2007), 
whereas rather limited and conflicting evidence concerning long-term psychoanalytic 
psychotherapy (Smit, Huibers, Ioannidis, van Dyck, van Tilburg, & Arntz, 2012).
Remarkably, the treatment literature on PD typically considers long-term treatments in 
an outpatient setting. An interesting and viable alternative might be Short-Term Inpa-
tient Psychotherapy (STIP). For example, Bartak et al. (2010) and Soeteman et al. (2011) 
have recently shown superior effectiveness and efficiency of STIP (with a maximum dura-
tion of six months) as compared to other treatment modalities in patients with a cluster 
C PD. In that particular study, STIP included a variety of durations (e.g. both 3-month 
and 6-month psychotherapy) and theoretical orientations (e.g. cognitive-behavioural 
and psychodynamic treatment). The current study focuses on the effectiveness of the 
shortest, 3-month variant, i.e. STIP based on Transactional Analysis (STIP-TA). Thunnissen 
et al. (2008) reported on treatment outcome of STIP-TA in a naturalistic cohort study and 
found an effect size of 2.0 two years after start of the treatment and a recent review of 
studies on TA in psychotherapy found a positive effect of TA in more than 80% of the 
studies reviewed (Ohlsson, 2010). This study will compare the effectiveness of STIP-TA 
to other specialized psychotherapies (OPs) in PD patients in a non-randomized, but 
nevertheless rigorously controlled trial.
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study population and design
Patients were recruited from March 2003 to March 2006 from a consecutive series of 
admissions to six mental health care institutes in the Netherlands offering specialized 
psychotherapy for adult patients with PD. In this period of time, 1,379 patients com-
pleted the intake procedure. Of these, 837 had a DSM-IV-TR PD diagnosis (American Psy-
chiatric Association, 2000), provided informed consent and were enrolled in the Study 
on Cost-Effectiveness of Personality Disorder Treatment (SCEPTRE), a large multicenter 
project in the Netherlands focusing on the effectiveness and cost-effectiveness of psy-
chotherapeutic treatments in PD patients (Bartak et al., 2010). After informed consent, 
38 patients dropped out prematurely. This left 764 patients of which 76 received STIP-TA 
at De Viersprong, Netherlands Institute for Personality Disorders, and 688 patients re-
ceiving other specialized psychotherapies (OP). Five patients of STIP-TA and 100 patients 
of OP were lost to follow-up. It was not possible to find a good match for four STIP-TA 
patients, therefore, 67 STIP-TA patients were matched to 67 OP patients 1-to-1 by the 
logit of the propensity score, which left 134 patients for this trial (see figure 4.1).
handling data
All outcome measures were assessed at baseline and several follow-up points. Various 
follow-up points had to be used due to logistic reasons: three treatment centers had 
their assessments at baseline, end of the treatment, six and 12 months after the end of 
treatment, and at 36 and 60 months after baseline, whereas three other centers had their 
assessments at baseline, at 12, 24, 36, and 60 months after baseline. Ninety-five percent 
of the STIP-TA patients had three or more follow-up measurements, as compared to 88% 
of the matched OP patients.
statistical analyses
The matching of patients was done by matching each patient 1-to-1 on the logit of 
the propensity score (Rosenbaum & Rubin, 1985). Both, the propensity score and the 
matching are explained below. The propensity score (PS) is defined as the conditional 
probability of assignment to one of two treatment groups given a set of observed 
pre-treatment variables (Bartak et al., 2009; Rosenbaum & Rubin, 1983). To estimate the 
PS, we fitted one logistic regression model with group membership (STIP-TA or OP) as 
outcome. In order to create two similar samples at baseline, relevant confounders which 
were related to the outcome variable were used as independent variables (Brookhart et 
al., 2006). Fifty-four sociodemographic and clinical variables were selected as potential 
confounders based on clinical knowledge and a literature review. Of these, 27 variables 
had a significant influence on the outcome and were used in the estimation of the PS. 
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Sociodemographic variables (e.g. age, sex, level of education) and clinical variables (e.g. 
motivation, baseline scores of the outcome measures, SIPP-118 scales, PD diagnoses) 
were included (a full list of these variables is provided in the appendix). Additionally, 
indirect and direct medical costs in a 12-month period before baseline were added as 
potential confounders in order to create a sample which can be used for future cost-
effectiveness analyses. Since the logit of the PS is more likely to be normally distributed 
than the propensity score, matching was done on the logit of the PS. The logit is the 
logarithm of the PS divided by one minus the PS. In order to receive optimal balance 
Enrolled/informed 
consent
n=837
Assessed for eligibility
n=1379
Not meeting inclusion criteria n=146
Met exclusion criteria n=9
No PD diagnosis n=115
Refusal n=100
Allocated
n=799
STIP-TA
n=67
Matched OPs
n=67
Short-Term Inpatient 
Psychotherapy - 
Transactional Analysis 
(STIP-TA)
n=76
Other Psychotherapies 
(OP)
n=723
Early drop-out n=38
Missing/unreliable data n=141
Logistic reasons n=31
Loss to follow-up n=100
Unable to find good match n=556
Loss to follow-up n=5
Unable to find good match n=4
figure 4.1. Patient flowchart.
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between the treatment groups, a caliper distance of .2 of the standard deviation (SD) of 
the logit of the PS was used (Austin, 2011).
The matching was done by first ordering subjects of the STIP-TA group randomly. The 
control subject with the smallest distance of the PS logit with the STIP-TA subject and 
whose PS logit fell within the caliper width, was identified as match. This pair was then 
removed from the pool and a match was sought for the next STIP-TA subject. STIP-TA 
subjects for whom no match could be found with a PS logit within the caliper, were also 
removed.
Multilevel models were used for the analysis of outcomes over time. We used multilevel 
modelling to deal with: (1) the dependency of the repeated measures within the same 
subject in time, (2) the dependency of patients within a pair, and (3) the longitudinal data 
with observations unequally spaced in time. The levels were (1) time within patients, (2) 
patients within pairs and (3) pairs. To estimate the treatment effects at 12, 24 and 36 
months after baseline, we used random effects for pairs, patients within pairs, and time 
within patients. We used a random intercept model with time as level I and pair number 
as level II and a second model with a random intercept and random slope with time as 
level I and patient number as level II. In addition to a linear time effect, we postulated 
knots (or splines) every six months which allowed the estimated course of the dependant 
variable to bend at these time points. Non-significant knots (p<0.05) were deleted from 
the models until a parsimonious model was reached that did not differ significantly from 
the original saturated model. This resulted in a final best fitting model with the change 
scores (from baseline) observed during follow-up for each of the outcome measures as 
dependent variables and the following independent variables: group membership, time, 
interaction between group membership and time, the deviation of the overall baseline 
score (in order to take the baseline scores into account), a linear spline (knot point at 
18 months), and interaction of the spline with the treatment group. Subsequently, we 
calculated within-group effect sizes (Cohen’s d) to describe change from baseline to 12, 
24, and 36 months in both groups (Cohen, 1988). We used the estimated pooled SDs 
combining the baseline SD with the follow-up SDs from the models.
Outcome analyses are based on the intention-to-treat (ITT) principle. All patients who 
received a ‘minimal exposed dose effective dosage’ (defined as at least two sessions of 
outpatient psychotherapy or at least two treatment days of day hospital or inpatient 
psychotherapy) were followed and included in the analyses. The analyses are performed 
using IBM SPSS 20.0 (IBM Corporation, USA) for data preparation and SAS 9.2 (SAS 
Institute Inc, USA) for multi-level modeling. Differences of p<0.05 were considered 
statistically significant.
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assessments
Baseline measures
An extensive standard assessment battery of instruments was administered to the 
patients before treatment assignment.
Classification of PD
PDs were classified using the Dutch version of the Structured Interview for DSM-IV 
Personality (SIDP-IV) (De Jong, Derks, van Oel, & Rinne, 1996; Pfohl, Blum, & Zimmerman, 
1997). This interview covers the 11 formal DSM-IV-TR Axis II diagnoses including PD 
Not Otherwise Specified (PDNOS). The PDNOS diagnosis applied to either an appendix 
diagnosis (i.e. depressive, passive-aggressive PD, or self-defeating PD) or a mixed PD 
(meeting ten or more diagnostic criteria of various PDs). Interviewers were master-
level psychologists, who were trained thoroughly, and who received monthly booster 
sessions to avoid deviation from the interviewer guidelines. Percentage of agreement 
between observer-raters ranged from 84% (avoidant PD) to 100% (schizoid) (median 
95%). To estimate the intraclass correlation coefficients (ICC(2,1)) for the sum of DSM-IV 
PD traits present (i.e. scores ‘2’ or ‘3’), 25 videotaped interviews were rated by three (out 
of 25) random observers, which resulted in 75 observations. The intraclass correlation 
coefficients (ICC(2,1)) ranged from 0.31 (schizotypal PD) through 0.88 (depressive PD) 
(median 0.66).
Self-report
Besides the three outcome measures GSI, OQ-45 and EQ-5D (discussed below), three 
additional self-report instruments to measure patient characteristics were included in 
the assessment battery at baseline and were used as potential confounders for the PS. 
First, the Dutch version of the Dimensional Assessment of Personality Pathology-Basic 
Questionnaire (DAPP-BQ) measures type and degree of personality pathology (Livesley, 
2002; van Kampen, 2002). We used patients’ scores on this questionnaire on the four 
higher-order factors: emotional dysregulation, dissocial behavior, inhibition, and com-
pulsivity. Second, to measure patients’ motivation for treatment, the two scales of the 
Motivation for Treatment Questionnaire (MTQ-8) were used: need for help and readiness 
to change (van Beek & Verheul, 2008). Third, the Severity Indices of Personality Prob-
lems-118 (SIPP-118) is a self-report questionnaire aimed to measure five core domains 
of personality pathology, i.e. self control, identity integration, responsibility, relational 
functioning, and social concordance (Verheul et al., 2008).
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Main outcome measures
The primary outcome measure was general psychiatric symptomatology, as measured 
by the Global Severity Index (GSI) of the Dutch version of the Brief Symptom Inventory 
(BSI). The BSI is a brief self-report questionnaire which covers nine symptom dimen-
sions and is developed from the Symptom Checklist 90 - Revised (SCL-90-R) (Arrindell & 
Ettema, 2003; Derogatis, 1983). The GSI is calculated as the mean score of the 53 items of 
the BSI, ranging from zero to four (De Beurs & Zitman, 2006; Derogatis, 1992; Derogatis 
& Melisaratos, 1983).
As secondary outcomes, psychosocial functioning was measured using two subscales 
of the Outcome Questionnaire-45 (OQ-45), i.e. Interpersonal Relations and Social Role 
(Lambert et al., 2004), and health-related quality of life was measured using the EQ-5D 
(EuroQolGroup, 1995). A study in the Netherlands measured and valuated the EQ-5D, 
resulting in the Dutch EQ-5D value set, which is used to calculate utilities for EQ-5D 
health states (Lamers, Stalmeier, McDonnell, Krabbe, & van Busschbach, 2005).
To evaluate clinically significant change at 36 months after baseline in terms of the GSI 
and the OQ-45, we followed the criteria by Jacobson and Truax (1991). The cut-off and 
reliable change index of the manual of the BSI (Derogatis, 2011) and of the article on the 
validation of the OQ-45 in a Dutch population (De Jong et al., 2007), respectively, were 
used. Differences between treatment groups were analyzed using McNemar’s test.
interventions
STIP-TA
Transactional analysis (TA) is a theory of personality development, intrapsychic func-
tioning, and interpersonal behavior developed by Eric Berne in the 1950s. It is based 
on psychoanalytical ideas and integrates elements of ego psychology, object relations 
theory, and learning theory (Barnes, 1996, 2007). The aim of TA is to think, feel, and act 
more adaptively by changing old and dysfunctional patterns of behavior. Although TA 
does not explicitly state to work on mentalizing and metacognition, these concepts are 
extensively addressed in TA and described in Hawkes (2011).
STIP-TA had incorporated the ideas of transactional analysis in a very short (13 weeks) 
inpatient psychotherapy. It was specifically designed for and tailored to the needs of 
patients with various PDs, particularly cluster C PD and PDNOS. The program typically 
includes patients with childhood traumatic experiences, such as severe illness, disability 
or death (sometimes by suicide) of a parent, emotional or physical neglect, and sexual 
or physical abuse. The treatment is guided by an individual treatment contract. In this 
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contract, patients state in which way they want to change their patterns of thinking, 
feeling, and behavior. The TA program helps them to understand how they function 
interpersonally, and start to see connections between the external and their internal 
world and the roots of their patterns, originating in their childhood experiences.
Specific for STIP-TA are the following eight characteristics: One shared vision which is 
carried out by the staff; one shared language; shared responsibility of patients and staff; 
working with contracts on a focal spectrum of problems; structure in time, place and 
person; continuous evaluation of progress; active and well trained therapists (Delimon, 
1999). STIP-TA included group psychotherapy, psychomotor and art therapy, sociother-
apy, and milieu therapy. Non-verbal therapies are included as these are better entrances 
for many patients to explore their dysfunctional patterns compared to verbal therapies. 
As therapists (including the psychotherapist, psychosocial nurses, psychiatrist, and non-
verbal therapist) work very closely together and share their experiences in working with 
the patient group two times a day, patients are followed carefully in their treatment 
process and progress (Delimon, 1999; Thunnissen, 2007).
Other psychotherapies
The specialized psychotherapies consisted of treatments varying widely in terms of 
setting (i.e. outpatient, day hospital, and inpatient), duration (i.e. ranging from 3-month 
to 36-month programs), and theoretical orientation (e.g. cognitive-behavioral or psy-
chodynamic). The matched OP group consisted of six patients (9%) following short-term 
and 18 patients (27%) following long-term outpatient therapy (i.e. individual or group 
psychotherapy sessions, up to two sessions per week), seven patients (10%) following 
short-term and 11 patients (16%) following long-term day hospital therapy (i.e. at least 
one morning/afternoon per week, various forms of psychotherapeutic and psychosocial 
treatments, but sleeping at home), and nine patients (13%) following short-term and 16 
patients (24%) following long-term inpatient therapy (i.e. staying at the hospital up to 
five days a week, including various forms of psychotherapeutic and psychosocial treat-
ments). Day hospital and inpatient programs typically consisted of group psychotherapy 
as a core element, mostly in combination with one or more non-verbal or expressive 
group therapies (such as psychomotor and art therapy), individual psychotherapy, 
sociotherapy, milieu therapy, community meetings, and/or pharmacological treatment. 
Twenty-two percent of treatments had a cognitive-behavioral orientation, 30% had a 
psychodynamic orientation, 42% had an integrative orientation, and the remaining 5% 
had an unspecified orientation. The psychotherapists were all licensed psychiatrists or 
psychologists. All treatments under study were tailored to patients with personality 
pathology and can be considered highly representative of specialist mental health care 
in the Netherlands.
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sample
The sociodemographic and clinical characteristics of STIP-TA and OP patients are 
displayed in table 4.1. As expected, differences between the two groups were not sig-
nificant (t-tests and χ²-tests). Mean age of patients in STIP-TA was 39.4 years, in OP 39.3. 
Thirty-three percent of STIP-TA and 27% of OP were male. Forty-nine percent of STIP-TA 
and OP patients were living together with a partner. Fifty-eight percent of STIP-TA and 
fifty-seven percent of OP worked or was studying. Most patients (91% STIP-TA, 88% 
OP) were diagnosed with either a cluster C PD (49% of STIP-TA, 39% of the OP group) 
and/or a PDNOS (42% STIP-TA, 49% OP). The largest part of the sample had a history of 
outpatient treatment.
Figure 4.2 displays the distribution of the estimated probabilities of assignment to STIP-
TA (propensity scores) before and after matching. After matching, the STIP-TA and the 
OP group were virtually equal with respect to the distribution of the propensity scores 
with STIP-TA having a propensity score of .259 (SD=.18), and matched controls of .260 
(SD=.18, t(66)=.26, p=.797).
Treatment adherence
Since the Sceptre study initially focused on treatment dosage only, intended and real-
ized treatments were described in terms of setting (outpatient, day hospital or inpatient 
psychotherapy) and duration of the treatments (short- or long-term). At the end of the 
treatment, 100% of the STIP-TA patients had completed the intended treatment dos-
age, compared to 85% of the OP, a significant difference (χ2=10.81, df=1, p=.001). Of 
the patients who changed treatment dosage, the deviation of the intended dosage 
was mainly due to the duration of treatment: 50% received a shorter treatment, while 
the remaining 50% received a longer treatment. One OP patient (2%) also changed the 
treatment setting.
Treatment Outcome
At all time points (12, 24, and 36 months), both groups showed symptomatic improve-
ments and large effect sizes (ES) (Cohen, 1992). Nevertheless, STIP-TA outperformed the 
OP group at all time points, especially at twelve months after start of treatment (b=.35, 
p<.001; see table 4.2). Effect sizes at 12 months follow-up were 2.02 for STIP-TA and 1.18 
for OP. At 36 months, STIP-TA still outperformed OP (b=.21, p=.0082; see table 4.2) with 
effect sizes of 1.93 for STIP-TA and 1.39 for OP. Figure 4.3 shows the course of general 
psychiatric symptomatology over 36 months.
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Table 4.1. Sociodemographic and clinical characteristics of STIP-TA and OP patients.
sociodemographic and clinical characteristics
sTiP-Ta OP
n=67 n=67
mean (s.d.)
Age, years 39.4 (9.8) 39.3 (10.2)
n (%)
Male gender 22 (33) 18 (27)
Education
High (EQF¹≥6) 26 (39) 24 (36)
Medium (EQF¹ 3-5) 27 (40) 31 (46)
Low (EQF¹≤2) 14 (21) 12 (18)
General way of living
Alone (with or without child) 31 (46) 25 (37)
With partner (with or without child) 33 (49) 33 (49)
With parent(s) 2 (3) 6 (9)
With other people 1 (2) 3 (5)
Care for child(ren) 19 (28) 27 (40)
Civil status
Married/steady relationship 23 (34) 26 (39)
Divorced/widowed 8 (12) 7 (10)
Never married 36 (54) 34 (51)
Mode of employment
Paid work/study 39 (58) 38 (57)
Unemployed/other 28 (42) 29 (43)
Presence PD*
Cluster A 1 (2) 2 (3)
Cluster B 8 (12) 7 (11)
Cluster C 33 (49) 26 (39)
PDNOS 28 (42) 33 (49)
mean (s.d.)
Number of PDs 1.8 (0.9) 1.6 (0.9)
Number of PD criteria 17.1 (5.6) 15.9 (6.2)
Previous treatment
Outpatient treatment 62 (93) 55 (82)
Inpatient treatment 11 (16) 16 (24)
Medication treatment 41 (61) 34 (51)
¹European Qualifications Framework
²Since it is possible to have more than one diagnosis, the sum of the prevalence is higher than 100%.
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t(692)=-13.17; p<.001 t(66)=.26; p=.797
figure 4.2. Distribution of estimated probabilities of assignment to STIP-TA treatment (propensity scores) 
before and after matching.
Table 4.2. Mean outcome and effect size in STIP-TA and OP patients.
mean (s.d.) baseline 12 months 24 months 36 months
Cohen’s d
(within-group)
12 months 24 months 36 months
GSI
STIP-TA (n=67) 1.59 (0.58) 0.55 (0.45) 0.62 (0.46) 0.57 (0.47) 2.02 1.87 1.93
OP (n=67) 1.59 (0.58) 0.90 (0.60) 0.80 (0.59) 0.78 (0.59) 1.18 1.36 1.39
b 0.35* 0.18* 0.21*
OQ-45
Social Role
STIP-TA (n=67) 16.53 (4.31) 11.35 (6.63) 11.02 (6.62) 10.83 (6.67) 0.93 0.99 1.02
OP (n=67) 15.63 (4.50) 11.74 (6.90) 10.86 (6.52) 10.57 (6.39) 0.67 0.86 0.92
b 1.29 0.75 0.64
Interpersonal Relations
STIP-TA (n=67) 21.22 (6.17) 15.49 (4.26) 15.67 (4.37) 14.87 (4.53) 1.09 1.05 1.18
OP (n=67) 20.39 (5.10) 16.37 (4.89) 15.10 (4.68) 14.77 (4.52) 0.81 1.09 1.05
b 1.71 0.26 0.73
EQ-5D
STIP-TA (n=67) 0.54 (0.27) 0.82 (0.20) 0.81 (0.21) 0.80 (0.22) 1.19 1.1 1.04
OP (n=67) 0.53 (0.26) 0.69 (0.27) 0.73 (0.26) 0.73 (0.25) 0.61 0.76 0.79
b   0.12* 0.07* 0.05      
GSI=Global Severity Index. OQ-45=Outcome Questionnaire-45. EQ-5D=EuroQol-5D.
b= regression-coefficient of the difference of the outcome measures, * regression-coefficient b significant at 
p<0.05.
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At 36 months after baseline, 44 pairs of patients (66%) had a 36-month follow-up mea-
surement and were compared in terms of clinically significant change. Ninety percent 
of the STIP-TA patients and 71% of the OP patients showed a reliable change (p=.03), 
and 0% of STIP-TA patients and 4% of OP patients demonstrated clinical deterioration in 
terms of psychiatric symptomatology (McNemar’s test can be carried out only for a pxp 
table, where p must be greater than 1.). Sixty-eight percent of STIP-TA patients and 48% 
of OP patients moved from a dysfunctional range to a normative range (p=.08). All pa-
tients who moved from a dysfunctional range to a normative range also demonstrated 
reliable change.
Two additional sensitivity analyses were done to further examine the data. First, a sen-
sitivity analysis was done on the severity of PD pathology. Patients scoring 15 or less PD 
criteria (median number of traits) were considered less severe, patients scoring higher 
than 15 traits were considered more severe. Up to three years, no significant differences 
were found on the GSI between more or less severe patients in STIP-TA or OP on neither 
follow-up point. Differences in recovery at 36 months follow-up between high or less se-
vere patients were also negligible. Second, analyses were done to compare STIP-TA with 
different dosages in the OP group, separately. These indicated that part of the superior 
effect of STIP-TA could be attributed to the lower effectiveness of inpatient treatments 
in the OP sample.
0.5
1
1.5
2
G
SI
mean STIP-TA
mean OP
95% Confidence 
interval
0
0 0.5 1 1.5 2 2.5 3
years
figure 4.3. Symptom severity over the course of three years.
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With respect to the secondary outcomes, i.e. psychosocial functioning (OQ-45) and 
health-related quality of life (EQ-5D), we found medium to large improvements from 
baseline to 36 months in both groups as well.
Regarding psychosocial functioning, STIP-TA showed larger ESs than OP on all scales at 
all time points, except for one (i.e. OQ-45 Interpersonal Relations, 24 months; STIP-TA: 
M=15.67, sd=4.37, OP: M=15.10, sd=4.68). However, differences between both groups 
were non-significant. Regarding the OQ-45 Interpersonal relations, at 36 months after 
baseline, 47 pairs of patients (70%) had a 36-month follow-up measurement. Fifty-one 
percent of the STIP-TA patients and 34% of the OP patients showed a reliable change 
(p=.17) and 2% and 2%, respectively, demonstrated clinical deterioration (p=1.00). Thir-
ty-eight percent of STIP-TA patients and 30% of OP patients moved from a dysfunctional 
range to a normative range (p=.56). Of these, 32% and 21% respectively moved from a 
dysfunctional range to a normative range and demonstrated reliable change (p=.38). 
With regard to the OQ-45 Social Role, 46 pairs of patients (69%) had a 36-month follow-
up measurement. We found that 50% of STIP-TA and 24% of OP showed a reliable change 
(p=.01). None of STIP-TA patients and 2% of OP patients demonstrated clinical deteriora-
tion. Fifty percent of STIP-TA and 37% of OP patients moved from a dysfunctional range 
to a normative range (p=.26) and of these, 30% of STIP-TA and 20% of OP moved from 
a dysfunctional range to a normative range and demonstrated reliable change (p=.30).
Regarding quality of life, significant larger effect sizes were found for STIP-TA compared 
to OP at 12 and 24 months, but not at 36 months (see table  4.2). The STIP-TA group 
approached the level of quality of life observed in the normal population (which was 
defined as a value of 0.88) at 12 months, with a small decline at 24 and 36 months, 
while the OP group stayed behind (Busschbach, Wolffenbuttel, Annemans, Meerding, & 
Koltowska-Haggstrom, 2011).
Significant differences between patients who completed their intended treatment 
dosage and patients who did not were found on the two outcome measures assessing 
psychosocial functioning at 12 months follow-up (OQ-45 Social Role: b=3.46, p=.03, 
OQ-45 Interpersonal Relations: b=5.54, p=.02). Patients who completed the intended 
treatment dosage showed significantly better psychosocial functioning than patients 
who did not.
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DisCussiOn
The current study showed that time-limited, short-term inpatient psychotherapy based 
on transactional analysis outperformed a variety of other specialized psychotherapies 
in terms of improvements in general psychiatric symptomatology and quality of life. Su-
periority of STIP-TA was most pronounced at 12-month follow-up, but remained intact 
over the course of the entire three-year follow-up period. Sensitivity analyses showed 
that our findings were (relatively) independent of baseline severity and dosage in the 
control condition. These results support and extend findings of previous studies of STIP-
TA (Thunnissen et al., 2008) and STIP in cluster C patients (Bartak et al., 2010), thereby 
strengthening the conclusion that STIP-TA is a very promising treatment program for 
patients with cluster C PD or PDNOS.
In terms of general psychiatric symptomatology we found effect sizes of 1.87 to 2.02 
for STIP-TA patients and 1.18 to 1.39 for OP patients across three years of follow-up. Our 
assessment of clinically meaningful change at 36 months after baseline showed a small 
but insignificant advantage in favor of STIP-TA with 68% of STIP-TA patients and 48% 
of OP patients being symptomatically recovered. Other studies on reliable change or 
recovery rates of PD patients showed varying results. In Cluster C, 10-54% of patients 
showed reliable change or recovery (Muran, Safran, Samstag, & Winston, 2005; Svart-
berg, Stiles, & Seltzer, 2004). In cluster B, response or reliable change rates of 38-80% 
were found (Chiesa & Fonagy, 2003, McMain, Guimond, Streiner, Cardish, & Links, 2012; 
Kröger, Harbeck, Armbrust, & Kliem, 2013). Thus, results of the current study showed 
higher recovery rates than other published effect studies of cluster C patients, and were 
within the range of rates found in studies of cluster B patients. However, it is difficult to 
interpret these differences as they might be accounted for by a variety of reasons, such 
as differences in (1) effectiveness of treatments, (2) the follow-up period, (3) definition of 
response or recovery, and (4) patient characteristics such as the severity of personality 
pathology.
Concerning the secondary outcome measures, we found that STIP-TA patients ap-
proached the level of quality of life observed in the normal population, while the OP 
patients lagged behind. Significant differences in quality of life between STIP-TA and 
OP patients vanished at the long-term follow-up. Less pronounced results were found 
concerning psychosocial functioning. About one third of STIP-TA patients and one fifth 
of OP patients could be considered recovered after 36 months. The limited impact of 
treatment on social functioning found in the current study is consistent with other 
studies showing that the treatment of PD has limited impact on social functioning (e.g. 
Arnevik et al., 2010; Chiesa & Fonagy, 2003; Skodol et al., 2005; McMain et al., 2012). 
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As these studies mainly studied long-term treatments, and about two-thirds of the OP 
treatments in the current study were considered long-term, the length of treatment 
may not be the main reason why we found lower effects in this area. The results rather 
support the hypothesis that maladaptive interpersonal patterns are core features of PDs 
and improve more slowly than psychiatric symptomatology. More research is necessary 
to study which variables need to be targeted in psychotherapy to receive better results 
and to be able to tailor treatments to the needs of individual PD patients (Dimaggio, 
Nicolò, Semerari, & Carcione, 2013). Chiesa and Fonagy (2003) suggested the following 
reasons for the slow pace of improvement: (1) social adjustment refers to a more complex 
dimension that is more difficult to change, (2) social adjustment could be “intrinsically 
linked to the concept of PD, with the notion of durability and persistence”, (3) parts of social 
adjustment could be heavily dependent on external factors like unemployment due to 
economic circumstances, and (4) instruments used could be unsuitable in PD patients.
methodological considerations
Several methodological considerations are worth mentioning. First, this study is not 
a randomized controlled trial (RCT), but a matched-control study which merely mim-
ics a RCT. However, this can be considered a limitation as well as a strength. RCTs are 
generally criticized for their limited external validity as treatments take place under 
strictly controlled or experimental circumstances, only patients are studied who agree 
to randomization, and exclusion criteria are typically stringent (e.g. Hodgson, Bushe, & 
Hunter, 2007). In contrast, the treatments in the current study can be considered highly 
representative of specialist mental health care in the Netherlands (Bartak et al., 2010). 
Furthermore, this limitation is somewhat mitigated by our rigorous matching procedure 
that ensures the similarity of the patient groups and partly rules out the possibility of 
selection bias. Nevertheless, since we matched patients on the PS which was computed 
using predetermined and observable variables, it is possible that other patient differ-
ences that were either not predetermined or not observable affected assignment to 
treatment and confounded the observed differences in treatment effectiveness (Austin, 
2008). The likelihood of confounding, however, is mitigated by the fact that we tested a 
large number of possible confounding variables.
Second, we only used self-report instruments as outcome measures. We do not have in-
formation whether the treatments were also able to change the PD diagnosis of patients 
or whether therapists considered the change sufficient.
Third, information about the treatment fidelity and adherence was not collected. 
However, it is reasonable to assume that treatments delivered in specialized treatment 
centers by experienced psychotherapists are of relatively high quality. Perhaps more 
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importantly, several ingredients of STIP-TA are specifically designed to maintain treat-
ment integrity, e.g. staff training, ongoing supervision, and multidisciplinary meetings 
twice a day.
Fourth, the interpretation of the results is limited by the variation of treatment modali-
ties in the OP condition. This study therefore does not clarify the observed superiority of 
STIP-TA. For example, it is not at all clear from this study whether the observed superior-
ity of STIP-TA is best accounted for by either setting (inpatient), duration (short-term), 
psychotherapeutic orientation (transactional analysis), a combination thereof, or even 
another factor such as the consistent application of the theoretic framework which has 
been hypothesized to be one of the general ingredients of effective treatments (Bate-
man & Fonagy, 2000). As inpatient or residential psychotherapeutic treatments in PD 
patients are not part of treatment as usual in other countries, and part of the superior 
effect of STIP-TA could be attributed to the lower effectiveness of inpatient treatments in 
the OP sample, the generalizability of the results to other countries is limited.
implications and future directions
The results of our study are consistent with several studies showing that psychological 
treatments tailored to PD patients are generally very effective and effect sizes of STIP-TA 
are even larger compared to those typically observed in previous studies (e.g. Arnevik 
et al., 2010; Leichsenring & Leibing, 2003). Since STIP-TA patients are hospitalized during 
13 weeks, it is also a relatively expensive treatment, which may be an obstacle in the re-
imbursement of this treatment in some countries. Nevertheless, Soeteman et al. (2011) 
showed that in cluster C PDs, STIP seemed to be most cost-effective compared to other 
treatment modalities. A cost-effectiveness study comparing STIP-TA to OP adds more 
evidence to the knowledge of effective and cost-effective treatments in PD patients and 
will be performed in the future.
Recent studies point to the need of a refinement of existing treatments in PD. Until now, 
treatments studied have mostly focused on BPD, on distinct areas of pathology and 
on comparisons of different psychotherapies. There is a paucity of research to guide 
treatment and enhance outcome in PD patients (Critchfield & Benjamin, 2006). As 
most research showed that differences in effectiveness of active treatments in PD are 
negligible (“equivalence effect”) (Budge et al., 2013; Dimaggio, 2014), a recent issue of 
the Journal of Personality Disorders stressed the need for the development of compre-
hensive and integrated treatments in PD patients (Dimaggio & Livesley, 2012). Instead 
of further comparing different treatments, research should be concentrated on the 
active ingredients of treatments (Clarkin, 2012). Recent studies point to generic effec-
tive principles of change in psychotherapeutic treatments of PD. Three factors which 
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seem to be potentially related to outcome were participant characteristics, therapeutic 
relationship variables, and technical factors (Castonguay & Beutler, 2006). Elements such 
as the therapeutic alliance, the ability of the therapist to repair ruptures in the alliance, 
and the cohesion in group therapy might be important factors of therapy relationship 
and therefore important factors in the effectiveness of treatment (Castonguay & Beu-
tler, 2006; Norcross, 2002; Tufekcioglu, Muran, Safran, & Winston, 2013). As STIP-TA is 
known for its low drop-out rates and ruptures in the alliance were a main issue of the 
therapy, these may be factors which could explain part of its high effectiveness. The 
abovementioned articles highlight the need for dismantling studies, research on the 
principles of change and on the efficacious ingredients of effective treatments in PD 
patients, including STIP-TA.
STIP-TA is known as a high-pressure and potentially destabilizing treatment and as such 
will not be the first choice of treatment in severely disturbed patients. In these more 
severe PD patients, this treatment may be too destabilizing, as not all patients seem to 
be able to withstand the “pressure cooker” of this kind of treatment (Chiesa, Fonagy, & 
Gordon, 2009) which could result in more dropouts, suicidality, or psychotic decompen-
sation. For example, Gullestad, Johansen, Hoglend, Karterud, and Wilberg, (2013) have 
found that day hospital treatments and its group therapy format were too demanding 
in patients with low reflective functioning (i.e. a low level of mentalizing) which resulted 
in worse treatment effects compared to individual therapy. Cluster C PD patients might 
be able to handle the pressure and intensity of these treatments when provided in a 
safe and holding environment. As these patients often show rigid patterns of behavior, 
motivated by anxiety, an intensive, inpatient treatment is pre-eminently suited for these 
patients. A short hospitalization further has less impact on daily life and reduces the 
risks of iatrogenic effects which can be associated with long-term inpatient treatments. 
It is further of practical relevance to study whether more seriously disordered patients 
can profit from this intensive kind of treatment and whether it is possible to expand the 
target population to (relatively mild) cluster A and B PD patients. In a previous study 
on the effectiveness of aftercare following STIP-TA, almost 30% of the studied patient 
population was diagnosed with either a cluster A or B PD (Thunnissen et al., 2008). A 
secondary analysis on these patient groups showed that patients with a cluster A or B 
PD did show a different pattern of improvement over time (Thunnissen, 2007). At 24 
months follow-up, however, patients showed similar symptom levels and large effect 
sizes. This might indicate that STIP-TA can also be effective for these patient groups. It is 
therefore clinically relevant to further investigate the safety and applicability of STIP-TA 
in cluster A and B PD.
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This study showed that STIP-TA is a very promising and effective treatment option in 
mainly cluster C PD and PDNOS patients. To make this treatment available to more pa-
tients, additional research on the effectiveness and cost-effectiveness of this treatment 
is recommended.
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summary
background
Short-term inpatient psychotherapy with transactional analysis (STIP-TA) in patients 
with personality disorders (PD) has shown to be more effective than comparable other 
specialised psychotherapies (OP).
aims
To assess whether the higher effectiveness of STIP-TA also results in a better cost-
effectiveness.
method
Patients treated with STIP-TA were matched with patients treated with OP by the pro-
pensity score. Healthcare costs and lost productivity costs were measured over three 
years and from the societal perspective. Cost-effectiveness was represented by costs per 
quality adjusted life years (QALYs). Uncertainty was assessed using bootstrapping.
results
Mean three year costs were €59,834 for STIP-TA and €69,337 for OP, a difference of €-9,503 
(95% CI -32,561 to 15,726). QALYs were 2.29 for STIP-TA and 2.05 for OP, a difference of 
.24 (95% CI .05 to .44). STIP-TA is a dominant treatment compared to OP: less costly and 
more effective.
Conclusions
STIP-TA is a cost-effective treatment in PD patients.
Declaration of interest
EKH, RV, MT, JD, and JJVB have worked or are still working for the ‘Viersprong’, Nether-
lands Institute for Personality Disorders. The ‘Viersprong’ offers STIP-TA. MT is a trainer 
and supervisor of TA. MT, JD, MS, AMMAM, UMZ, and BVR have been or are still involved 
with the control conditions.
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inTrODuCTiOn
Personality disordered (PD) patients are a highly prevalent group in the community 
(Coid, Yang, Tyrer, Roberts, & Ullrich, 2006) with a high individual and societal burden 
(Soeteman, Verheul, & Busschbach, 2008). PD patients report a quality of life compared 
to patients with a serious somatic illness, such as rheumatic disease or lung cancer 
(Soeteman, Verheul, & Busschbach, 2008), and the presence of a PD is associated with 
high costs for society (Maclean, Xu, French, & Ettner, 2013; Soeteman, Hakkaart-van 
Roijen, Verheul, & Busschbach, 2008). Psychotherapy is considered to be the first choice 
in treatment based on evidence showing the effectiveness of psychotherapy for PD 
(Dixon-Gordon, Turner, & Chapman, 2011; Landelijke Stuurgroep Multidisciplinaire Rich-
tlijnontwikkeling in de GGZ, 2008; National Institute for Health and Clinical Excellence, 
2009a, 2009b).
State-of-the-art cost-effectiveness analyses (CEAs) on psychotherapeutic treatments in 
PD populations revealed differences in cost-effectiveness between treatments (Bamelis, 
2013; Berghout, Zevalkink, & Hakkaart-van Roijen, 2010; Palmer et al., 2006; Priebe et 
al., 2012; Soeteman et al., 2010; Soeteman et al., 2011; van Asselt et al., 2008). A large 
cost-effectiveness study on different modalities in PD patients showed that short-term 
inpatient psychotherapy (STIP) in general was most cost-effective compared to other 
treatment modalities in a cluster C PD population (Soeteman et al., 2011). The initial 
higher costs of STIP were offset by savings in other parts of the health care system 
(Soeteman et al., 2011). STIP based on Transactional Analysis (STIP-TA) was the shortest 
treatment of the short-term inpatient modality of this study. As all modalities of STIP 
were combined, the cost-effectiveness of STIP-TA, specifically, was not determined. 
However, the evidence of cost-effective treatments in a PD population is still scarce 
given the large number of different modalities of psychotherapy involved in these stud-
ies. Furthermore, more evidence is essential to make deliberate decisions for reimbursed 
treatments in restricted healthcare budgets (Soeteman & Kim, 2013).
A trial on different types of aftercare following a STIP-TA treatment found a substan-
tial decrease of symptoms at the end of the treatment (Thunnissen et al., 2008). In a 
matched controlled effectiveness study in which STIP-TA was compared to other special-
ized psychotherapies (OP) in PD patients, STIP-TA proved to be an effective treatment 
option over a three year follow-up in terms of general psychiatric symptomatology 
(Brief Symptom Inventory [BSI]), psychosocial functioning (Outcome Questionnaire-45 
[OQ-45]) and quality of life (EuroQol; Horn et al., 2014). As the more effective STIP-TA is 
also likely to be more costly then less intensive alternatives, a cost-effectiveness study 
on this comparison is warranted. The current study extends the matched controlled 
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effectiveness study mentioned above with a cost-effectiveness analysis. This analysis 
is performed from the societal perspective, with the outcome expressed in costs per 
quality-adjusted life years (QALY).
mEThODs
study population and design
We compared the costs and effects of Short-Term Inpatient Psychotherapy based on 
Transactional Analysis (STIP-TA) with Other Psychotherapies (OP) in a matched controlled 
study. The matching was done on the basis of the propensity score (Bartak et al., 2009). 
The data used was collected as part of the SCEPTRE study, a large naturalistic study 
about the cost-effectiveness of psychotherapeutic treatments in PD patients which took 
place from 2003 to 2011 (Bartak et al., 2010). Six mental health centres participated in 
the SCEPTRE study which all offered psychotherapeutic treatments for PD patients. They 
offered a wide range of treatments that varied regarding duration (i.e. 3 to 36 months), 
setting (i.e. outpatient, day hospital, or inpatient treatment), format (i.e. individual or 
group meetings), as well as theoretical orientation (e.g. cognitive-behavioural, psycho-
dynamic). Eight hundred thirty-seven patients gave informed consent for the study and 
were enrolled. Of these, 38 patients dropped out prematurely. Five patients of STIP-TA 
and 100 patients of OP were lost to follow-up. This left 694 patients of which 71 received 
STIP-TA at De Viersprong, Netherlands Institute for Personality Disorders (one of the six 
mental health centres), and 623 patients who received other specialized psychothera-
pies (OP) at one of the six mental health centres. The PS is defined as the conditional 
probability of assignment to one of two treatment groups given a set of observed pre-
treatment variables (Bartak et al., 2009; Rosenbaum & Rubin, 1983). To estimate the 
PS, we fitted one logistic regression model with relevant confounders (see Horn et al., 
2014) for more details), and medical and productivity costs at baseline as independent 
variables, and group membership (STIP-TA or OP) as outcome variable (Brookhart et al., 
2006). The relevant confounders consisted of sociodemographic variables (e.g. age, sex, 
level of education) as well as clinical variables (e.g. motivation, baseline scores of the 
outcome measures, SIPP-118 scales, PD diagnoses). A full list of these variables is pro-
vided in the appendix. Nearest neighbourhood matching using a caliper distance of .2 
of the standard deviation of the logit of the PS was used (Austin, 2011). The construction 
and characteristics of this dataset were described in more detail elsewhere (Horn et al., 
2014).
In this study, STIP-TA is compared to other psychotherapy (OP). STIP-TA is based on 
the ideas of transactional analysis (e.g. Barnes, 2007; Berne, 1996) and has integrated 
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these ideas in a short (13 weeks) inpatient treatment (Delimon, 1999; Horn et al., 2014; 
Thunnissen, 2007). STIP-TA includes psychotherapy, psychomotor and art therapy, so-
ciotherapy and milieu therapy. This program is designed for patients with PDs, mainly 
cluster C PD or personality disorder not otherwise specified (PDNOS; see for more details 
Horn et al., 2014).
The results are based on intention to treat analyses. The study protocol was approved by 
the Medical Ethics Committee of the Erasmus University Medical Centre in Rotterdam, 
the Netherlands.
assessments
Costs
The economic evaluation was undertaken from the societal perspective, the preferred 
perspective in health economics (Drummond et al., 2005). This perspective describes 
that all costs related to medical resource utilization, and all costs due to productivity 
losses should be included. To collect data on costs in other part of health care than the 
initial intervention and to collect costs related to work (productivity losses), the Trimbos 
and Institute for Medical Technology Assessment (iMTA) Questionnaire on Costs Associ-
ated with Psychiatric Illness (TiC-P) was used (Hakkaart-van Roijen, 2002). A study about 
the feasibility, reliability, and validity of the TiC-P in patients with a psychiatric disorder 
showed the questionnaire to be a feasible and a reliable instrument in this patient group 
(Bouwmans et al., 2013).The TiC-P consists of two sections:
The first section covers the medical costs, which were split up in somatic and psychiatric 
healthcare costs, medication costs and other costs (e.g. alternative healers, domiciliary 
care). For mean somatic and psychiatric healthcare costs, the total number of contacts 
with medical and psychological/psychiatric healthcare providers (e.g. outpatient visits, 
length of stay in hospital) was asked and multiplied by unit costs of the corresponding 
health care services (Health Care Insurance Board, 2014; Hakkaart-van Roijen, Tan, & 
Bouwmans, 2010). The costs of medication were calculated as the cost price per medica-
tion multiplied by the daily dose multiplied by the number of prescription days, plus 
the pharmacist’s dispensing costs of €7.50 per prescription. Other costs were valued 
according to prices reported in the Dutch manual for cost research (Hakkaart-van Roijen 
et al., 2010).
The second section includes the short form Health and Labour questionnaire (SF-HLQ) 
for collecting data on productivity losses. Productivity losses could be due to absence 
from work (absenteeism) or due to reduced efficiency at work (presenteeism; Roijen, 
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Essink-Bot, Koopmanschap, Bonsel, & Rutten, 1996). To value long-term absence from 
work, we applied the friction-cost method, which takes into account that a formerly 
unemployed person may replace a person who becomes disabled (Koopmanschap & 
Rutten, 1996). The period needed to replace a worker (the so-called friction period) in 
2011 was estimated to be 115 days; maximum productivity costs to society were there-
fore limited to productivity losses during a period of 115 days.
The costs of the primary treatment were estimated using a micro costing approach and 
the hospital information system. The assessment at the end of treatment did not consist 
of the TiC-P, as it was expected that patients would confuse questions about possible 
other treatments in the TiC-P with their primary treatment. This would lead to double 
counting and therefore overestimated costs. As a result of that decision, the TiC-P at 
the six months after start of treatment was missing for all patients. To create plausible 
estimates of the direct costs of other treatments and productivity costs at that measure-
ment point, several methods were used:
Direct medical costs. First, for the time outpatients were in treatment, medical costs were 
set to the level of the 12 months measure. Second, it was assumed that patients in day 
hospital and inpatient psychotherapy did not generate any additional medical costs 
during their psychotherapeutic treatments. Medical costs additional to their primary 
treatment costs were therefore set to zero. Third, medical costs during the waiting list 
period were set to the baseline level for all patients, since we did not expect any altera-
tions in medical costs during the waiting list.
Productivity costs. First, patients were not able to work during the hours or days being 
in treatment. These productivity costs due to absence from work were calculated taking 
into account the number of days and hours of treatment corrected for numbers of paid 
employment of the patient per week. These productivity costs were considered to be 
a good representation of the productivity costs at six months follow-up. Second, costs 
related to presenteeism were set to the level of the 12 months measure.
Reference unit prices of health care services were applied and adjusted to the year of the 
study (2011) according to the consumer price index. For medical and productivity costs, 
we assumed that the recall period of the TiC-P was representative of the six months 
prior to the assessment. Costs were discounted at an annual rate of 4%, effectiveness as 
measured by QALYs were discounted at a rate of 1.5%, as recommended by the Dutch 
guidelines for cost research (Hakkaart-van Roijen et al., 2010). The uncertainty around 
the mean costs and QALY scores was assessed with bootstrap simulations with 1000 
replications for the imputed datasets. The uncertainty interval was represented by the 
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2.5th and 97.5th percentiles. The results were presented in a cost-effectiveness plane and 
an acceptability curve (Briggs, Wonderling, & Mooney, 1997; Van Hout, Al, Gordon, & 
Rutten, 1994).
Effects
For the economic evaluation, the effects were measured in health-related quality of life 
years (QALYs) using the EQ-5D-3L (EuroQolGroup, 1995). The EQ-5D is a standardised in-
strument and has shown to be sensitive to change in PD patients (Papaioannou, Brazier, 
& Parry, 2013). Five health states were measured: ‘mobility’, ‘self-care’, ‘usual activities’, 
‘pain/discomfort’, and ‘anxiety/depression’. Possible response levels were ‘no problems’, 
‘some or moderate problems’ and ‘extreme problems or complete inability’. This resulted 
in 243 different possible health states, which were weighted to obtain a single index 
score between –0.33 (worst imaginable health state) and 1.00 (best imaginable health 
state). QALYs were further calculated as the area under the curve for the three year 
follow-up period. To calculate the mean EQ-5D index values, the Dutch norm scores 
were used (Brooks, Rabin, & de Charro, 2003; EuroQolGroup, 1995; Lamers, Stalmeier, 
McDonnell, Krabbe, & van Busschbach, 2005).
Analyses
All outcome measures were assessed at baseline and several follow-up points up to five 
years after baseline. Due to logistic reasons, three treatment centres had their assess-
ments at baseline, end of the treatment, and six, and 12 months after the end of treat-
ment, and at 36 and 60 months after baseline, whereas three other centres had their 
assessments at baseline, at 12, 24, 36, and 60 months after baseline. Since the period 
between the last two follow-up points was rather long (two years), and the number of 
missing data increased in time, we limited the analyses to a time horizon of three years 
after baseline. The recall period for the utilization of medical resources was four weeks 
prior to completion of the questionnaire. Costs were multiplied by 6.5 to calculate the 
6-month costs. The recall period for productivity losses was two weeks prior to comple-
tion of the questionnaire. Costs were multiplied by 13 to calculate the 6-month costs.
The expectation-maximization algorithm was used to impute missing quantitative base-
line data. For missing categorical data, multinomial logistic regression was used. Since 
the distribution of the costs was skewed, multiple imputation with ten imputations was 
used in the case of intermittent missing data (Rubin, 1996). In this multiple imputation, 
cost data are considered semi-continuous data, which is characterized by a mixture of 
a considerable proportion of zero values and a skewed distribution of positive values. 
Using these assumptions, the predictive mean matching (PMM) approach was used 
to impute the missing values. PMM can account for the semi-continuous nature and 
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therefore skewed distribution of costs and ensures that imputed values are plausible 
(Yu, Burton, & Rivero-Arias, 2007). In PMM, the imputed variable takes on the value of 
one of a set of nearest observed values in the dataset (Horton & Kleinman, 2007). The 
imputed datasets were further analyzed conforming to the rules established by Rubin 
(Rubin, 1987; Wayman, 2003).
To compare treatments in terms of costs and effects, the incremental cost-effectiveness 
ratio (ICER) is determined. The ICER is calculated as the difference in costs of treatments 
divided by the difference in effectiveness of treatments. With limited health-care re-
sources, thresholds for the ICER’s are used to inform decisions on allocation of these 
resources. In our study, we used a threshold of 40,000 euro/QALY which is diverted from 
recommendations by the Dutch Council for Public Health and Health Care (Council for 
Public Health and Health Care, 2006; Soeteman et al., 2011).
The analyses were performed using IBM SPSS 20.0 (IBM Corporation, USA) for data 
preparation, STATA 12.1 (StataCorp LP, USA) for imputing missing data, and SAS 9.2 (SAS 
Institute Inc, USA) for bootstrapping.
Sensitivity analyses
To assess the robustness of results under different assumptions, four sensitivity analy-
ses were done. In a first sensitivity analysis, we studied the impact of applying a 3.5% 
discount rate for both costs and health outcomes as recommended by the UK guideline 
on health technology assessment of the National Institute for Health and Clinical Excel-
lence (NICE, 2008). A second sensitivity analysis was undertaken using the healthcare 
perspective: only the medical costs were taken into account. Third, the cost-effectiveness 
was adjusted for differences in baseline costs. Four different types of regression-based 
methods were carried out (standard, split, trimmed, and replacement regression) with 
total costs as dependent variable and costs at baseline and treatment group as indepen-
dent variables (van Asselt et al., 2009). Fourth, to study the influence of missing data, an 
analysis was done on the complete follow-up data only.
rEsuLTs
sample
The matching procedure resulted in 67 pairs of patients, as it was not possible to find 
a good match for four STIP-TA patients. Therefore 67 patients were matched 1-by-1 by 
the logit of the propensity score (PS), which left 134 patients for this trial (see figure 5.1). 
The sample consisted mainly of patients with a cluster C PD or a PDNOS diagnosis (see 
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Table 5.1). The majority of patients (93% of STIP-TA and 82% of OP) had a history of out-
patient treatment and over half (61% of STIP-TA and 51% of OP) had a history of psycho-
tropic drug treatment. Eighty-two percent of STIP-TA and 85% of OP patients reported 
that they suffered from psychological problems since more than five years. Educational 
level was high (European Qualifications Framework [EQF] ≥6; van der Sanden, Smit, & 
Dashorst, 2012) for two-thirds of both groups, and about 60% of both groups worked 
or was studying. The matching on the basis of the propensity score was successful in 
Enrolled/informed 
consent
n=837
Assessed for eligibility
n=1379
Not meeting inclusion criteria n=146
Met exclusion criteria n=9
No PD diagnosis n=115
Refusal n=100
Allocated
n=799
STIP-TA
n=67
Matched OPs
n=67
Short-Term Inpatient 
Psychotherapy - 
Transactional Analysis 
(STIP-TA)
n=76
Other Psychotherapies 
(OP)
n=723
Early drop-out n=38
Missing/unreliable data n=141
Logistic reasons n=31
Loss to follow-up n=100
Unable to find good match n=556
Loss to follow-up n=5
Unable to find good match n=4
figure 5.1. Patient flowchart.
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Table 5.1. Characteristics of patients and costs per year before allocation to STIP-TA and OP (costs in Euros).
sTiP-Ta n=67 OP n=67
[mean (SD)]
Age, years 39.4 (9.8) 39.3 (10.2)
N (%)
Male gender 22 (33%) 18 (27%)
Education
High (EQF¹≥6) 26 (39%) 24 (36%)
Medium (EQF¹ 3-5) 27 (40%) 31 (46%)
Low (EQF¹≤2) 14 (21%) 12 (18%)
Mode of employment
Study 3 (5%) 5 (8%)
Paid work 36 (54%) 33 (49%)
Unemployed/other 28 (42%) 29 (43%)
Presence PD2
Cluster A 1 (2%) 2 (3%)
Cluster B 8 (12%) 7 (11%)
Cluster C 33 (49%) 26 (39%)
PD NOS 28 (42%) 33 (49%)
mean (sD) median mean (sD) median
Healthcare Costs
Somatic care 5,620 (24,647) 758 1,962 (8,403) 379
Psychiatric care 3,606 (8,499) 2,303 8,272 (18,897) 2,336
Other care 868 (1,670) 377 1,280 (3,787) 377
Medication 303 (332) 209 331 (326) 195
Total direct costs 10,398 (30,260) 4,471 11,845 (20,427) 5,430
Lost Production Costs
Absenteeism 9,750 (16,435) 2,869 7,164 (13,163) 0
Presenteeism 3.868 (10,116) 0 1,595 (5,096) 0
Total productivity costs3 13,618 (19,234) 6,698 8,759 (13,988) 0
Total costs 24,016 (37,302) 11,747 20,603 (22,518) 14,055
EQ-5D .54 (.27) .69 .53 (.26) .65
STIP-TA, Short-Term Inpatient Psychotherapy - Transactional Analysis; OP, Other Psychotherapies
¹European Qualifications Framework.
2Since it is possible to have more than one diagnosis, the sum of the prevalence is higher than 100%.
3One-sample sign test on medians significant between groups.
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reducing all differences between background variables as presented in table 5.1, except 
for the overall costs due to productivity losses (see below).
The matched OP group (see above) consisted of the following short-term (up to six 
months) and long-term (longer than six months) treatments [mean(SD)]:
• short-term outpatient: N=6 (9%), mean length of treatment 5.4 (1.0) months
• long-term outpatient: N=18 (27%), mean length of treatment 16.9 (5.4) months
• short-term day hospital: N=7 (10%), mean length of treatment 6 (0.0) months
• long-term day hospital: N=11 (16%), mean length of treatment 11.5 (1.0) months
• short-term inpatient: N=9 (13%), mean length of treatment 3.3 (0.9) months
• long-term inpatient: N=16 (24%), mean length of treatment 10.5 (2.3) months.
Day hospital and inpatient programs typically consisted of group psychotherapy 
as a core element, mostly in combination with one or more nonverbal or expressive 
group therapies (such as psychomotor and art therapy), individual psychotherapy, 
sociotherapy, milieu therapy, community meetings, and/or pharmacological treatment. 
Twenty-two percent of treatments had a cognitive-behavioural orientation, 30% had a 
psychodynamic orientation, and 42% consisted of integrative treatments (e.g. cognitive-
behavioural/psychodynamic). The orientation of the remaining 5% was not specified 
(Horn et al., 2014).
Costs and effects
Costs
Total costs at baseline for the past year were €24,016 (sd=€37,302) for STIP-TA and 
€20,603 (sd=€22,518) for OP, a difference of €3,413. High somatic and psychiatric 
costs were primarily due to hospitalizations prior to completion of the questionnaires. 
Costs were not distributed normally (Kolmogorov–Smirnov test on total costs: df=134, 
p<.000, see table 5.1). The overall medical and total societal costs at baseline were not 
significantly different between the two conditions (one-sample sign test). The overall 
costs due to productivity losses, however, differed significantly between both groups 
(p=.021).
After bootstrap, mean three year total costs were €59,829 (95% CI 45,544 to 82,797) for 
STIP-TA and €71,007 (95% CI 54,965 to 90,137) for OP, resulting in a non-significant differ-
ence in costs of €-9,503 (95% CI -36,719 to 16,597; see table 5.2). There was a trend that 
STIP-TA patients generated lower costs associated with healthcare and costs associated 
with productivity losses. Within the healthcare costs, we found a trend that STIP-TA 
patients generated lower costs in psychiatric and other care but more costs in somatic 
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healthcare compared to OP. High somatic and psychiatric costs were mainly due to 
hospitalizations. In terms of productivity losses, there was a trend that STIP-TA patients 
reported being more often absent from work, while OP patients reported less efficiency 
during work. The STIP-TA treatment was significantly cheaper (mean €19,420, 95% CI 
€18,676 to €20,163) compared to the OP treatments (mean €25,459, 95% CI €20,458 to 
€30,434), a difference of 6,040 (95% CI €1,050 to 11,029). Figure 5.2 shows the distribu-
tion of cost categories in STIP-TA and OP patients.
Table 5.2. Costs and QALYs for patients in the STIP-TA and OP group over three years follow-up (costs in 
Euros).
sTiP-Ta, € OP, €
incremental 
costs, €
2.5-97.5 
percentile
healthcare costs
Somatic care, mean(SE) 11,981 (7,978) 7,352 (4,862) 4,715 -12,079 to 24,744
Psychiatric care, mean(SE) 5,579 (1,745) 12,963 (3,510) -7,317 -14,962 to -634
Intervention, mean(SD) 19,420 (3,048) 25,459 (20,395) 6,040 1,050 to 11,029
Other care, mean(SE) 1,122 (220) 1,586 (368) -483 -1,309 to 268
Medication, mean(SE) 738 (125) 714 (132) 11 -331 to 338
Subtotal, mean, mean(SE) 38,839 (9,123) 48,075 (4,269)
Bootstrapped subtotal, mean(SD) 39,087 (9,059) 48,178 (6,882) -9,091 -29,838 to 15,380
Lost production costs
Absenteeism, mean(SE) 15,289 (1,880) 18,294 (3,354) -2,921 -10,434 to 4,417
Presenteeism, mean(SE) 5,405 (1,212) 4,611 (1,599) 834 -3,354 to 4,256
Subtotal, mean, mean(SE) 20,694 (2,542) 22,905 (4,068)
Bootstrapped subtotal, mean(SD) 20,741 (2,508) 22,828 (3,953) -2,087 -36,719 to 7,143
Total societal costs, mean(SE) 59,533 (9,789) 70,981 (9,131)
Bootstrapped total costs, mean(SD) 59,829 (9,733) 71,007 (8,907) -11,178 -36,719 to 16,597
QALY, mean(SE) 2.30 (.06) 2.03 (.07)
Bootstrapped QALY, mean(SD) 2.29 (.06) 2.02 (.07) .27 .08 to .45
STIP-TA, Short-Term Inpatient Psychotherapy - Transactional Analysis; OP, Other Psychotherapies
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figure 5.2. Distribution of costs for patients in the STIP-TA and OP group over three years follow-up.
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Effects
Mean three year bootstrapped QALYs were 2.29 for STIP-TA and 2.05 for OP meaning a 
significant difference in QALYs of .24 (95% CI .05 to .43). Figure 5.3 shows the course of 
the QALYs over 36 months.
Cost-Effectiveness
Mean three year costs were €59,834 for STIP-TA and €69,337 for OP, a difference of 
€-9,503 (95% CI -32,561 to 15,726). QALYs were 2.29 for STIP-TA and 2.05 for OP, a differ-
ence of .24 (95% CI .05 to .44). The trend towards lower costs and the significant better 
effects of STIP-TA, resulted in STIP-TA being a ‘dominant intervention’ compared to OP: 
less costly and more effective. To display the impact of uncertainty around the estimated 
mean costs and QALYs, a cost-effectiveness plane with the bootstrapped results was 
constructed. Eighty-three percent of the cost-effectiveness pairs lie in the south-east 
quadrant of the plane, implying lower costs and higher effectiveness, and 17% in the 
north-east quadrant, implying both higher costs as well as higher effectiveness (see 
figure 5.4).
The cost-effectiveness acceptability curve (CEAC) indicates that the probability that 
STIP-TA is cost-effective is between 80% and 90% until a threshold of approximately 
€20,000/QALY. The probability that STIP-TA is cost-effective increases up to 93% with a 
ceiling ratio of 40,000/QALY (see figure 5.5).
sensitivity analyses
Although sensitivity analyses displayed minor differences, the dominance of STIP-TA 
over OP remained. Costs for STIP-TA ranged from 37,750 (health care perspective) to 
61,732 (replacement regression; see table 5.3 for the difference split up per sensitivity 
0.00
0.25
0.50
0.75
1.00
Baseline 12 months 24 months 36 months
STIP-TA
OP
figure 5.3. Course of the QALY for patients in the STIP-TA and OP group over three years follow-up.
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analyses). In OP patients, costs ranged from 44,908 (health care perspective) to 72,298 
(replacement regression). QALYs ranged from 1.97 (OP, 3.5% discount rate) to 2.36 (STIP-
TA, complete data). ICERs ranged from -23,717 (trimmed regression) to -49,146 (standard 
regression).
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Figure 4. Cost-effectiveness plane of STIP-TA versus OP.
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figure 5.4. Cost-effectiveness plane of STIP-TA versus OP.
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figure 5.5. Acceptability curve of STIP-TA versus OP.
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DisCussiOn
The current study compared the cost-effectiveness of an intensive short-term inpatient 
treatment based on Transactional Analysis (STIP-TA) to other specialized psychothera-
pies (OP) in patients with PD over a three-year time horizon. OP was dominated by STIP-
TA: STIP-TA patients generated lower costs and reported a significantly better quality of 
life, in terms of QALYs gained. With a ceiling ratio of 40,000 Euro/QALY, the probability 
that STIP-TA is cost-effective compared to OP is 93%. Sensitivity analyses on different 
discount rates, analyses from the health care perspective, corrections for baseline cost 
differences, and complete case analysis showed similar results. In both groups, about 
one third of all costs over 36 months were due to the intervention itself, and about one 
quarter were due to absenteeism.
strengths and limitations
A strength of this study is its representativeness and therefore high external validity 
due to the naturalistic nature and a minimal set of exclusion criteria. The OP group was 
found to have a great variation in treatments which supports the assumption that OP 
is representative for psychotherapeutic treatments for many cluster C PD and PDNOS 
patients in the Netherlands.
Abovementioned also leads to the first limitation: patients were not randomized but 
were assigned to treatment by clinical knowledge which limits the internal validity. 
However, a comparison of such different dosages of treatment by means of a RCT is 
Table 5.3. Sensitivity analyses on costs and QALYs for patients in the STIP-TA and OP group.
Costs qaLys
iCEr
(Costs per qaLy)
3.5% discount rate STIP-TA 59,785 2.21
OP 69,802 1.97 -41,738
Payer perspective STIP-TA 38,839 2.29
OP 48,075 2.05 -38,483
Correction baseline differences Standard regression STIP-TA 58,688 2.29
OP 71,826 2.05 -54,742
Split regression STIP-TA 58,428 2.29
OP 71,254 2.05 -53,442
Trimmed regression STIP-TA 53,611 2.29
OP 63,920 2.05 -42,954
Replacement 
regression
STIP-TA 61,723 2.29
OP 73,333 2.05 -48,375
Complete data only STIP-TA 53,623 2.43
OP 61,034 2.11 -23,159
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difficult or even impossible. This is reflected in an earlier attempt to compare STIP-TA to 
outpatient treatment in cluster C PD patients in a RCT, and which failed due to patient 
preferences (PSILO trial, National Academic Research and Collaborations Information 
System). Furthermore, in economic evaluations, controlled but nevertheless nonran-
domized designs can even be considered an advantage, since the external validity of 
these studies is often higher than that of a RCT as these often make use of artificial 
research settings, strict in- and exclusion criteria, and mostly a limited time horizon 
(Soeteman et al., 2011). Economic evaluations are supposed to be done on estimates 
of the actual costs and effects in practice (Wells, 1999). To use data collected in RCT’s 
for health economic studies, the wider inclusion criteria and the longer time horizon 
relevant for practice has to be modelled which leads to additional uncertainty. In the 
present study, data is collected in regular clinical practice. Thus, analyses are already 
based on the wide inclusion criteria and long-term follow-up, and the introduction of 
this uncertainty is avoided. At the same time, the generalizability to a PD population 
at large is limited: to the OP condition is not representative for all patients who have 
the same pathology as the patients in the STIP-TA group, neither is the OP group repre-
sentative for all specialized psychotherapies in general. We can therefore not conclude 
in absolute terms that STIP-TA is the most cost-effective option for all cluster C PD and 
PDNOS patients. The external validity of this study is limited to the included alterna-
tive treatments. Moreover, given that data on treatments were collected from 2003 to 
2007, due to changes in psychiatry and reimbursements one could question whether 
the OP treatments studied are still similar to contemporary PD treatments. The trend 
towards less (long-term) inpatient treatments, inpatient treatments which are less often 
open-ended, and treatment durations which are limited in general are, among others, 
important changes.
We used the TiC-P to estimate costs which had a recall period of two to four weeks and 
extrapolated these to estimate the costs of patients for six months. The assumption 
that these weeks are representative can be questioned, however we assumed that the 
over– as well as the under-estimation of costs will balance each other out on average. 
The long-term follow-up of three years and varying measurement points led to a high 
amount of missing data. This made assumptions about the missing healthcare costs 
and productivity losses necessary and led to uncertainty about the results. However, we 
handled missing data with sophisticated analyses (multiple imputation) and carried out 
a secondary analysis on the complete data to confirm the robustness of results.
implications
The current study compared STIP-TA to a variety of other psychotherapies (OP), het-
erogeneous in method, duration and dosage and adds evidence to the knowledge of 
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cost-effective treatment options in PD patients. (Dixon-Gordon et al., 2011; Soeteman & 
Kim, 2013). Soeteman et al. have studied the value of further research on cost-effective 
psychotherapies in cluster B and C PD patients in the Netherlands and concluded that 
the societal value of additional research is considerable (Soeteman et al., 2011).
Currently, mental health care for PD patients mainly consists of long-term outpatient 
psychotherapy. Inpatient treatments are generally not the first choice of treatment but 
are mainly used for crisis intervention and stabilization, especially in BPD patients. A 
hospitalization of three months, although a relatively short period of time, can be an 
obstacle for many patients. In the current economic climate, less radical and (on the 
short-term) cheaper outpatient treatments are preferred. However, although STIP-TA 
is viewed as an expensive treatment, these treatment costs were generally lower than 
the costs for OP. This was due to two-thirds of OP patients following (rather expensive) 
long-term treatments of more than a year on average. The current study further points 
to savings elsewhere in society and even when considering only health care costs, our 
estimates are that STIP-TA remains less costly compared to OP. A study on whether the 
dominance of STIP-TA holds when compared to evidence-based outpatient treatments 
gives relevant information for decision making and clinical practice and adds evidence 
to make well-informed decisions about the preservation or dispensation of inpatient 
treatments for this patient group.
Moreover, more knowledge about the efficacious ingredients of this specific treatment is 
needed. With the knowledge of these factors, it might be possible to add some of these 
factors to other, less expensive and less intense outpatient treatments. This would be in 
line with the deinstitutionalisation of mental health care and the emphasis on patient 
empowerment. The question remains whether it is possible to keep the high pressure 
used in the inpatient treatment which seems to be one of the efficacious ingredients of 
treatments (van Manen, Horn, Stijnen, van Busschbach, Verheul, 2015).
An extension of the current study with a subgroup analysis would furthermore provide 
more evidence to give a strong and evidence-based advice. Since STIP-TA is known as 
a high pressure and sometimes destabilizing treatment, mainly rather stable cluster C 
PD and PDNOS patients are admitted to this treatment. A study of van Manen et al. 
(2015) showed that destabilizing treatments (which use techniques as interpretation 
and confrontation) in general seemed more effective than stabilizing treatments (which 
use techniques as empathic validation and advice) in psychological strong as well as in 
psychological rather weak patients. These results point to the importance of a study on 
the expansion of STIP-TA to (relatively mild) cluster A and B PD patients.
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Conclusion
The present study showed that STIP-TA is a cost-effective treatment when compared 
to other specialized psychotherapies (OP). As studies like the present one showed that 
investments in expensive treatments can be earned back on the long-term, these cost-
effective treatments should be continued in spite of the high initial expenses. These 
treatments should be preserved as an alternative treatment for outpatient psychothera-
pies and should be adopted in clinical guidelines. The present study invites clinicians, 
patients and payers to reconsider the direct medical costs of treatments in the light of 
favourable effects and future savings.
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absTraCT
background
Clinical evidence suggests that patients high on psychological strengths profit more 
from destabilizing psychotherapy, whereas patients low on strengths profit more from 
stabilizing psychotherapy. This matching hypothesis was tested.
methods
This quasi-experimental study was conducted between 2003 and 2008 in 735 patients 
with personality disorders from 6 psychotherapy centers in the Netherlands. Patients 
were assigned to different levels of stabilizing and destabilizing psychotherapies. Levels 
of psychological strengths were measured. We used multilevel modeling to estimate 
outcome at 12 months after baseline. The propensity score controlled for initial differ-
ences at baseline.
results
The findings show that destabilizing psychotherapies have slightly better outcomes 
than stabilizing psychotherapies. Patients high on psychological strengths improve 
slightly more than patients low on psychological strengths. The observed interaction 
effect contradicted our hypothesis.
Conclusion
The results imply that destabilizing psychotherapies can be considered as first treat-
ment option for patients both high and low on psychological strengths.
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inTrODuCTiOn
Personality disorders (PDs) are highly prevalent mental disorders with high individual, 
societal and economic burden of disease (Soeteman, Hakkaart-van Roijen, Verheul, & 
Busschbach, 2008; Soeteman, Verheul, & Busschbach, 2008). Although PDs are relatively 
enduring conditions, amenability to psychological treatments has been established and 
documented (APA, 2001; Binks et al., 2006; Leichsenring & Leibing, 2003; Perry, Banon, 
& Ianni, 1999). Importantly, the efficacy of psychotherapy for PD is not primarily deter-
mined by the specific theoretical orientation, but rather by the consistent application of 
a coherent and – both to patient and to therapist – comprehensible therapeutic method 
(Verheul & Herbrink, 2007). In addition, efficacious treatments are typically characterized 
by a high level of structure, effort to enhance compliance, a clear focus, a long-term and 
powerful attachment relationship, an active stance, and integration with other services 
(Bateman & Fonagy, 2000).
An element that has received less attention but is nevertheless likely to be essential, is the 
optimal level of destabilizing in treatment. Patients with PD are typically characterized by 
persistent and pervasive patterns of cognition, emotion and behavior. From a dynamic 
systems theory perspective, it can be predicted that such patterns or ‘attractor states’ need 
to be destabilized first. Then more functional patterns can be organized (Hayes & Strauss, 
1998; Thelen & Smith, 1994). This prediction is in line with the principles of psychody-
namic psychotherapy promoting the application of various interpretive or expressive 
techniques (Gabbard, 2005). Such techniques are focused on uncovering unconscious 
wishes, fears, conflicts and defenses, as opposed to supportive techniques that help the 
patients to adapt to stresses while avoiding insights. The broad spectrum of psychothera-
peutic techniques can be placed on an expressive-supportive continuum, running from 
typically expressive or destabilizing categories such as interpretation and confrontation 
to typically supportive or stabilizing categories such as empathic validation, advice and 
praise, and affirmation (Horwitz et al., 1996). Psychodynamic psychotherapy explicitly 
encourages to “be as expressive as you can be, and as supportive as you have to be” (Waller-
stein, 1986, p.688). In this study we defined three levels of destabilization. The focus in the 
‘stabilizing treatments’ is on acceptance and help patients to cope with his PD problems. 
Therapists typically work with supportive and structuring interventions, which results in 
relatively low stress levels during treatment. The focus in the ‘destabilizing treatments’ is 
on change and help the patient to replace their dysfunctional patterns by adaptive ones. 
Therapists typically work with confrontative, expressive, insight-oriented interventions, 
which results in relatively high stress levels during treatment. In the intermediate variant 
therapists focus simultaneously on acceptance and change, and use both stabilizing and 
destabilizing interventions, resulting in changing stress levels in the patient.
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To the best of our knowledge we are not aware of any empirical study focusing directly 
on the importance of stabilizing versus destabilizing in the treatment of PD. However, 
various studies provide pieces of evidence that are consistent with the psychodynamic 
literature which suggests that patients scoring high on psychological strengths or 
ego-adaptive capacities (e.g. capacity to relate, identity integration and the ability to 
mentalize) are better able to tolerate and profit from destabilizing techniques than 
patients scoring low on such psychological strengths. This ‘matching hypothesis’ is for 
instance supported by various studies that have shown that patients with severe PD 
drop out prematurely from expressive psychotherapies more often than from support-
ive psychotherapies (Piper, Joyce, McCallum, & Azim, 1998; Piper, McCallum, Joyce, Azim, 
& Ogrodniczuk, 1999). Secondly, the studies of Bartak et al. (2011, 2010) have shown 
superiority of short-term inpatient psychotherapy in patients with cluster C but not with 
cluster B PD. Short-term inpatient treatments are characterized by a high level of thera-
peutic intensity and pressure. The authors suggest that “patients with cluster C personality 
pathology might be able to handle the high pressure of this treatment modality better than 
(pure) cluster B PD patients, who probably have a lower tolerance for therapeutic pressure” 
(Bartak et al., 2010, p. 28). Third and finally, the matching hypothesis is consistent with 
Gabbard et al. (2000) suggestion of patient characteristics that can help clinicians decide 
whether a predominantly expressive versus a predominantly supportive treatment focus 
is indicated. According to Gabbard, indications for a highly expressive modality are, for 
instance: a strong motivation, suffering, tolerance of frustration, psychological minded-
ness, and intact reality testing, whereas indications for a highly supportive modality are, 
for instance: low anxiety tolerance, poor frustration tolerance, poor impulse control, and 
little capacity for self-observation. Some research in a non-PD population supports the 
suggestion of Gabbard of a matching relation, i.e. matching between level of personality 
organization (Koelen et al., 2012) or different personality types (anaclitic/introjective) 
(Blatt, Zuroff, Hawley, & Auerbach, 2010) and type of intervention (interpretive versus 
supportive) (Piper et al., 1998; Piper et al., 1999).
The present study aims to explore the matching hypothesis outlined above in a large 
quasi-experimental, naturalistic study. In this population we study whether patients 
high on strengths profit more from predominantly destabilizing treatments, whereas 
patients low on strengths might profit more from predominantly stabilizing treatments. 
Research questions are focused on (1) the impact of psychological strengths on treat-
ment outcome, (2) the impact of level of destabilization on treatment outcome, and (3) 
the interaction between the patient’s psychological strength and the treatment’s level 
of destabilization with respect to outcome.
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mEThOD
Participants
Participants (n=735) were recruited from a consecutive series of admissions to six men-
tal health care centers in the Netherlands (i.e. de Viersprong, Netherlands Institute for 
Personality Disorders, Halsteren; Altrecht, Utrecht; Zaans Medical Centre, Zaandam; Pro 
Persona, Centre of Psychotherapy, Lunteren; GGZWNB, Halsteren; Arkin, Amsterdam). 
These centers offer specialist psychotherapy for adult patients with PDs. From March 
2003 to March 2006, a total of 1,379 admissions completed the intake and screening 
procedure and were selected for treatment (Figure 6.1). The intake and screening proce-
dure included self-report questionnaires and a semi-structured interview for diagnosing 
Do not comply with inclusion
and exclusion criteria study
(n=155)
Patients selected for
treatment (n = 1379)
Refused to participate and
other reasons (n=303)
Patients enrolled in treatment
(n = 921)
No Personality Disorder
diagnosis assessed with SIDP-IV
(n = 115)
No follow-up measurement (n
= 71)
Patients analyzed
(n  = 735)
Stabilizing treatment
N = 401
Destabilizing treatment
n =334
figure 6.1. Patient flow.
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PDs. The data obtained from this initial assessment served as baseline data for our study. 
As it was part of the standard screening procedure, and not involved additional risks or 
load, informed consent for the baseline data collection was not mandatory under Dutch 
law. The study was approved by the medical ethics committee of the Erasmus MC.
Of the 1,379 admissions, 146 were excluded from the study because of one of the fol-
lowing inclusion criteria: age between 18 and 70 years (n=13), personality pathology is 
primary psychiatric disorder (not eating disorder for example) (n=34), and referral for 
psychotherapeutic treatment aimed at personality problems (n=99). Nine patients met 
one of the following exclusion criteria: insufficient command of the Dutch language 
(n=6), organic cerebral impairment (n=1), mental retardation (n=1), and schizophrenia 
(n=1).
This left 1,224 eligible patients, of whom 100 refused to participate (i.e., did not provide 
informed consent) and 38 patients did not enter treatment (i.e., received less than two 
treatment sessions or less than two days of inpatient or day hospital psychotherapy).
Another 31 patients could not participate due to logistic reasons (i.e., no appointment 
could be made to provide informed consent), and 134 patients were excluded due to 
missing or unreliable self-report questionnaires or semi-structured interview (mostly 
because of lack of interviewers at the start of the study, n=106).
The remaining 921 patients were informed about the study and its procedures, provided 
written informed consent for follow up data, and entered the study. Of those, 186 were 
post hoc excluded because they could either not be diagnosed with a PD (n=115) or the 
follow-up data were not available (n=71). There was no difference in psychiatric symp-
toms (BSI), their social role and relational functioning (OQ-45), their level of personal-
ity pathology (SIPP-118) and the socio-demographic variables age and sex at baseline 
between patients with follow-up data and those without. The final sample consisted of 
735 patients who were included in this study.
Treatments and level of destabilization
Patients were assigned to the different psychotherapeutic treatments available in the 
six treatment centers in the local standard way, i.e. based on the available test results, 
expert opinion and clinical experience (for more information about the treatment selec-
tion: Van Manen et al., 2008; Van Manen et al., 2011; Van Manen et al., 2012). Treatments 
were delivered by licensed psychiatrists of psychologists. They had an average of 15 
years of postgraduate clinical experience (SD =10.1).
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The available treatments differ in terms of setting (i.e. outpatient, day-hospital and 
inpatient), duration (i.e., varying from three to 24 months), theoretical orientation (pre-
dominantly cognitive-behavioral and psychodynamic orientations) and level of destabi-
lization. The latter characteristic is focused on in this study. The level of destabilization of 
all individual treatment programs in the six treatment centers were scored on a 3-point 
Likert scale (i.e., low, intermediate, and high level) at two times during the investigation. 
In 2002 (before the inclusion started), the intake clinicians of each center provided a 
consensus rating for each treatment program. As we were interested in the reliability 
and validity of this measurement, we repeated the scoring procedure in 2007 (after the 
inclusion was completed), but this time we asked the managers in the steering commit-
tee of the investigation, to independently provide scores. Both times we instructed the 
respondents to score the level of destabilization independent from the setting and the 
duration of the treatment. The three levels were described as follows:
(1) Low level of destabilization: Predominantly stabilizing psychotherapies focus on 
acceptance and help patients to cope with his PD problems. Therapists typically work 
with supportive and structuring interventions. Examples of therapeutic techniques are: 
giving advice, psycho-education and empathic validation. As a result the tension or 
stress in the patient is kept as low as possible.
(2) Intermediate level of destabilization: These psychotherapies focus simultaneously 
on acceptation of the PD problems as well as on helping patients to replace their dys-
functional patterns by adaptive ones. Therapists work both with confrontative, expres-
sive, insight oriented interventions and with supportive and structuring interventions. 
Because of the flexibility in using both techniques, a therapist tailors his interventions 
to the tension and stress level of the patient, or by the psychic state of the patient at the 
specific moment in treatment.
(3) High level of destabilization: Predominantly destabilizing psychotherapies focus on 
change and help the patient to replace their dysfunctional patterns by adaptive ones. 
Therapists typically work with confrontative, expressive, insight-oriented interventions 
aiming at uncovering unconscious wishes, fears, conflicts and defenses. Examples of 
therapeutic techniques are: interpretation, confrontation and clarification. As a result 
the tension and stress level in a patient can increase to a high level.
The two measurements in 2002 and 2007 were highly correlated (r=.69, p<.001), sup-
porting the reliability and construct validity of our operationalization of level of desta-
bilization. In this study we used the level of destabilization scores by the managers in 
the steering committee of the investigation. Because only 36 out of the 735 patients 
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had a treatment with a low level of destabilization, we combined the low and inter-
mediate level into a group with low level of destabilization (referred to as ‘stabilizing 
psychotherapy’) and a group with high level of destabilization (referred to as ‘destabiliz-
ing psychotherapy’).
assessments
PD diagnosis
DSM-IV-TR PD diagnoses were measured using the Dutch version of the Structured Inter-
view for DSM-IV Personality Disorders (SIDP-IV) (Jong, de Derks, Oel, & van Rinne, 1995; 
Pfohl, Blum, & Zimmerman, 1997). This interview covers the 11 formal DSM-IV-TR axis II 
diagnoses including PD not otherwise specified (PDNOS), two appendix diagnoses (i.e. 
depressive and negativistic PD), and self-defeating PD. Interviewers were Master level 
psychologists, who were trained thoroughly by one of the authors (R.V.). They received 
monthly booster sessions to avoid deviation from the interviewer guidelines. Inter-
scorer reliability was evaluated in a convenience sample of 25 videotaped interviews, 
which were rated by three observer raters resulting in 75 observations. Percentage of 
agreement between observer raters ranged from 84% (avoidant PD) to 100% (schizoid) 
(median 95%). Intraclass correlation coefficients for the sum of DSM-IV PD traits present 
(i.e. scores ‘2’ or ‘3’) ranged from 0.60 (schizotypal) through 0.92 (antisocial) (median 
0.74).
Strength measures
As there is no golden standard for measuring psychological strengths or ego adaptive 
capacities, we considered this variable a ‘latent construct’ and used four operationaliza-
tions: severity of PD, adaptive personality functioning, overall defensive functioning, 
and motivation for treatment. These variables fit into the internal strength domain as 
revealed by a recent concept map study of patient characteristics relevant for treatment 
assignment (Van Manen et al., 2012). First, severity of PD was measured with the SIDPIV 
(describing of the administration is given above). To form mutually exclusive diagnostic 
groups, we clustered the formal DSM-IV-TR Axis II diagnoses hierarchically into: (a) Low 
strength group: at least one cluster A or B PD present (i.e., paranoid, schizoid, schizo-
typal, antisocial, borderline, histrionic, and/or narcissistic PD) versus (b) High strength 
group: at least one cluster C PD or PDNOS present (i.e., avoidant, dependent, obsessive-
compulsive, depressive, passive aggressive, and/or mixed PD, but no cluster A or B PD). 
Second, adaptive personality functioning was measured using the Severity Indices of 
Personality Pathology (SIPP-SF) (Verheul et al., 2008). The SIPP-SF measures five domains 
of adaptive personality functioning; high scores reflect adaptive personality, whereas 
low scores reflect maladaptive personality. We computed a total score by adding all 
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items and applied a median split to distinguish high from low adaptivity. Third, overall 
defensive functioning was measured using the Dutch version of the Defense Style Ques-
tionnaire (DSQ-60). The DSQ-60 is designed to measure type and degree of the defensive 
style (Bond, Gardner, Christian, & Sigal, 1983; Thygesen, Drapeau, Trijsburg, Lecours, & de 
Roten, 2008), high scores reflect a more mature level of defensive functioning, whereas 
low scores reflect less mature level of defensive functioning. We applied a median split 
on the Overall Defensive Functioning (ODF) score, to form (a) a relatively mature group 
versus (b) a relatively immature group. Finally, motivation for treatment was measured 
using the 8-item Motivation for Treatment Questionnaire (MTQ) (Van Beek & Verheul, 
2008). The MTQ consists of two subscales, i.e., Need for help and Readiness to change; 
high scores reflect high level of motivation, whereas low scores reflect a low level of mo-
tivation. A median split was applied on the total score of the 8 items and distinguishes 
high from low motivation.
Outcome measures
The primary outcome measures were psychiatric symptoms and psychosocial function-
ing. Psychiatric symptoms were measured using the Dutch version of the Brief Symptom 
Inventory (BSI) (De Beurs & Zitman, 2006; Derogatis & Melisaratos, 1983), a validated 
self report scale derived from the revised Symptom Checklist-90 (SCL-90-R) (Arrindell & 
Ettema, 2003; Derogatis, 1986). In this study, we used the Global Severity Index (GSI) as 
the mean score of the 53 BSI items. The GSI ranges from 0-4, with higher scores indicat-
ing more problems. Psychosocial functioning was measured with two subscales of the 
Outcome Questionnaire-45 (OQ-45), i.e. Interpersonal relations and Social role function-
ing (Lambert et al., 1996). The subscale Interpersonal relations ranges from 0-44, the 
subscale Social role functioning ranges from 0-36, with higher scores indicating more 
problems. All three outcome measures were assessed at baseline and several follow-
up points. Three treatment centers conducted follow-ups at approximately 12, 24, and 
36months after baseline; the other three treatment centers conducted follow-ups at the 
end of treatment, subsequently after about 6 and 12months, and again at 36months 
after baseline. The use of different assessment points was due to logistic reasons and 
was taken into account by choosing multilevel modeling as the statistical method for 
the analyses.
Statistical analyses
Baseline differences between stabilizing groups were analyzed with t-tests for normally 
distributed variables, Mann-Whitney U tests for non-normal distributed variables and 
continuity corrected chi2 tests for categorical variables.
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We used multilevel modeling to deal with the dependency of repeated measures on 
the same subject in time and longitudinal data with observations unequally spaced in 
time. First, we estimated the uncorrected treatment effect at 12 months after baseline 
using a random intercept and random slope model with time as level I and patient 
number as level II. Within-group effect sizes (Cohen’s d) (Cohen, 1988) were calculated 
to describe changes from baseline to 12 months for each treatment group. Second, 
we estimated the treatment effects at 12 months corrected for baseline differences by 
means of the ‘propensity score’ (for a detailed description of this method and its use in 
psychotherapy research, see Bartak et al. (2009) and Spreeuwenberg et al. (2010). Using 
the propensity score, we attempt to ‘mimic’ random assignment (as in a randomized 
clinical trial) to psychotherapies with high and low levels of ‘destabilization’. To identify 
relevant confounders to be used to calculate the propensity score, we considered a list 
of social and economic variables. All variables significantly related to a specific outcome 
were used to estimate the univariate propensity scores in a regression analysis, with 
group membership (high versus low levels of destabilization) as a dependent variable. 
Diagnostic variables likely to be correlated with the psychological strengths, and the 
psychological strength variables themselves were not included in the propensity score, 
as including those would decrease the sensitivity of our design and diminish effects. 
To compare change in outcome variables across the treatment groups, a sophisticated 
multilevel model was used. Dependent variables were the change scores (follow up 
minus baseline) as observed during follow-up for each of the outcome measures. The 
following independent variables were entered in the model: time, outcome measure at 
baseline, the propensity score, group membership (high or low level of destabilization), 
the patient strength characteristic and the interaction between group membership and 
patient strength characteristic. This model estimated differences in change scores at 12 
months after baseline between the two treatment groups.
All analyses were based on intention-to-treat (ITT). ITT is defined as assignment and a 
minimal exposure to the intended treatment modality. All patients completed at least 
one follow-up assessment, and received a ‘minimally effective dosage’ of psychotherapy 
(defined as at least two sessions of outpatient psychotherapy or at least two treatment 
days of day hospital or inpatient psychotherapy). The ITT analyses are based on the 
initial treatment assignment and not on the treatment eventually received. Drop-out 
and crossover between treatments are possible. However, dropout rage seems quite 
manageable; the proportion of dropout were 12.9% in stabilizing treatments and 19.5% 
in destabilizing treatments. Furthermore 79.2 percent of patients received the treatment 
setting they were allocated to. The analyses were performed using SPSS 21 for data 
preparation and baseline differences. Proc Mixed of SAS 9.3 was applied for multilevel 
modeling (SAS Institute Inc., Cary, N.C., USA).
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rEsuLTs
sample characteristics
Of the 735 patients, 69.9% were female, and 30.1% male. The mean age was 33.7 years 
(SD=9.7). Education was medium to high for 73.6% of the patients. Furthermore, 22.9% 
of the sample had a parental responsibility. The percentage of patients without a job 
was 35.2%. The percentage of patients that were married was 21.1%. In terms of PD 
diagnoses, 8.2% had a cluster A PD, and an additional 24.9% had a cluster B (but no 
cluster A) PD. Thus, 33.1% of the patients had a cluster A and/or B PD, constituting the 
‘low strength’ group. Furthermore, 38.9% had a cluster C (but no cluster A and/or B) PD, 
and an additional 28.0% had a PDNOS (but no cluster A, B, and/or C) PD. Thus, 66.9% of 
the patients had a cluster C PD and/or PDNOS, constituting the ‘high strength’ group.
Treatment characteristics
Table 6.1 shows that the average length of the destabilizing psychotherapies is some-
what shorter (7.6±4.8 months) than of stabilizing psychotherapies (11.7±5.3months). 
Furthermore, destabilizing psychotherapies are more likely to be executed in an inpa-
tient setting than stabilizing psychotherapies (55.1% versus 25.4%), whereas stabilizing 
psychotherapies are more likely to be executed in a day hospital setting (39.4% versus 
30.2%) or outpatient setting (35.2% versus 14.7%) than destabilizing psychotherapies. 
Higher mean scores for the strength operationalizations DSQ-odf, SIDP-IV and MTQ-total 
were observed for the destabilizing group. No baseline differences were found for the 
outcome variables.
uncorrected outcome
Table 6.2 shows the uncorrected effect sizes for patients with low versus high psychologi-
cal strengths, both in stabilizing and destabilizing psychotherapies, for each outcome 
variable and strength operationalization separately. One year after treatment all patients 
in destabilizing as well as in stabilizing psychotherapies showed improvements in terms 
of psychiatric symptoms, social role, and relational functioning (Table 6.2). Remarkably, 
we can observe a consistent pattern in the data, with substantially greater effect sizes 
in patients with low strengths (effect sizes range 0.8-2.0, median 1.3) than in those with 
high strengths (effect sizes range 0.0-1.0, median 0.5), both across outcome variables, 
levels of destabilization and across strength dichotomies (i.e., severity of PD, adaptive 
personality functioning, and overall defensive functioning), but not for motivation for 
treatment. With respect to motivation for treatment, we can observe a reversed pattern, 
with substantially greater effect sizes in patients with high motivation (effect sizes range 
1.1-1.9, median 1.2) than in those with low motivation (effect sizes range 0.4-0.6, median 
0.5), both across outcome variables and levels of destabilization.
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Table 6.1. Socio-demographics, diagnostic and treatment characteristics of all 735 patients and of the pa-
tients in the two different psychotherapies
Total 
population
Destabilizing
psychotherapy
stabilizing
psychotherapy
p-value
N 735 334 401
Socio-demographics
Sex (% female) 69.9 64.4 74.6 0.004
Age (mean years ± SD) 33.7 (9.7) 34.7 (10.0) 32.8 (9.3) 0.008
Medium/high education (%) 73.6 77.5 70.3 0.027
Parental responsibility (%) 22.9 21.3 24.4 0.375
Unemployed (%) 35.2 33.2 39.9 0.337
Marital situation
Never married (%) 67.5 67.4 67.6 0.120
Married (%) 21.1 23.7 19.0 0.057
Widowed or divorced (%) 11.4 9.0 13.5 0.950
Diagnostics a
Cluster A (%) 8.2 8.1 8.2 1.000
Cluster B (%) 24.9 19.5 29.4 0.002
Cluster C (%) 38.9 43.3 35.2 0.027
Cluster NAO (%) 28.0 29.0 27.2 0.634
Strength operationalizations
SIPP: total 2.6 (0.4) 2.6 (0.4) 2.6 (0.4) 0.168
DSQ: odf 3.6 (0.4) 3.7 (0.4) 3.6 (0.4) 0.006
SIDP-IV: AB vs CNOS (%) 38.9 43.4 35.2 0.027
MTQ: total 59.1 (8.5) 59.8 (7.8) 58.4 (8.9) 0.027
Outcome variables
GSI 1.5 (0.7) 1.5 (0.6) 1.6 (0.7) 0.619
OQ-45 Interpersonal Relations 21.2 (6.2) 21.2 (6.0) 21.3 (6.3) 0.792
OQ-45 Social Role 15.6 (4.8) 15.8 (4.7) 15.5 (4.9) 0.473
Treatment characteristics
Duration (mean months ± SD) 9.8 (5.5) 7.6 (4.8) 11.7 (5.3) <0.001
Outpatient (%) 25.9 14.7 35.2 <0.001
Day-hospital (%) 35.2 30.2 39.4 0.009
Inpatient (%) 38.9 55.1 25.4 <0.001
Drop-out rate (%) 16.5 12.9 19.5 0.022
a Assessed with the SIDP-IV, a semi-structured interview for DSM-IV axis II diagnoses. Hierarchically ordered: 
cluster A (at least one cluster A PD present); cluster B (at least one cluster B PD present, but no cluster A PD), 
cluster C (at least one cluster C PD present,
but no cluster A or B PD) and cluster NAO (at least one mixed or appendix PD present, but no cluster A,B 
or C PD).
SIPP=Severity Indices of Personality Pathology, DSQ: odf=Overall Defensive Functioning scale of the De-
fense Style Questionnaire, SIDP-IV: cluster AB vs CNOS=hierarchically clustered PD groups measured with 
the Structured Interview for DSM-IV Personality Disorders, MTQ=Motivation for Treatment Questionnaire
GSI = Global Severity Index of the Brief Symptom Inventory, OQ-45 = Outcome questionnaire-45
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Table 6.2. Uncorrected mean outcomes (SD) and effect sizes in the four patient-psychotherapy groups for 
all outcome variables estimated at 12 months after baseline
Outcome
Patient’s strenght 
operationalizationsb
Patient-psychotherapy groupsa
Stabilizing psychotherapy Destabilizing psychotherapy
Low 
strenghtsb
High 
strenghtsb
Low 
strenghtsb
High 
strenghtsb
GSI SIPP: total Baseline 1.90 (0.65) 1.20 (0.52) 1.82 (0.55) 1.27 (0.53)
    12 months 0.61 (0.72) 0.96 (0.62) 0.74 (0.80) 1.09 (0.60)
    ES 1.98 0.47 1.96 0.35
    n 200 195 158 169
  DSQ: odf Baseline 1.84 (0.67) 1.21 (0.52) 1.77 (0.56) 1.33 (0.57)
    12 months 0.65 (0.73) 0.88 (0.64) 0.76 (0.78) 1.06 (0.65)
    ES 1.76 0.61 1.79 0.48
    n 220 178 151 182
  SIDP-IV:
cluster AB
vs CNOS
 
Baseline 1.80 (0.73) 1.41 (0.62) 1.61 (0.62) 1.50 (0.60)
  12 months 0.79 (0.72) 0.78 (0.68) 0.86 (0.81) 0.93 (0.68
  ES 1.38 1.02 1.22 0.95
  n 149 249 92 241
  MTQ: total Baseline 1.33 (0.63) 1.79 (0.66) 1.38 (0.64) 1.68 (0.52)
    12 months 0.95 (0.69) 0.63 (0.66) 1.09 (0.63) 0.70 (0.78)
    ES 0.59 1.75 0.45 1.87
    n 202 190 162 170
OQ-45: 
Interpersonal
relations
SIPP: total Baseline 24.30 (5.34) 18.18 (5.71) 23.98 (4.95) 18.43 (5.72)
  12 months 14.21 (7.28) 17.95 (6.76) 15.54 (7.45) 17.86 (6.99)
  ES 1.89 0.04 1.71 0.10
    n 143 241 90 238
  DSQ: odf Baseline 23.46 (5.93) 18.59 (5.70) 23.37 (5.55) 19.30 (5.77)
    12 months 14.87 (7.75) 16.98 (6.77) 15.93 (7.20) 17.39 (7.40)
    ES 1.45 0.28 1.34 0.33
    n 220 179 152 181
  SIDP-IV:
cluster AB
vs CNOS
Baseline 22.78 (6.37) 20.38 (6.10) 21.53 (5.59) 21.02 (6.17)
  12 months 16.13 (7.95) 16.04 (7.04) 16.87 (7.31) 16.48 (7.34)
  ES 1.04 0.71 0.83 0.74
  n 149 250 91 242
  MTQ: total Baseline 20.30 (6.34) 22.33 (6.08) 20.18 (6.05) 22.09 (5.84)
    12 months 17.03 (7.02) 15.17 (7.40) 17.44 (7.28) 15.73 (7.29)
    Cohen’s d 0.52 1.18 0.45 1.09
    n 202 191 162 171
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Corrected outcome
Table 6.3 shows the corrected effect sizes for patients with low versus high psychological 
strengths, both in stabilizing and destabilizing psychotherapies, for each outcome vari-
able and strength characteristic separately. Furthermore, the main effects of level of de-
stabilization (low versus high), psychological strengths (low versus high), and the inter-
action effect between level of destabilization and psychological strengths on treatment 
outcome are shown. Regarding the main effect of level of destabilization, destabilizing 
psychotherapies showed significantly more improvement on psychiatric symptoms than 
stabilizing treatments, for the strength variables: ‘severity of PD’ (SIDP-IV) and ‘motivation 
Table 6.2. Uncorrected mean outcomes (SD) and effect sizes in the four patient-psychotherapy groups for 
all outcome variables estimated at 12 months after baseline (continued)
Outcome
Patient’s strenght 
operationalizationsb
Patient-psychotherapy groupsa
Stabilizing psychotherapy Destabilizing psychotherapy
Low 
strenghtsb
High 
strenghtsb
Low 
strenghtsb
High 
strenghtsb
OQ-45: Social 
role 
SIPP: total Baseline 16.95 (4.75) 14.07 (4.67) 17.21 (4.57) 14.49 (4.37)
  12 months 10.90 (5.76) 12.34 (5.07) 11.17 (6.32) 12.86 (5.63)
  ES 1.27 0.37 1.32 0.37
    n 195 188 155 166
  DSQ: odf Baseline 16.65 (4.95) 14.14 (4.52) 17.18 (4.53) 14.63 (4.46)
    12 months 11.07 (5.93) 12.03 (5.08) 11.23 (6.32) 12.76 (5.67)
    ES 1.13 0.47 1.31 0.42
    n 212 173 148 179
  SIDP-IV:
cluster AB
vs CNOS 
Baseline 16.52 (5.12) 14.95 (4.71) 16.22 (4.52) 15.62 (4.71)
  12 months 11.21 (5.84) 11.75 (5.34) 11.83 (6.44) 12.03 (5.84)
  ES 1.04 0.68 0.97 0.76
  n 141 244 89 238
  MTQ: total Baseline 14.87 (4.57) 16.35 (5.14) 14.80 (4.70) 16.70 (4.45)
    12 months 12.75 (5.34) 10.58 (5.40) 12.91 (5.56) 10.91 (6.42)
    ES 0.46 1.12 0.40 1.30
    n 198 182 158 169
GSI = Global Severity Index of the Brief Symptom Inventory, OQ-45 = Outcome questionnaire-45
SIPP=Severity Indices of Personality Pathology, DSQ: odf=Overall Defensive Functioning scale of the De-
fense Style Questionnaire
SIDP-IV: cluster AB vs CNOS=hierarchically clustered PD groups measured with the Structured Interview for 
DSM-IV Personality Disorders
MTQ=Motivation for Treatment Questionnaire
ES = effect size calculated as Cohen’s d
a Effect of stabilizing and destabilizing psychotherapy presented for the two levels of patient’s psychologi-
cal strenghts
b The high versus low psychological strengths are operationalized with four different measures: SIPP, DSQ, 
SIDP-IV and MTQ, as presented in the second column.
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for treatment’ (MTQ). Furthermore, destabilizing treatments were superior to stabilizing 
treatments in terms of their impact on relational functioning, only for the psychological 
strength ‘severity of PD’ (SIDP-IV). For social role functioning, we observe the superiority 
of destabilizing psychotherapies for the psychological strengths ‘defensive functioning’ 
(DSQ), ‘severity of PD’ (SIDP-IV) and motivation for treatment (MTQ).
Regarding the main effect of psychological strengths, patients high on psychological 
strengths show generally significantly better outcomes than patients low on psycho-
logical strength. This pattern is most obvious with respect to psychiatric symptoms and 
interpersonal relational outcome, and least obvious with respect to social role function-
ing.
Regarding the interaction effect between level of destabilization and psychological 
strengths, only one significant effect occurred. Patients low on adaptive personality 
functioning (SIPP) profit more from destabilizing than from stabilizing psychotherapy 
(which is the opposite towards our hypothesis), whereas patients high on adaptive 
personality functioning (SIPP) do equally well in both levels of destabilization (also not 
according to our hypothesis). This matching effect was observed for the improvement in 
terms of relational functioning, but not for the other outcome variables.
DisCussiOn
In this study we investigated whether patients high on psychological strengths profit 
more from predominantly destabilizing treatments, whereas patients low on psycho-
logical strengths profit more from predominantly stabilizing treatments. This hypothesis 
is often stated in psychodynamic clinical literature (e.g. Gabbard (2005) and Winston, 
Rosenthal, and Pinsker (2004)) and used in clinical practice when matching patients to 
psychotherapies (Van Manen et al., 2012). However, in this large quasi experimental 
naturalistic study we cannot confirm this matching hypothesis. The findings do show 
main effects for the level of destabilization (i.e., high level of destabilization is associated 
with better outcomes) and psychological strengths (i.e., patients high on strengths have 
better outcomes than those low on strengths), but no interaction effects in line with 
the matching hypothesis. The only interaction effect that emerged, was opposite to our 
hypothesis.
main findings
This study shows a positive impact of a high level of destabilization on treatment 
outcome, irrespective of psychological strengths and specific outcome variable. Fur-
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thermore, to some extent this finding is in contrast with the prevailing view that too 
much pressure on vulnerable patients increases the risk of drop-out, difficulties to form 
a stable working alliance, and even psychotic decompensation (Horwitz et al., 1996). 
Our finding suggests that even vulnerable patients profit from confrontative, expressive, 
and insight-oriented interventions. Moreover, we found a higher drop-out rate in the 
stabilizing therapy group. This finding is consistent with the dynamic systems theory 
perspective as described in the introduction (Hayes & Strauss, 1998; Thelen & Smith, 
1994). We suspect that the majority of destabilizing treatments included in our sample, 
which were predominantly executed in an day-hospital or inpatient setting (86.6%), 
provide a highly structured and safe environment for patients to have corrective social-
emotional experiences, to let go of their old dysfunctional patterns, and to experiment 
with and adopt new functional patterns. In other words, we suggest that these settings 
can provide the necessary positive holding environment patients need to work through 
the high anxiety levels that can occur in an insight-oriented treatment (Bateman & 
Fonagy, 2001; Lorentzen & Hoglend, 2008).
Our finding that destabilizing psychotherapy has a more positive impact on treatment 
outcome then stabilizing psychotherapy contrasts with the results of the study of Piper 
et al. (Piper et al., 1998; Piper et al., 1999). They found in a randomised clinical trial, in 
an outpatient patient population with a majority suffering from PD, that interpretive 
psychotherapy provided the same effectiveness as the supportive psychotherapies. The 
differences in outcome between our study and the study of Piper could be explained by 
the more intensive setting of the destabilizing treatments in our study. Our hypothesis is 
that PD patients can only profit fully from a high pressure, destabilizing psychotherapy 
if the setting provides enough safety, which is for example in a day hospital or inpatient 
setting. In the study of Piper and colleagues the expressive therapy was (even as the 
supportive variant) in an outpatient setting.
Furthermore, this study revealed that patients high on psychological strengths, for 
instance, overall mature defensive functioning, benefit more from psychotherapy than 
patients low on psychological strengths, irrespective of the level of destabilization and 
specific outcome variable. This finding is in line with previous research indicating that 
healthier patients tend to do better in psychotherapy than more severely ill patients 
(Luborsky et al., 1980). Possibly, healthier patients have psychological resources that 
enables them to profit from psychotherapy more than severely ill patients. Note that in 
our study ‘healthier’ does not mean ‘less psychiatric symptoms, and healthy interpersonal 
relations and social role’ as we entered these outcome measures at baseline in our multi-
level model. The term healthier in this study is restricted to ‘psychological strengths’, e.g. 
motivation and overall defensive functioning.
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The matching effect found in this study revealed that patients low on personal strengths 
profit more from a destabilizing treatment, and patients high on psychological strengths 
profit equally from destabilizing and stabilizing psychotherapies. This finding is oppo-
site to our hypothesis. Perhaps a consistent reasoning according to the dynamic systems 
theory can help us interpret this interaction effect: patients high on psychological 
strengths only require a limited adjustment within the same pattern or attractor state, 
whereas those low on psychological strengths require a major change including replac-
ing dysfunctional patterns or attractor state by functional ones. Thus, destabilization is 
not necessary in those high on psychological strengths, while it is in their low-scoring 
counterparts.
Clinical and scientific implications
Our findings have two important clinical implications. First, our findings discourage clini-
cal practice to routinely match patients low on psychological strengths to supportive or 
stabilizing variants of psychotherapy. Second, the overall positive effect of destabilizing 
psychotherapies in a PD population and the lack of evidence for a matching hypothesis 
strengthens the position of predominantly destabilizing psychotherapies or, at least, 
the application of expressive and confrontative techniques within psychotherapeutic 
treatments. Destabilization seems to be beneficial for both the more vulnerable and 
the relatively healthier PD patient. However, our results do not preclude the possibil-
ity that destabilization can involve safety risks and thus iatrogenic effects for patients 
such as premature drop-out and difficulties in forming a stable working alliance. We 
would therefore recommend to apply destabilizing techniques in a well-structured, 
safe, and holding therapeutic environment. An approach to safety in psychotherapeutic 
environments is offered by Hutsebaut and colleagues, who distinguish between organi-
zational, team and therapist adherence to a treatment model as necessary components 
of treatment integrity in the implementation of complex interventions for PD patients 
(Hutsebaut, Bales, Busschbach, & Verheul, 2012).
It is important to note that this study is the first study of treatment matching in PD, 
which is a highly complex domain of research. Replication of this study will help to build 
further on a clinically useful evidence base for practitioners, but only a replication of the 
results in this study in a randomized clinical trial will give enough evidence to implement 
the results in daily practice. Therefore RCTs are recommended. Furthermore, we would 
recommend future studies to elaborate on the potentially moderating role of the level 
of structure, safety and holding in the therapeutic environment, with a beneficial impact 
of destabilization in safe environments and a negative impact in unsafe environments.
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strengths and limitations
A clear strength of this study is its relatively high external validity. The study is conducted 
in clinical practice and not under stringent experimental conditions. Nevertheless, it 
should be recognized that all patients were referred and admitted to specialist psycho-
therapy. It can therefore not be precluded that our results are not applicable to PD pa-
tients who are not referred and admitted to specialist psychotherapy. A second strength 
is the large number of patients enabling the search for a matching effect. Despite these 
strengths the present findings have to be interpreted considering several limitations. 
First, although we controlled for pre-treatment differences or potential confounders 
using the propensity score, we cannot rule out that some potential confounders still 
influence the results (Bartak et al., 2010). Furthermore we used an alternative propensity 
score enabling to find matching effects. For example we did not control for patient char-
acteristics highly correlated with the concept of ‘psychological strengths’ in the propen-
sity score. This concern is somewhat mitigated by the fact that reanalysing de data with 
or without several correlated strength characteristics in the propensity score did not 
alter the results. Furthermore, the main effect of destabilization and the lack of matching 
effects were observed with all variants of the propensity score. Further research is under-
taken by our research group to investigate the use of the propensity score in subgroup 
analyses to optimize the power to find a matching effect, while simultaneously retaining 
control for confounding effects (Van Eeren et al., 2011). A second limitation is that the 
treatments available in the destabilizing and stabilizing psychotherapies are a mixture 
of different settings, theoretical orientations and durations (table 6.1). One could argue 
that the effects we found can be attributed to the differences in for example the setting, 
not to the ‘level of (de)stabilization’ in the treatments. We considered however that the 
differences in duration and setting is inherent to the concept of ‘(de)stabilization of treat-
ment’. In other words: the setting and duration are not independent of the level of de-
stabilization. Destabilizing treatments often use a ‘high pressure cooker model’ that yield 
good results in a relatively short time span. Stabilizing treatments use a more supportive 
and time-consuming trajectory. A third limitation concerns the operationalization and 
measurement of the concept ‘destabilization’. Although we have indications that the reli-
ability of our operationalization is sufficient (correlation among two ratings was r=.69), 
the validity of our operationalization might be improved. Further investigations could 
describe at a detailed level all possible stabilizing and destabilizing therapist interven-
tions. Each treatment could then be scored on the most prominent interventions the 
therapist uses, for example by rating the videotaped sessions by multiple raters. A fourth 
limitation is that the operationalization of the psychological strength characteristics re-
mains open for debate. We could not find one variable that captured the whole concept, 
and others have also outlined this definition problem (Bjorklund, 2000; Lake, 1985). In 
an attempt to overcome this problem, we decided to use four constructs likely to be 
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highly associated to the ‘latent construct’ of psychological strengths. A fifth limitation is 
the presence of non-response in our data. This may cause a problem for internal validity 
if non-response is not at random, but related to systematic bias in effect estimation. 
However, this bias seems unlikely because responders and non-responders did not differ 
in psychiatric symptoms at baseline, and therefore it seems that they do not represent 
two structurally different groups of patients (Bartak et al., 2010).
Conclusion
In conclusion our findings do not encourage clinical practice to routinely match patients 
low on psychological strengths to supportive or stabilizing variants of psychotherapy, 
and may encourage to routinely consider predominantly destabilizing psychotherapies 
as an interesting treatment option in these patients. These findings are in favor of the 
position of destabilizing psychotherapies in the treatment of PD patients.
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In the introductory chapter of this thesis, three research questions were formulated 
and these questions will be discussed below in the light of the results presented in the 
previous chapters. Subsequently, we will elaborate on the implications of this research 
for clinical practice and future research.
rEsEarCh quEsTiOns Of This ThEsis
1. Are the improvements previously observed in patients with a cluster A, B, or C Personality 
Disorder (PD) or Personality Disorder Not Otherwise Specified (PDNOS) stable over five 
years of follow-up? Are there differences in the effectiveness of outpatient, day hospital, 
and inpatient treatments on the long-term outcome in patients with a cluster A, B, or C 
PD or PDNOS? Chapter 2 showed that five years after baseline, patients with a cluster 
A, B or C PD had still maintained a reduced symptom levels and better functioning 
as compared to before treatment. The differences in outcomes of the various treat-
ment modalities at 1-year follow-up were still present at 5-years follow-up. However, 
most of these differences were small with the exception of the superiority of short-
term inpatient psychotherapy in patients with cluster C PDs. Chapter 3 showed that 
patients with PDNOS also benefitted from psychotherapy – both at short-term and 
long-term follow-up. Especially short-term inpatient psychotherapy was superior to 
the other treatment modalities up to 36-months follow-up. At 60-months follow-up, 
treatment modalities in patients with PDNOS showed mostly comparable effective-
ness. In this regard, the superiority of short-term inpatient treatments in PDNOS is 
less pronounced than that in cluster C PD. In summary, our findings are consistent 
with: (1) patients with PDs benefit from psychotherapy; (2) the improvements are 
long-lasting; (3) the long-term outcome is generally independent of treatment mo-
dality, with the exception of (4) short-term inpatient psychotherapy, which continues 
to be superior to most other treatment modalities in patients with a cluster C PD up 
to 5-years follow-up.
2. What are the effectiveness and cost-effectiveness of Short-Term Inpatient Psychotherapy 
based on Transactional Analysis (STIP-TA) in PD patients? Chapter 4 showed that in 67 
matched pairs of patients, patients in both STIP-TA and Other specialized Psychother-
apies (OP) showed large symptomatic and functional improvements up to 3-years 
follow-up. STIP-TA outperformed OP in terms of improvements in general psychiatric 
symptomatology and quality of life. The superiority of STIP-TA was most pronounced 
at 12-months follow-up, but remained intact until 3-years follow-up, when two thirds 
of the STIP-TA patients were symptomatically recovered versus almost half of the OP 
patients. Chapter 5 showed that STIP-TA is a cost-effective and dominant treatment 
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compared to OP: i.e. less costly and more effective. The mean three-year costs were 
€59,834 for STIP-TA and €69,337 for OP, a difference of €-9,503 (95% CI -32,561 to 
15,726). QALYs were 2.29 for STIP-TA and 2.05 for OP, a significant difference of .24 
(95% CI .05 to .44).
3. Is there an interaction between the patient’s level of psychological strength and the treat-
ment’s level of destabilization with respect to outcome? Chapter 6 studied the hypoth-
esis that psychological strong patients profit more from destabilizing treatments, 
while psychological weak patients profit more from stabilizing treatments. This 
study found that PD patients high on psychological strengths generally improved 
more than patients low on psychological strengths. There was no interaction with 
the treatment’s level of destabilization: patients profited more from a higher level of 
destabilizing psychotherapy irrespective of their level of psychological strengths.
Below we highlight some clinical relevant results, together with directions for future 
research that may surpass the limitations of the present research.
imPLiCaTiOns fOr CLiniCaL PraCTiCE anD fuTurE rEsEarCh
Large effects of treatment in PD, but impairment remains
Though we found large and statistically significant effects of PD treatments five years 
later, patients were still more impaired than the general population. This finding is in line 
with previous work on treatments in PD patients (Bateman, Gunderson, & Mulder, 2015). 
Whether this difference is due to research factors (Budge, 2015), the fact that PDs or 
certain aspects of PD might not be changeable (Ferguson, 2010), or inherent limitations 
or insufficiencies of the included treatments (Morey & Hopwood, 2013), is impossible to 
determine on the basis of the results and literature presented in this thesis. The finding 
that impairment is sustained after treatment, combined with the fact that knowledge 
about the causes is missing, justifies more research on the intrapsychic and extrapsychic 
processes underlying the pathogenesis, natural course and change in PD in relation to 
the mechanisms underlying treatment efficacy.
a neglected group: cluster a PD
The desirability of making treatments for PD patients more effective is especially justifi-
able for individuals with a cluster A PD, as there is a general paucity of treatment studies 
in this group. One reason for this is that cluster A PD is relatively rare in psychothera-
peutic treatment settings. This might be partially due to aspects of the pathology itself. 
Their social aversions and relative indifference to their disabilities in relationships make 
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individuals with a cluster A PD less inclined to seek treatment for their personality prob-
lems (Bateman et al., 2015). And if they seek treatment at all, they rather seek treatment 
for axis 1 disorders (Coid, Yang, Tyrer, Roberts, & Ullrich, 2006). A second reason is that 
the changeability of cluster A PD is often questioned and – as a result – individuals with 
this pathology are often excluded from psychotherapeutic treatments (Parnas, Licht, & 
Bovet, 2005). Recent research on the temporal stability of paranoid and schizotypal PD 
showed that over two thirds of the stability of cluster A symptoms can be attributed to 
genetic influences and that these genetic risk factors are highly stable. Furthermore, en-
vironmental experiences have less influence on the stability of cluster A symptoms and 
are found unstable (Kendler et al., 2015). Most treatment and research in these patients is 
therefore dedicated to the effects of psychopharmacology. Remarkably, in our study we 
found encouraging effect sizes and high clinical significant change rates for this group 
five years after baseline, which were comparable to those found in patients with other 
PDs. This suggests that patients with a cluster A PD can profit from psychotherapeutic 
treatments and that these positive effects of treatment are long-lasting. Our study in 
cluster A is one of the largest so far, but includes nevertheless only a modest number 
of patients. Moreover, a control group not receiving treatment was lacking. Given these 
limitations, the findings as yet cannot be translated into an evidence-based treatment 
advice. Larger controlled studies are needed to better understand the natural course 
and role of treatment in the changeability of cluster A PD. However, this is not to say that 
patients with a cluster A PD should be excluded from psychotherapeutic treatments by 
default.
short-term inpatient treatments: an underestimated treatment
In patients with cluster C PD or PDNOS, STIP-TA has proven to be an effective and a 
cost-effective treatment. STIP-TA improves quality of life more and faster than other 
specialized treatments in an outpatient, day hospital or inpatient setting. Furthermore, 
although this treatment is initially expensive, it is cost saving on the medium and long 
run in these patients, who are typically seen as less fragile and might thus be responsive 
to brief and intensive treatments. On the basis of these findings, a short-term inpatient 
treatment ought to be one of the treatment options, especially in cluster C patients and 
PDNOS.
Effective ingredients of STIP-TA
We do not know exactly why the effectiveness of STIP-TA is superior, but propose some 
likely reasons. For one, the amount of confronting and destabilization in this treatment is 
considerable (van Manen, Horn, Stijnen, Busschbach, & Verheul, 2015), which is why this 
treatment is also referred to as a “pressure cooker”. The high amount of destabilization 
is achieved by several aspects worth mentioning. First, the treatment is limited in time. 
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This probably promotes therapeutic engagement and motivation and leads to a height-
ened focus on the individual treatment aims (Town, Abbass, & Hardy, 2011). Second, 
STIP-TA is a so-called focal treatment and has integrated the redecision model of Gould-
ing and Goulding [13]. This is reflected in the formulation of an individually determined 
therapeutic contract at the beginning of treatment about the goals for change – and 
which drives the treatment. In this way the therapeutic focus is established early in 
treatment and helps to address defences and works against avoidance (Town et al., 
2011). The ‘focality of treatment’ further enables the therapists to allocate their efforts 
more effectively, which is often hypothesized to be associated with outcome, although 
so far no study has found conclusive evidence (Irving et al., 2004). Third, all treatment 
components are considered to be therapeutic. The pressure is kept high, not only in the 
treatment sessions but also by the presence and interventions of psychosocial nurses. 
Furthermore, daily activities are constantly linked to the treatment contract which 
makes it almost impossible for patients to avoid painful emotions and experiences in 
the treatment group. The finding that avoidance in treatment is linked to interferences 
with processes necessary for therapeutic progress reinforces the importance of the high 
pressure (Meier, 2014). Fourth, the treatment is daily evaluated by the staff and by the 
patients on the basis of their treatment contracts, which routine helps to keep both 
patients and the staff focused on the objectives of the therapeutic contract.
This intensive and destabilizing treatment might be possible and effective only in this 
patient group, since STIP-TA at the same time is also a highly structured treatment and 
much attention is directed to create and keep a safe and holding environment. This is 
reflected in the many staff meetings scheduled, on account of which the patients can be 
carefully monitored in their treatment process and progress and the staff members are 
able to timely anticipate to events in the treatment. The therapists are actively involved 
and the transference relationship is used to mirror patients and to obtain more insight 
in the individual patient. The creation and maintaining of a strong therapeutic alliance 
on itself might be a strong contributor to effective treatments (Falkenstrom, Granstrom, 
& Holmqvist, 2013). Furthermore, much attention is directed to the group cohesiveness, 
which is found to have a large influence on treatment outcome (Burlingame, McClen-
don, & Alonso, 2011).
Another possible reason is that STIP-TA reinforces patients to be actively involved and 
responsible for their own treatment progress. After allocation to the treatment, patients 
spend an orientation day on the ward and are supposed to write a reflection letter af-
terwards in which they motivate why they have chosen for this treatment. The possibly 
resultant heightened feeling of autonomy is in itself positively correlated with treatment 
outcome (Ryan & Deci, 2008). A second aspect which might have a positive influence 
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on autonomy and motivation is the use of the easily learned theoretical language of TA. 
This empowers the patient to have a positive influence on his or her own treatment and 
might enhance compliance to treatment.
STIP-TA is a treatment with half-open groups including ’senior’ patients who have started 
the treatment six weeks earlier than the ’junior’ patients. In this way, the senior patients 
can function as role models for the junior patients; they pass on the treatment culture 
and demonstrate how to explore and deal with problems. This might also lead to height-
ened feelings of hope and it can foster optimism in junior patients with a beneficial 
effect on the treatment outcome (Irving et al., 2004). The group in itself may function as 
a platform for the sharing of corrective experiences, which in combination with build-
ing insight and emotional processing appeared to be key factors in psychotherapeutic 
change (Abbass et al., 2014).
In sum, the combination of a high amount of destabilization and confronting in an em-
pathic manner within a safe and holding environment seems to be the most effective 
aspect of STIP-TA. Furthermore, the attention to the increase of autonomy and motiva-
tion, and the half-open group setting seem to be factors positively related to outcome.
Extension patient group
We found that short-term inpatient treatments were superior in cluster C PD and slightly 
less so in PDNOS patients. In patients with cluster A PD or cluster B PD, inpatient and 
day hospital treatments were associated with the largest effect sizes. However, after 
correction for differences at baseline, the differences between treatment modalities 
disappeared, too. This difference in results might be due to the broader definition of the 
treatment modality and the lack of specification of length in cluster A and B PD. While 
treatment modalities in cluster C and PDNOS were defined in terms of a combination 
of length and setting of treatment  –  which resulted in five and six treatment groups, 
respectively – in the treatment studies of cluster A and B PD, modality was only defined 
in terms of setting – which resulted in three treatment groups. At least in cluster C we 
found significant differences between treatment modalities only when the treatment 
length was added to the modality and the treatments were split up in short-term and 
long-term treatments. It is possible that smaller effects of long-term inpatient treat-
ments reduced the overall effects of inpatient treatments. Most cluster A and B patients 
followed long-term treatments however: 81% and 75%, respectively. This implies that 
clinicians are inclined to send these patients to long-term treatments which might 
be based on the hypothesis that more vulnerable patients cannot handle the higher 
pressure in short-term treatments. One can imagine that in BPD patients a destabilizing 
treatment might impair the mentalizing capabilities and eventually leads to an ineffec-
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tive treatment (Fonagy, Luyten, & Strathearn, 2011). Some investigators have pointed to 
a possible risk for iatrogenic effects in this patient group, such as disturbed therapeutic 
alliances, suicidality or drop-outs (Fonagy & Bateman, 2006). There is limited evidence 
for this idea, although the observation by Giesen-Bloo et al. (2006) that BPD patients 
show significant higher attrition rates in transference focused therapy (TFP) as compared 
to schema-focused therapy (SFT) is consistent with this idea. This finding might be ac-
counted for by more confronting and therefore destabilizing techniques of TFP, thereby 
evoking too much anxiety in some BPD patients and leading to dropout. Nonetheless, 
some patients with a BPD or a different cluster B PD seem to be able to bear the pres-
sure. Though it would be premature to allocate these patients to a short-term inpatient 
treatment, it is well worth investigating whether some of these patients can profit from 
a short-term inpatient treatment.
In PDNOS the short-term inpatient treatments in general were most effective up to 36 
months of follow-up. Hereafter, differences between modalities disappeared. However, 
patients in the short-term treatments on average experienced fewer symptoms over 
the follow-up period than did patients in the other modalities. When combining these 
results with the fact that almost half of the STIP-TA group consisted of patients with a 
PDNOS diagnosis, the recommendation that a short-term inpatient treatment should be 
a treatment option for PDNOS patients is justifiable.
Costs and effects
The recommendation that a short-term inpatient treatment should be a treatment 
option for patients with a cluster C PD or PDNOS is opposed to the current ideas of 
deinstitutionalization and the phasing out of inpatient treatments for (PD) patients in 
the Netherlands and other countries. In the Netherlands, and also in other countries, 
health care reforms, economic crises, and the resultant emphasis on patient empower-
ment have led to a reduction of long-term intensive treatments. Within this movement, 
all inpatient psychotherapies seem to be reduced, both long- and short-term. The pres-
ent thesis suggests that despite the high initial costs, short-term inpatient treatments 
are effective as well as cost-effective in patients with cluster C PD or PDNOS. Though 
the treatment price per patient seems leading in the reimbursement of treatments, 
intensive treatments in these patient groups pay back their investments as initially 
inexpensive treatments become more expensive on the long run due to costs outside of 
the primary treatment. The trend to phase out inpatient treatments will therefore result 
in the reduction of cost-effectiveness in the treatment of personality disorders.
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inTEGraTivE TrEaTmEnTs: COmbininG ThE bEsT ParTs Of EquaLs
The current study found that a short-term inpatient treatment was superior in terms 
of costs and effectiveness compared to other psychotherapies in cluster C PD and PD-
NOS. Concerning cluster A and B PDs, the treatment modality, defined as setting and 
duration, seemed not to influence effectiveness of the treatment. This thesis does not 
clarify which factors account for a higher or lower effectiveness, whether effectiveness 
depends on setting, duration, psychotherapeutic orientation, a combination thereof, or 
even another yet unknown factor. A recent review concluded that evidence-based treat-
ments were more effective than treatment as usual (TAU) and that comparative trials on 
active treatments have not yet provided conclusive evidence for the superiority of one 
theoretical orientation over another ( Budge et al., 2013). A recent review on potential 
mechanisms of change in psychotherapeutic treatments for personality disorders found 
that most evidence points to the importance of ‘common or non-specific factors’ such as 
the therapeutic alliance and the resolution of ruptures in the alliance in the process of 
change (Forster, Berthollier, & Rawlinson, 2014). Studies confirmed that these common 
factors have the largest impact on treatment effectiveness and that its impact is consid-
ered twice as large compared to the used techniques (Lambert & Barley, 2002). Next to 
the therapeutic alliance and the resolution of its ruptures, three other factors emerged: 
1) therapy factors (e.g. a coherent conceptual structure and a treatment which should 
provide a rationale for selecting interventions); 2) therapist factors (e.g. the attitude 
of empathy); and 3) patient factors (e.g. motivation; Livesley, 2012). Instead of further 
comparing one treatment with another, the next logical step in psychotherapeutic re-
search to improve mental health treatments in PDs are studies on how treatments work: 
research on the pathways to improvement, on effective ingredients of treatments, and 
on common elements is warranted.
With more knowledge about effective ingredients and common elements, effective and 
innovative integrative treatments can be conceptualized for PD patients. Most evidence-
based treatments have their own focus, such as emotion regulation in DBT or mentaliz-
ing in MBT. However, PDs are ’multidimensional phenomena’ with a large degree of axes I 
and II comorbidity which require treatments that address several problem areas (Nelson, 
Beutler, & Castonguay, 2012). Livesley (2012) proposed a framework for an integration 
of general and PD specific therapeutic approaches and techniques. Treatments ought to 
be based on generic change methods with the addition of specific psychotherapeutic 
interventions of different psychotherapeutic schools to target specific problems of the 
individual patients, e.g. focusing on emotion regulation skills or mentalizing (Livesley, 
2012). Combining different treatment approaches potentially endangers treatment co-
herence. The therapist can be inclined to bend with the patient every session. One of the 
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efficacious elements of treatments in general is the consistent application of a theoretic 
framework (Bateman & Fonagy, 2000). Therefore, in the integration and evaluation of 
evidence based treatments, psychotherapy manuals are vital. Instead of providing a 
session-to-session manual as is mostly done in axis 1 disorders, in PDs this should be 
rather in the form of guidelines and operationalization of treatment (Westen, 2002). By 
reducing the individual variability, the quality of treatments is improved by lowering 
the propensity for errors and treatments can be evaluated on their (cost-)effectiveness. 
Treatments should furthermore be limited in time and provide for fixed evaluation 
moments to keep the focus on the target(s) of treatment and to prevent open-ended 
treatments.
On the other hand, different psychotherapeutic treatments might have more in common 
than seen at first sight. This line of thought is also reflected in the Common Language for 
Psychotherapy (CLP) project. This project stresses the fact that the absence of a common 
language in psychotherapy might lead to confusion in both therapists and patients as 
different terms seem to be used for identical interventions. By creating an ecumenical 
lexicon of psychotherapy procedures, a widely accepted, common language for psy-
chotherapy procedure can be developed that will reduce confusion and accelerate the 
evolution of psychotherapy into a scientific craft (Marks & Fullana).
sTrEnGThs anD LimiTaTiOns
The strength of the Sceptre study stems from the following factors: a) the high number 
of patients, b) the long-term follow-up over five years, c) a high follow-up response, d) 
the wide range of treatments under study (which can be considered highly representa-
tive of specialist mental health care in the Netherlands), and e) the naturalistic design 
of using a sophisticated statistical technique to mimic randomized treatment allocation 
(propensity score).
The need for such a sophisticated statistical technique is rooted in the principal limita-
tion of this study, the lack of randomization of patients to treatment. This limitation 
is mitigated that we rigorously controlled for initial patient differences as potential 
confounders by means of the multiple propensity score. It is important to acknowledge 
that this score corrects for observed differences only. It is possible that other patient 
differences, which were either not predetermined or not observable, affected assign-
ment to treatment and confounded the observed differences in treatment effectiveness 
(Austin, 2008). However, we controlled for a substantial number of social and diagnostic 
variables, minimizing the likelihood of non-observed confounding factors. Furthermore, 
163
Discussion
7
Randomized Controlled Trials (RCTs) are often criticized for their limited external validity 
as treatments take place under strictly controlled or experimental conditions: only pa-
tients who agree to randomization are studied, and exclusion criteria are typically strin-
gent (e.g. Hodgson, Bushe, & Hunter, 2007). Besides, comparisons between markedly 
different treatment modalities or dosages, as were made in this study, are not feasible in 
a randomized study. This is reflected in an earlier attempt to compare the short-term in-
patient treatment (STIP-TA) to an outpatient treatment in cluster C PD patients in a RCT, 
and which failed due to patient preferences (PSILO trial, National Academic Research 
and Collaborations Information System).
A second limitation of this study is the focus on treatment dosage and it did not con-
sider other treatment or patient attributes such as a) the potential impact of theoretical 
orientation, b) the occurrence of axis I disorders and the use of psychotropic medication 
or c) treatment fidelity.
We came across three complications to investigate the impact of theoretical orientation 
(a) in this study design. First, more than 50% of the given treatments were considered in-
tegrative treatments (e.g., Schema-Focused Therapy (SFT), Dialective Behavior Therapy 
(DBT) and Mentalization Based Treatment (MBT)). Second, as theoretical orientation was 
associated with setting and duration, a different study design would have been neces-
sary to explore the effect of theoretical orientations in addition to treatment modalities. 
Third, studies for PD typically show that theoretical orientations only account for small 
differences in effectiveness (Bartak et al., 2007). Other aspects of treatment, such as a 
coherent theoretical structure or the strength of the therapeutic alliance seem more 
effective ingredients of treatment than the theoretical orientation (Bateman & Fonagy, 
2000).
We do not have information on the occurrence of axis I comorbidity in PD patients (b), 
though they are often reported to be associated with PDs (Tyrer, Reed, and Crawford, 
2015). An earlier study furthermore showed that the severity of symptoms (thereby 
including the presence of axis I disorders) had an influence on treatment allocation (spe-
cifically treatment intensity) (van Manen et al. 2008). The prescription of psychotropic 
medication is not part of the guideline to the treatment of PDs in general but is advised 
as a supplementary treatment for comorbid axis I disorders. In our study, almost half of 
the patients had used psychotropic medication before entering the study. The use of 
psychotropic medication might have facilitated patients with an axis I disorder to profit 
from the psychotherapeutic treatment aimed at PD and therefore might have had an 
effect on treatment effectiveness.
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We did not assess the treatment fidelity (c) and therefore do not know whether 
therapists have administered the treatments as described in the treatment manuals. It 
is reasonable to assume that treatments delivered in specialized treatment centers by 
experienced psychotherapists are of relatively high quality, however without evidence 
of treatment fidelity we do not know whether the treatments described were actually 
performed.
A third limitation of this study is the absence of a control group (i.e. a group of patients 
not receiving treatment). Thus, we cannot evaluate which part of the improvement is due 
to therapy and which part is due to, e.g. natural recovery. For ethical reasons, it would 
be impossible to compare an active treatment with a placebo or waiting list. The current 
study can therefore rather be described as a “comparative effectiveness” approach, com-
paring two or more effective treatments in patients that are representative for regular 
practice. The objective of these studies is to deliver the information decision makers 
need to know (Sox & Greenfield, 2009; Institute of Medicine, 2009). Nonetheless, previous 
research has shown that PD patients in treatment have a seven-fold faster recovery than 
patients without treatment (Perry et al., 1999) and that psychotherapeutic treatment 
can lead to a remission of symptoms (Zanarini, Frankenburg, Reich, & Fitzmaurice, 2012). 
However, the changeability of PDs is still an ongoing discussion (Morey & Hopwood, 
2013) and in a recent meta-analysis it was concluded that psychotherapy should aim on 
behaviour change, rather than on global personality change, since expecting changes in 
fundamental personality structures may be unrealistic (Ferguson, 2010).
Fourth, we do not know whether the underlying personality pathology in our study 
changed as the outcome variables relied on certain assessment instruments and on self-
reporting. However, it seems unlikely that the large effect sizes on the outcome variables 
found in the current study can occur when the underlying pathology still exists in its 
original form.
COnCLusiOn
The current study showed that psychotherapy in patients with a PD yielded long-lasting 
treatment results, though functional impairments remained. In patients with cluster A 
or B PD, differences between modalities or dosages of treatment were small and mostly 
non-significant in the long run. In patients with cluster C PD or PDNOS, short-term inpa-
tient treatment based on transactional analysis (STIP-TA) proved to be the most effective 
and cost-effective treatment option, at both short and long term. This specific treatment 
program deserves more clinical and scientific attention than it currently is receiving. 
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From a clinical perspective, STIP-TA would be an interesting option to be considered in 
any treatment allocation process in patients with cluster C PD or PDNOS. From a scientific 
perspective, it is worthwhile to compare the (cost-)effectiveness of STIP-TA with that of 
well established, evidence-based treatment options for the target population. More in 
general, this thesis underlines the need for more studies about the question which treat-
ment works for whom, studies into the effective general ingredients of psychotherapy in 
PD patients, and the need for the integration of treatment techniques.
“The time is ripe for the treatment of PD to move beyond a “competing schools or therapies” 
approach and adopt a more integrated perspective that combines treatment principles and 
methods that work regardless of their conceptual origins.” (Livesley, 2012) Dr. John Livesley 
in ‘Integrated Treatment: A Conceptual Framework for an Evidence-Based Approach to the 
Treatment of Personality Disorder’ (Journal of Personality Disorders, 2012. 26(1): p. 17-42)
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Summary
summary
The current thesis studied the effectiveness of psychotherapeutic treatments in patients 
with a personality disorder (PD). Personality disorders are highly invalidating disorders 
and one of the most frequent disorders treated in outpatient mental health care. In spite 
of this, there is a paucity of research on effective and cost-effective treatments in this 
patient group. This thesis uses data collected from a quasi-experimental study on the ef-
fectiveness and cost-effectiveness of treatment dosages in patients with a PD, the Study 
on Cost-Effectiveness of Personality Disorder Treatment (SCEPTRE). Treatment dosages 
are defined as outpatient, day hospital or inpatient treatment with a short (<six months) 
or long (≥ six months) duration. Earlier studies based on the SCEPTRE data showed that 
dosage had some influence on the effectiveness on the short- and mid-term follow-up 
and some influence on the modelled cost-effectiveness of treatments. The main findings 
of each chapter are discussed in this summary.
Chapter 1 is the general introduction of this thesis.
Chapters 2 and 3 both report on the long-term effectiveness of different modalities of 
psychotherapy. As the SCEPTRE study was quasi-experimental we used multiple pro-
pensity scores to correct for initial baseline differences. The two research questions were 
as follows: 1) Are the improvements previously observed in patients with a DSM-IV-TR 
cluster A, B, C PD, or PDNOS stable over five years of follow-up? 2) Are there differences in 
the effectiveness of outpatient, day hospital, and inpatient treatments on the long-term 
outcome in patients with a DSM-IV-TR cluster A, B, C PD, or PDNOS? The effectiveness 
studies described below (Chapters 2, 3, and 4) all used symptom severity as the primary 
outcome measure and psychosocial functioning and health related quality of life as 
secondary outcome measures. Effectiveness was assessed over 60 months after base-
line. Chapter 2 reports on the long-term effectiveness of different treatment modalities 
in patients with a cluster A, B and/or C PD. Previous research on short- and mid-term 
follow-up showed some dosage-effect relationships, with superiority of short-term in-
patient psychotherapy in patients with a cluster C PD being the most significant finding. 
We followed 519 patients who were assigned to outpatient, day hospital or inpatient 
treatments during five years. Of these, 59 patients had a cluster A PD, 210 patients had a 
cluster B PD, and 416 patients had a cluster C PD. As patients could have more than one 
PD, the sum of these exceeds the total number. In patients with cluster C PD, short-term 
treatments (<  six months) were distinguished from long-term (≥  six months) treat-
ments. Uncorrected results showed that all patient groups except cluster A outpatients 
reported significantly less symptom severity, and that initial positive outcomes were 
sustained over the 5-year follow-up period. Corrected differences showed small and 
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mostly non-significant differences between the modalities in the three patient groups. 
When distinguishing between long-term outpatient, short- and long-term day hospital 
and short- and long-term inpatient treatments for cluster C patients, the previously ob-
served superiority of short-term inpatient psychotherapy compared to other treatment 
modalities at 12 months follow-up was still present at 5-year follow-up. In chapter 3 we 
explored the long-term effectiveness of different modalities in patients with a PDNOS, 
i.e. short- or long-term outpatient, short- or long-term day hospital, and short- or long-
term inpatient treatments. A total of 205 patients with PDNOS were assigned to one 
of these six treatment modalities. At all time points, all treatment modalities showed 
positive outcomes, especially in terms of improvements of symptom severity and social 
role functioning. When we adjusted for initial baseline differences, short-term outpa-
tient psychotherapy and short-term inpatient psychotherapy were associated with the 
greatest improvement and generally outperformed the other modalities in terms of 
symptom severity at 12-months follow-up. At 60 months after baseline, observed dif-
ferences between modalities mostly had diminished. This might be due to a decrease 
in effects in short-term outpatient and short-term inpatient psychotherapies over time 
while the effects in long-term outpatient and long-term inpatient psychotherapies 
were increasing. We concluded that patients with PDNOS benefit from psychotherapy 
both at the short and long term. And while short-term outpatient psychotherapy and 
short-term inpatient psychotherapy seem to be superior to the other treatment modali-
ties at 12-months follow-up, the differences in effectiveness disappeared at 60-months 
follow-up.
Chapters 4 and 5 report on the effectiveness and cost-effectiveness of Short-Term In-
patient Psychotherapy based on Transactional Analysis (STIP-TA) to Other specialized 
Psychotherapies (OP) in 67 pairs of patients with mainly a cluster C PD or PDNOS. As the 
SCEPTRE study was quasi-experimental we used the propensity score to match STIP-TA 
patients with OP patients. The effectiveness and cost-effectiveness were assessed over 
36 months after baseline. Chapter 4 compares the effectiveness of STIP-TA to OP. In 67 
pairs of patients, both STIP-TA and OP showed large symptomatic and functional im-
provements, with STIP-TA patients showing more symptomatic improvement at all time 
points compared to OP patients. At 36 months, 68% of STIP-TA patients were symptom-
atically recovered compared to 48% of OP patients. STIP-TA outperformed OP in terms of 
improvements in general psychiatric symptomatology and quality of life. The superiority 
of STIP-TA was most pronounced at 12-months follow-up, but remained intact over the 
course of the 3-year follow-up. In chapter 5 we compared the cost-effectiveness of 
STIP-TA to OP. We made use of the societal perspective and measured healthcare costs 
next to lost production costs. Cost-effectiveness was represented by costs per quality 
adjusted life years (QALYs) and uncertainty was assessed using bootstrapping. STIP-TA 
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was less costly and more effective than OP, which makes STIP-TA a dominant treatment. 
We concluded that STIP-TA is a cost-effective treatment in PD patients.
Chapter 6 reports on the matching hypothesis that patients high on psychological 
strengths profit more from predominantly destabilizing treatments while patients low 
on psychological strengths profit more from predominantly stabilizing treatments. 
We followed 735 PD patients who were assigned to different levels of stabilizing and 
destabilizing psychotherapies. Outcome measures were symptom severity and psy-
chosocial functioning. At 12-months follow-up, patients who followed destabilizing 
psychotherapies had slightly better outcomes than patients who followed stabilizing 
psychotherapies. Patients high on psychological strengths generally improved slightly 
more than patients low on psychological strengths. We further found that patients 
profited more from a higher level of destabilizing psychotherapy – irrespective of their 
psychological strengths. The results therefore imply that destabilizing psychotherapies 
should be considered a first treatment option for PD patients with either high or low 
psychological strength.
Chapter 7 is the general discussion where the findings of this thesis are summarized 
and in which the implications for clinical practice and future research are discussed. 
We conclude that psychotherapy in patients with a PD yields long-lasting treatment 
results, but that functional impairments can remain. In patients with cluster A or B PD, 
differences between modalities or dosages of treatment were small and mostly non-
significant in the long run. In patients with cluster C PD or PDNOS, short-term inpatient 
treatment based on transactional analysis (STIP-TA) proved to be the most effective and 
cost-effective treatment option, at both short and long term. This specific treatment 
program deserves more clinical and scientific attention than it currently is receiving. 
From a clinical perspective, STIP-TA would be an interesting option to be considered in 
any treatment allocation process in patients with cluster C PD or PDNOS. From a scientific 
perspective, it is worthwhile to compare the (cost-)effectiveness of STIP-TA with that of 
well established, evidence-based treatment options for the target population. More in 
general, this thesis underlines the need for more studies about the question which treat-
ment works for whom, studies into the effective general ingredients of psychotherapy in 
PD patients, and the need for the integration of treatment techniques.
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summary in DuTCh
In dit proefschrift staat de effectiviteit van psychotherapeutische behandelingen bij pa-
tiënten met een persoonlijkheidsstoornis (PS) centraal. Persoonlijkheidsstoornissen zijn 
ernstige stoornissen en behoren tot de meest behandelde stoornissen in de ambulante 
GGZ. Desalniettemin bestaan er slechts een beperkt aantal wetenschappelijke studies 
naar effectieve en kosteneffectieve behandelingen voor deze stoornis. Het voorliggende 
proefschrift gebruikt data die zijn verzameld in het kader van een quasi-experimenteel 
onderzoek naar de effectiviteit en kosteneffectiviteit van psychotherapeutische be-
handelingen voor patiënten met een PS, de “Study on Cost-Effectiveness of Personality 
Disorder Treatment” (SCEPTRE). Centraal in de SCEPTRE studie staat de vergelijking van 
verschillende modaliteiten of doseringen van behandelingen. Deze doseringen zijn ge-
definieerd als ambulante, dagklinische en klinische behandelingen met een korte (< zes 
maanden) of lange (≥ zes maanden) duur. Eerdere onderzoeken die zijn gebaseerd op 
data van het SCEPTRE onderzoek, wezen uit dat dosering inderdaad invloed heeft op de 
effectiviteit op de korte en middenlange duur van de follow-up. Met name bij de zoge-
naamde type C persoonlijkheidsstoornissen bleek een kortdurende klinische psycho-
therapie de meest effectieve behandeling. Daarnaast bleek dosering van invloed op de 
kosteneffectiviteit van de behandelingen van type B en C persoonlijkheidsstoornissen. 
In dit proefschrift wordt gekeken naar de effectiviteit op de lange termijn, naar de effec-
tiviteit van behandeling van “persoonlijkheidsstoornissen niet anderszins omschreven” 
(PSNAO) en naar de (kosten-) effectiviteit van een bepaalde behandeling, namelijk de 
kortdurende klinische psychotherapie gebaseerd op de principes van de Transactionele 
Analyse (Short-term Inpatient Psychotherapy - Transactional Analysis; STIP-TA).
hoofdstuk 1 vormt de algemene inleiding van dit proefschrift.
In de hoofdstukken 2 en 3 wordt de effectiviteit van verschillende modaliteiten van 
psychotherapie over vijf jaar follow-up beschreven. Aangezien SCEPTRE als een quasi-
experimentele studie is opgezet, hebben we gebruik gemaakt van de multipele propen-
sity score om te corrigeren voor initiële verschillen tussen patiënten vóór begin van de 
studie. De drie onderzoeksvragen voor onderstaande drie studies zijn als volgt:
1) Zijn de behaalde verbeteringen die eerder zijn gevonden bij patiënten met een 
cluster A, B of C PS stabiel over de vijf jaar follow-up?
2) Profiteren patiënten met een PSNAO van een psychotherapeutische behandeling en 
zijn de verbeteringen stabiel over vijf jaar follow-up?
3) Worden er op de lange termijn verschillen gevonden aangaande de effectiviteit 
tussen ambulante, dagklinische en klinische behandelingen bij patiënten met een 
cluster A, B of C PS of PSNAO?
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De effectiviteitsstudies die hieronder beschreven staan (hoofdstukken 2, 3 en 4), ge-
bruiken allen de ‘ernst van de psychische klachten (GSI)’ als de primaire uitkomstmaat. 
‘Psychosociaal functioneren (OQ-45)’ en ‘aan gezondheid gerelateerde kwaliteit van leven 
(EQ-5D)’ vormen de secundaire uitkomstmaten. hoofdstuk 2 beschrijft de effectiviteit 
van verschillende behandelmodaliteiten bij patiënten met een cluster A, B en/of C PS 
over vijf jaar follow-up. De studies toonden met name aan dat een kortdurende klini-
sche psychotherapie voor patiënten met een cluster C PS het meest effectief was. In de 
huidige studie zijn 519 patiënten die toegewezen waren aan ambulante, dagklinische 
of klinische behandelingen, gedurende vijf jaar gevolgd. Van deze patiënten voldoen 59 
patiënten aan een cluster A PS, 210 aan een cluster B PS en 416 patiënten voldoen aan 
een cluster C PS. Aangezien patiënten kunnen voldoen aan de criteria voor meer dan 
een PS is de som van deze aantallen patiënten hoger dan het totale aantal patiënten. 
Bij patiënten met een cluster C PS worden naast de modaliteit ook de kortdurende 
behandelingen (<  zes maanden) van de langdurige behandelingen (≥  zes maanden) 
onderscheiden. Ongecorrigeerde resultaten wijzen uit dat bijna alle patiëntgroepen na 
vijf jaar een significant lager niveau van klachten rapporteren en dat de initiële positieve 
uitkomsten over de vijf jaar van follow-up worden behouden. Alleen binnen de cluster 
A PS groep die een ambulante behandeling heeft gevolgd, wordt geen significante 
afname van klachten gevonden. Gecorrigeerde verschillen laten vooral kleine en niet-
significante verschillen zien tussen de modaliteiten in de drie patiëntgroepen. Wanneer 
we naast verschillen tussen modaliteiten ook onderscheid maken tussen de duur van 
behandeling en zodoende langdurige ambulante behandelingen, kort- en langdurige 
dagklinische behandelingen en kort- en langdurige klinische behandelingen bij cluster 
C PS patiënten vergelijken, vinden we na vijf jaar dat kortdurende klinische psychothe-
rapieën nog steeds grotere effecten behalen dan de andere behandelmodaliteiten. In 
hoofdstuk 3 wordt het onderzoek naar de effectiviteit van verschillende modaliteiten 
voor patiënten met een PSNAO over vijf jaar follow-up gepresenteerd. Tweehonder-
denvijf patiënten die waren toegewezen aan kort- en langdurige ambulante, kort- en 
langdurige dagklinische of kort- en langdurige klinische psychotherapie zijn met elkaar 
vergeleken. Op alle onderzochte tijdstippen wordt een positief effect gevonden van 
alle behandelmodaliteiten. Het grootste effect wordt gevonden op de primaire uit-
komstmaat, de ‘ernst van de psychische klachten’, en op het ‘functioneren in een sociale 
rol’. Na een jaar en met correctie voor initiële verschillen tussen patiënten, blijken de 
kortdurende ambulante en de kortdurende klinische psychotherapie geassocieerd 
met de grootste verbetering met betrekking tot de ‘ernst van de psychische klachten’ 
en zijn deze verschillen over het algemeen significant in vergelijking met de andere 
modaliteiten. Vijf jaar na baseline zijn de eerder geobserveerde verschillen tussen de 
modaliteiten voor het grootste gedeelte verdwenen. Dit is mogelijk te verklaren door 
de afname van effectiviteit in de kortdurende ambulante en de kortdurende klinische 
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psychotherapieën over de tijd heen, en een verdere toename van effectiviteit bij de 
langdurige ambulante en de langdurige klinische psychotherapieën. Op grond hiervan 
is de conclusie dat patiënten met een PSNAO zowel op de korte als de lange termijn pro-
fiteren van psychotherapie. Hoewel kortdurende ambulante en kortdurende klinische 
psychotherapieën na een jaar superieur lijken boven de andere behandelmodaliteiten, 
zijn deze verschillen in effectiviteit na vijf jaar verdwenen.
De hoofdstukken 4 en 5 beschrijven de effectiviteit en kosteneffectiviteit van de Kort-
durende Klinische Psychotherapie gebaseerd op de Transactionele Analyse (STIP-TA) in 
vergelijking met andere gespecialiseerde psychotherapieën (Other Psychotherapies; 
OP). Voor dit onderzoek zijn 67 patiëntparen gevolgd met voornamelijk een cluster C PS 
en een PSNAO. Aangezien SCEPTRE een quasi-experimentele studie is, is de propensity 
score gebruikt om STIP-TA patiënten te matchen met OP patiënten. De effectiviteit en 
kosteneffectiviteit is over 36 maanden na baseline berekend. hoofdstuk 4 vergelijkt 
de effectiviteit van de STIP-TA behandeling met de OP behandeling. Zowel STIP-TA 
patiënten als ook OP patiënten laten grote symptomatische (‘ernst van de psychische 
klachten’) en functionele verbeteringen (‘psychosociale functioneren’ en ‘aan gezondheid 
gerelateerde kwaliteit van leven’) zien, waarbij STIP-TA patiënten echter op alle tijdstip-
pen meer symptomatische verbeteringen laten zien vergeleken met OP patiënten. 
Na 36 maanden is 68% van de STIP-TA patiënten symptomatisch genezen, vergeleken 
met 48% van de OP patiënten. STIP-TA patiënten laten meer vooruitgang zien dan OP 
patiënten met betrekking tot verbeteringen in de ‘ernst van de psychische klachten’ en 
de ‘aan gezondheid gerelateerde kwaliteit van leven’. De superioriteit van STIP-TA is het 
best zichtbaar na 12 maanden van follow-up, maar blijft waarneembaar over de drie 
jaar van follow-up. In hoofdstuk 5 is de kosteneffectiviteit van de STIP-TA behandeling 
vergeleken met de kosteneffectiviteit van de OP behandeling. Het maatschappelijk per-
spectief is hierin gebruikt. Dat betekent dat naast de kosten in de gezondheidszorg ook 
de kosten in verband met productieverlies in de berekeningen zijn meegenomen. De 
kosteneffectiviteit is uitgedrukt in de kosten per extra levensjaar in goede gezondheid 
(QALYs). De onzekerheid rondom de uitkomsten is gemeten door bootstrapping. STIP-TA 
patiënten bleken over de drie jaar follow-up minder kosten te generen dan OP patiën-
ten. STIP-TA blijkt aldus goedkoper en effectiever dan OP, waardoor STIP-TA gezien kan 
worden als een dominante behandeling. We komen tot de conclusie dat STIP-TA een 
kosteneffectieve behandeling is voor veel patiënten met een cluster C PS en PSNAO.
hoofdstuk 6 rapporteert over de matching hypothese dat patiënten die over veel psy-
chologische vermogens beschikken meer profiteren van voornamelijk destabiliserende 
behandelingen, terwijl patiënten die over weinig psychologische vermogens beschik-
ken meer profiteren van voornamelijk stabiliserende behandelingen. We hebben 735 
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patiënten met een PS gevolgd die zijn toegewezen aan verschillende levels van stabilise-
rende en destabiliserende psychotherapieën. De gebruikte uitkomstmaten zijn de ‘ernst 
van de psychische klachten’ en het ‘psychosociale functioneren’. Na 12 maanden follow-up 
behalen patiënten die destabiliserende psychotherapieën hebben gevolgd enigszins 
betere uitkomsten dan patiënten die stabiliserende psychotherapieën hebben gevolgd. 
Patiënten die over veel psychologische vermogens beschikken, verbeteren over het 
algemeen meer dan patiënten die over weinig psychologische vermogens beschikken. 
Bovendien vonden we dat patiënten onafhankelijk van hun psychologische vermogens 
meer profiteren van een hogere mate van destabiliserende psychotherapieën. Deze 
resultaten duiden erop dat destabiliserende psychotherapieën zouden moeten worden 
overwogen als eerste behandeloptie bij PS patiënten, onafhankelijk van hun psycholo-
gische vermogens.
hoofdstuk 7 bevat de algemene discussie waarin de resultaten van dit proefschrift zijn 
samengevat en waarin de implicaties voor de klinische praktijk en voor toekomstig on-
derzoek worden besproken. We concluderen dat psychotherapie bij patiënten met een 
PS langdurige behandelresultaten teweegbrengt maar dat functionele belemmeringen 
kunnen blijven bestaan. Bij patiënten met een cluster A of B PS blijken de verschillen 
tussen de modaliteiten of doseringen klein en over het algemeen niet significant op 
de lange termijn. Voor patiënten met een cluster C PS of PSNAO blijkt een kortdurende 
klinische behandeling (STIP-TA) de meest effectieve en kosteneffectieve behandeling te 
zijn, zowel op de korte als lange termijn. Dit specifieke behandelprogramma verdient 
dan ook meer klinische en wetenschappelijke aandacht. Vanuit een klinisch perspectief, 
zou STIP-TA een interessante optie zijn om in elke behandeltoewijzing te overwegen 
bij patiënten met een cluster C en PSNAO. Vanuit een wetenschappelijk perspectief 
kan het lonend zijn om de (kosten-) effectiviteit van STIP-TA te vergelijken met erkende 
en gerenommeerde, evidence-based behandelopties voor deze doelpopulatie. In het 
algemeen blijkt uit dit proefschrift de behoefte aan meer studies naar de vraag welke 
behandeling voor wie werkt, studies naar de effectieve bestanddelen van psychothera-
pie in PS patiënten en studies naar de mogelijke integratie van behandeltechnieken. De 
Sceptre studie heeft de kennis over zowel de effectiviteit als ook de kosteneffectiviteit 
van psychotherapie bij patiënten met een persoonlijkheidsstoornis vergroot en kan als 
voorbeeld dienen voor pragmatisch wetenschappelijk onderzoek.
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